Learn how NEJM.org uses cookies at the Cookie Information page.

Original Article

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Paul M. Ridker, M.D., Mary Cushman, M.D., Meir J. Stampfer, M.D., Russell P. Tracy, Ph.D., and Charles H. Hennekens, M.D.

N Engl J Med 1997; 336:973-979April 3, 1997DOI: 10.1056/NEJM199704033361401

Abstract

Background

Inflammation may be important in the pathogenesis of atherothrombosis. We studied whether inflammation increases the risk of a first thrombotic event and whether treatment with aspirin decreases the risk.

Methods

We measured plasma C-reactive protein, a marker for systemic inflammation, in 543 apparently healthy men participating in the Physicians' Health Study in whom myocardial infarction, stroke, or venous thrombosis subsequently developed, and in 543 study participants who did not report vascular disease during a follow-up period exceeding eight years. Subjects were randomly assigned to receive aspirin or placebo at the beginning of the trial.

Results

Base-line plasma C-reactive protein concentrations were higher among men who went on to have myocardial infarction (1.51 vs. 1.13 mg per liter, P<0.001) or ischemic stroke (1.38 vs. 1.13 mg per liter, P = 0.02), but not venous thrombosis (1.26 vs. 1.13 mg per liter, P = 0.34), than among men without vascular events. The men in the quartile with the highest C-reactive protein values had three times the risk of myocardial infarction (relative risk, 2.9; P<0.001) and two times the risk of ischemic stroke (relative risk, 1.9; P = 0.02) of the men in the lowest quartile. Risks were stable over long periods, were not modified by smoking, and were independent of other lipid-related and non–lipid-related risk factors. The use of aspirin was associated with significant reductions in the risk of myocardial infarction (55.7 percent reduction, P = 0.02) among men in the highest quartile but with only small, nonsignificant reductions among those in the lowest quartile (13.9 percent, P = 0.77).

Conclusions

The base-line plasma concentration of C-reactive protein predicts the risk of future myocardial infarction and stroke. Moreover, the reduction associated with the use of aspirin in the risk of a first myocardial infarction appears to be directly related to the level of C-reactive protein, raising the possibility that antiinflammatory agents may have clinical benefits in preventing cardiovascular disease.

Media in This Article

Figure 1Relative Risk (and 95 Percent Confidence Intervals) of a First Myocardial Infarction Associated with Each Increasing Quartile of Base-Line C-Reactive Protein Values, According to the Year of Study Follow-up.
Figure 2Relative Risk of a First Myocardial Infarction Associated with Base-Line Plasma Concentrations of C-Reactive Protein, Stratified According to Randomized Assignment to Aspirin or Placebo Therapy.
Article

Thrombus formation is the proximate cause of myocardial infarction, but atherosclerosis, the chief underlying cause, is a chronic disease that progresses over decades of life.1 Laboratory and pathological data support the idea that inflammation has a role in both the initiation and the progression of atherosclerosis, and antiinflammatory agents may have a role in the prevention of cardiovascular disease.2-5 However, there are few data to indicate whether inflammation increases the risk of first myocardial infarction, stroke, and venous thrombosis or whether antiinflammatory therapy decreases that risk.

C-reactive protein is an acute-phase reactant that is a marker for underlying systemic inflammation. Elevated plasma concentrations of C-reactive protein have been reported in patients with acute ischemia6 or myocardial infarction7,8 and have been found to predict recurrent ischemia among those hospitalized with unstable angina.9 C-reactive protein is also associated with a risk of myocardial infarction among patients with angina pectoris10 and with a risk of fatal coronary disease among smokers with multiple risk factors for atherosclerosis.11 However, since concentrations of C-reactive protein and other acute-phase reactants increase after acute ischemia6 and are directly related to cigarette smoking,11,12 it has been uncertain whether associations observed in previous studies of acutely ill patients9 or high-risk populations10,11 are causal or are due to short-term inflammatory changes or to interrelations with other risk factors, in particular smoking and hyperlipidemia.

To address these issues, we measured base-line plasma C-reactive protein concentrations in 1086 apparently healthy men participating in the Physicians' Health Study13,14; myocardial infarction, stroke, or venous thrombosis subsequently developed in 543. We hypothesized a priori that levels of C-reactive protein would predict the risk of myocardial infarction and stroke but not of venous thrombosis — an occlusive vascular disease generally not associated with chronic atherosclerosis. After providing base-line blood samples, study participants were randomly assigned to receive aspirin or placebo. Thus, we had the unique opportunity to evaluate directly whether aspirin, an agent with both antiplatelet and antiinflammatory properties, might modify any relation between C-reactive protein and the risk of first myocardial infarction.

Methods

Study Population and Collection of Plasma Samples

The Physicians' Health Study was a randomized, double-blind, placebo-controlled two-by-two factorial trial of aspirin and beta carotene in the primary prevention of cardiovascular disease and cancer. A total of 22,071 U.S. male physicians 40 to 84 years of age in 1982, with no history of myocardial infarction, stroke, transient ischemic attack, or cancer, were assigned to one of four treatments: 325 mg of aspirin on alternate days (Bufferin, provided by Bristol-Myers), 50 mg of beta carotene on alternate days (Lurotin, provided by BASF Corporation), both, or neither. The aspirin component of the study was terminated early, on January 25, 1988, primarily because of a statistically extreme 44 percent reduction in the risk of a first infarction in the aspirin group.13 The beta carotene component continued until the study's scheduled termination on December 31, 1995.14

Before randomization, between August 1982 and December 1984, potential participants were asked to provide base-line blood samples during a 16-week run-in period during which all subjects were given aspirin and none received placebo. Blood-collection kits, including EDTA Vacutainer tubes, were sent to participants with instructions for taking blood. Participants were asked to have their blood drawn into the EDTA tubes, centrifuge the tubes, and return the plasma (accompanied by a cold pack provided to participants) by overnight courier. The specimens were then divided into aliquots and stored at -80°C. Of the 22,071 participants in the Physicians' Health Study, 14,916 (68 percent) provided base-line plasma samples. Over the 14 years of the trial, no specimen inadvertently thawed during storage.

Confirmation of End Points and Selection of Controls

We requested hospital records (and for fatal events, death certificates and autopsy reports) for all reported cases of myocardial infarction, stroke, and venous thrombosis. The records were reviewed by a committee of physicians using standardized criteria to confirm or refute reported events. Reviewers of end points were unaware of treatment assignments.

Reported myocardial infarction was confirmed if its symptoms met World Health Organization (WHO) criteria and it was associated with either elevated plasma concentrations of enzymes or characteristic electrocardiographic changes. Silent myocardial infarctions were not included, since they could not be dated accurately. Deaths due to coronary disease were confirmed on the basis of autopsy reports, symptoms, circumstances of death, and a history of coronary disease. Reported stroke was confirmed on the basis of medical records showing a neurologic deficit of sudden or rapid onset that persisted for more than 24 hours or until death. Strokes were classified as ischemic or hemorrhagic. Computed tomographic scans were available for more than 95 percent of the confirmed strokes. Reported deep venous thrombosis was confirmed by the documentation of a positive venography study or a positive ultrasound study; deep venous thromboses documented only by impedance plethysmography or Doppler examination without ultrasound were not considered confirmed. Reported pulmonary embolism was confirmed by a positive angiogram or a completed ventilation-perfusion scan demonstrating at least two segmental perfusion defects with normal ventilation.

Each participant who provided an adequate base-line plasma sample and had a confirmed myocardial infarction, stroke, or venous thrombosis after randomization was matched with one control. Controls were participating physicians who provided base-line plasma samples and reported no cardiovascular disease at the time the patient reported his event. Controls were selected randomly from among study participants who met the matching criteria of age (±1 year), smoking status (smoking currently, smoked in the past, or never smoked), and length of time since randomization (in 6-month intervals). Using these methods, we evaluated 543 patients and 543 controls in this prospective, nested, case–control study.

Laboratory Analysis

For each patient and control, plasma collected and stored at base line was thawed and assayed for C-reactive protein by enzyme-linked immunosorbent assay (ELISA) based on purified protein and polyclonal anti–C-reactive protein antibodies (Calbiochem).15 Antibodies were used to coat microtiter-plate wells, and biotinylated C-reactive protein, together with the patient's plasma, was diluted 1:700 in assay buffer (phosphate-buffered saline with 0.1 percent Tween 20 and 1 percent bovine serum albumin). The excess was then washed off and the amount of biotinylated protein estimated by the addition of avidin–peroxidase (Vectastain, Vector Laboratories). Purified C-reactive protein was used as the standard, with protein concentrations as determined by the manufacturer. The C-reactive protein assay was standardized according to the WHO First International Reference Standard and had a sensitivity of 0.08 μg per microliter, with a standard reference range of between 0.5 and 2.5 mg per liter. Methods used to measure plasma total and high-density lipoprotein (HDL) cholesterol, triglyceride, lipoprotein(a), total homocysteine, fibrinogen, d-dimer, and endogenous tissue plasminogen activator (t-PA) antigen have been described elsewhere.16-20

Blood specimens were analyzed in blinded pairs, with the position of the patient's specimen varied at random within the pairs to reduce the possibility of systematic bias and decrease interassay variability. The mean coefficient of variation for C-reactive protein across assay runs was 4.2 percent.

Statistical Analysis

Means or proportions for base-line risk factors were calculated for patients and controls. The significance of any difference in means was tested by using Student's t-test, and the significance of any differences in proportions was tested by using the chi-square statistic. Because C-reactive protein values are skewed, median concentrations were computed and the significance of any differences in median values between patients and controls was assessed by using Wilcoxon's rank-sum test. Geometric mean concentrations of C-reactive protein were also computed after log transformation that resulted in nearly normal distribution. We used tests for trend to assess any relation of increasing C-reactive protein values with the risk of future vascular disease after dividing the sample into quartiles defined by the distribution of the control values. We obtained adjusted estimates by using conditional logistic-regression models that accounted for the matching variables and controlled for the random treatment assignment, body-mass index, diabetes, history of hypertension, and parental history of coronary artery disease. Similar models were employed to adjust for measured base-line plasma concentrations of total and HDL cholesterol, triglyceride, lipoprotein(a), t-PA antigen, fibrinogen, d-dimer, and homocysteine. To evaluate whether aspirin affected these relations, analyses were repeated for all cases of myocardial infarction occurring on or before January 25, 1988 — the date when randomized aspirin assignment was terminated. All P values are two-tailed, and confidence intervals were calculated at the 95 percent level.

Results

Table 1Table 1Base-Line Characteristics of the Study Participants. shows the base-line characteristics of the study participants. As expected, those in whom myocardial infarction subsequently developed were more likely than those who remained free of vascular disease to have a history of hypertension or hyperlipidemia or a parental history of coronary artery disease. Similarly, those in whom stroke subsequently developed were more likely to be hypertensive. Because of the matching, patients and controls were similar in age and history of smoking.

Geometric mean and median plasma concentrations of C-reactive protein at base line were significantly higher among those in whom any vascular event subsequently developed than among those who remained free of vascular disease (P<0.001). The difference between patients and controls was greatest for those in whom myocardial infarction subsequently developed (1.51 vs. 1.13 mg per liter, P<0.001), although differences were also significant for stroke (P = 0.03), particularly ischemic stroke (P = 0.02). In contrast, concentrations of C-reactive protein were not significantly higher among those in whom venous thrombosis subsequently developed (P = 0.34) (Table 2Table 2Base-Line Plasma Concentrations of C-Reactive Protein in Study Participants Who Remained Free of Vascular Disease during Follow-up (Controls) and in Those in Whom Myocardial Infarction, Stroke, or Venous Thrombosis Developed (Patients).).

The relative risk of first myocardial infarction increased significantly with each increasing quartile of base-line concentrations of C-reactive protein (P for trend across quartiles, <0.001), in such a way that the men in the highest quartile had a risk of future myocardial infarction almost three times that among those in the lowest quartile (relative risk, 2.9; 95 percent confidence interval, 1.8 to 4.6; P<0.001) (Table 3Table 3Relative Risk of Future Myocardial Infarction, Stroke, and Venous Thrombosis According to Base-Line Plasma Concentrations of C-Reactive Protein.). Similarly, men with the highest base-line C-reactive protein values had twice the risk of future ischemic stroke (relative risk, 1.9; 95 percent confidence interval, 1.1 to 3.3; P = 0.02). No significant associations were observed for venous thrombosis. The findings were similar in analyses limited to nonfatal events.

To evaluate whether increased base-line C-reactive protein values were associated with early rather than late thrombosis, we stratified the analysis of myocardial infarction according to the number of years of follow-up. The relative risk of future myocardial infarction that was associated with the highest quartile of C-reactive protein (as compared with the lowest quartile) ranged from 2.4 for events occurring in the first two years of follow-up to 3.2 for events occurring six or more years into follow-up (Table 4Table 4Relative Risk of First Myocardial Infarction Associated with the Highest Quartile of Base-Line Plasma C-Reactive Protein Concentrations as Compared with the Lowest Quartile, According to the Year of Study Follow-up.). Similarly, the relative risk of future myocardial infarction that was associated with a one-quartile change in the C-reactive protein concentration was stable over long periods (Figure 1Figure 1Relative Risk (and 95 Percent Confidence Intervals) of a First Myocardial Infarction Associated with Each Increasing Quartile of Base-Line C-Reactive Protein Values, According to the Year of Study Follow-up.).

Smokers had significantly higher median concentrations of C-reactive protein than nonsmokers (2.20 vs. 1.19 mg per liter, P<0.001). By matching patients and controls for smoking status, we minimized the potential for confounding by smoking. To assess for effect modification, however, we repeated the analyses, limiting the cohort to nonsmokers. As Table 3 also shows, the relative risk of future myocardial infarction among nonsmokers increased significantly with each increasing quartile of C-reactive protein (P for trend, <0.001). Similarly, the long-term effects of the concentration of C-reactive protein on the risk of myocardial infarction were virtually identical among nonsmokers (Table 4). Moreover, the relation between the concentration of C-reactive protein and myocardial infarction was not significantly altered in analyses that adjusted for body-mass index; the presence or absence of diabetes, hypertension, or a family history of premature coronary artery disease; and the plasma concentrations of total cholesterol, HDL cholesterol, triglycerides, lipoprotein(a), t-PA antigen, d-dimer, fibrinogen, or homocysteine (Table 5Table 5Relative Risk of Future Myocardial Infarction, According to Base-Line Plasma Concentrations of C-Reactive Protein, Adjusted for Lipid and Nonlipid Variables.).

Finally, to assess whether the beneficial effect of aspirin on the risk of myocardial infarction varied according to the base-line level of C-reactive protein, we repeated these analyses for events occurring before January 25, 1988, the date when randomized aspirin treatment was terminated.

The risk of future myocardial infarction increased with each increasing quartile of C-reactive protein values for men randomly assigned to either aspirin or placebo, and the rates of myocardial infarction were lower in the aspirin group for all quartiles of C-reactive protein (Figure 2Figure 2Relative Risk of a First Myocardial Infarction Associated with Base-Line Plasma Concentrations of C-Reactive Protein, Stratified According to Randomized Assignment to Aspirin or Placebo Therapy.). However, the magnitude of the beneficial effect of aspirin in preventing myocardial infarction was directly related to base-line levels of C-reactive protein. Specifically, randomized aspirin assignment was associated with a large and statistically significant reduction in the risk of myocardial infarction among men with base-line levels of C-reactive protein in the highest quartile (risk reduction, 55.7 percent; P = 0.02). Among those with base-line levels of C-reactive protein in the lowest quartile, however, the reduction in risk associated with aspirin was far smaller and no longer statistically significant (risk reduction, 13.9 percent; P = 0.77). These effects were linear across quartiles, so that the apparent benefit of aspirin diminished in magnitude with each decreasing quartile of inflammatory risk (Figure 2). This finding remained essentially unchanged after further adjustment for other coronary risk factors, and the interaction between assignment to the aspirin group and base-line levels of C-reactive protein (treated as a log-transformed continuous variable) was statistically significant (P = 0.048).

Discussion

These prospective data indicate that the base-line plasma concentration of C-reactive protein in apparently healthy men can predict the risk of first myocardial infarction and ischemic stroke. In addition, the risk of arterial thrombosis associated with the level of C-reactive protein was stable over long periods and was not modified by other factors, including smoking status, body-mass index, blood pressure, or the plasma concentration of total or HDL cholesterol, triglyceride, lipoprotein(a), t-PA antigen, d-dimer, fibrinogen, or homocysteine. In contrast, the benefits of aspirin in reducing the risk of a first myocardial infarction diminished significantly with decreasing concentrations of C-reactive protein — an intriguing finding, since this substance has antiinflammatory as well as antiplatelet properties. Finally, there was no significant association for venous thromboembolism, suggesting that the relation of inflammation to vascular risk may be limited to the arterial circulation.

Because blood samples were collected at base line, we can exclude the possibility that acute ischemia affected levels of C-reactive protein. Furthermore, the statistically significant associations observed were present among nonsmokers, indicating that the effect of C-reactive protein on vascular risk is not simply the result of cigarette smoking.11,12 Thus, our prospective data relating base-line levels of C-reactive protein to future risks of myocardial infarction and stroke among apparently healthy men greatly extend previous observations from studies of acutely ill patients,9 patients with symptomatic coronary disease,10 or those at high risk partly because of cigarette smoking.11 Moreover, in these data, the effects of C-reactive protein were independent of a large number of lipid-related and non–lipid-related risk factors.

The mechanism that relates the level of C-reactive protein to atherothrombosis is unclear. Previous infection with Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, or cytomegalovirus may be a source of the chronic inflammation detected by C-reactive protein.21-27 It is also possible that C-reactive protein is a surrogate for interleukin-6,28 a cellular cytokine associated with the recruitment of macrophages and monocytes into atherosclerotic plaques.29 In addition, C-reactive protein can induce monocytes to express tissue factor, a membrane glycoprotein important in initiating coagulation.30 Finally, it had been hypothesized that bronchial inflammation due to smoking was responsible for associations seen in previous studies relating C-reactive protein to vascular risk.11 In this regard, our observation that the effect of C-reactive protein is present among nonsmokers makes bronchial inflammation a less likely mechanism. Furthermore, the finding that the effects are stable over long periods suggests that short-term effects on clotting are unlikely.

Our data regarding the interrelation of C-reactive protein and aspirin merit careful consideration. In the Physicians' Health Study, aspirin reduced the risk of a first myocardial infarction by 44 percent.13 The present findings indicate that the effect of aspirin in preventing a first myocardial infarction was greatest among the men with the highest base-line C-reactive protein concentrations and that the benefit diminished significantly with decreasing concentrations of this inflammatory marker. Thus, although the antiplatelet effects of aspirin may be modified by underlying inflammation, these data also suggest the possibility that the benefit of aspirin may have been due, at least in part, to antiinflammatory effects.31 Alternatively, patients with large inflammatory burdens may have a distinct vascular mechanism leading to thrombosis that is affected differently by aspirin therapy. For example, the protective effect of aspirin may differ in the setting of plaque rupture as compared with focal endothelial erosion.32,33

The potential limitations of these data also merit consideration. First, our analyses are based on a single base-line determination that may not accurately reflect inflammatory status over long periods. Furthermore, although coefficients of variation were low, misclassification due to laboratory error cannot be ruled out. It is important to note, however, that neither of these sources of variability can account for the observed associations, since any random misclassification would bias results toward the null hypothesis. Since our study was limited to measures of C-reactive protein, other prospective studies evaluating specific cytokines, cellular adhesion molecules, and chronic infectious agents will be required to further elucidate the role of inflammation in the initiation and progression of atherosclerosis.

We draw four main conclusions from these data. First, among apparently healthy men, the base-line level of inflammation as assessed by the plasma concentration of C-reactive protein predicts the risk of a first myocardial infarction and ischemic stroke, independently of other risk factors. Second, the base-line concentration of C-reactive protein is not associated with the risk of venous thrombosis, a vascular event generally not associated with atherosclerosis. Third, C-reactive protein is not simply a short-term marker of risk, as has previously been demonstrated in patients with unstable angina,9 but is also a long-term marker of risk, even for events occurring six or more years later. This observation suggests that the effects of inflammation are probably mediated through a chronic process and excludes the possibility that undetected acute illness at base line is responsible for the observed effects. Finally, the benefits of aspirin appear to be modified by underlying inflammation — an observation that raises the possibility of antiinflammatory as well as antiplatelet effects of this agent. The latter observation also suggests the possibility that other antiinflammatory agents may have a role in preventing cardiovascular disease. Moreover, these data suggest that inflammatory markers such as C-reactive protein may provide a method of identifying people for whom aspirin is likely to be more or less effective — a hypothesis requiring direct testing in randomized trials.

Supported by grants (HL-26490, HL-34595, HL-46696, CA-34944, CA-42182, and CA-40360) from the National Institutes of Health. Dr. Ridker is supported by a Clinician Scientist Award from the American Heart Association.

Source Information

From the Divisions of Preventive Medicine (P.M.R., C.H.H.) and Cardiovascular Disease (P.M.R.) and the Channing Laboratory (M.J.S.), Department of Medicine, Brigham and Women's Hospital; the Department of Ambulatory Care and Prevention, Harvard Medical School (C.H.H.); and the Departments of Epidemiology (M.J.S., C.H.H.) and Nutrition (M.J.S.), Harvard School of Public Health — all in Boston; and the Laboratory for Clinical Biochemistry Research, University of Vermont, Burlington (M.C., R.P.T.).

Address reprint requests to Dr. Ridker at the Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave. E., Boston, MA 02215-1204.

References

References

  1. 1

    Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-250
    Full Text | Web of Science | Medline

  2. 2

    Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988;58:249-261
    Web of Science | Medline

  3. 3

    Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809
    CrossRef | Web of Science | Medline

  4. 4

    Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-469
    Full Text | Web of Science | Medline

  5. 5

    Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993;14:Suppl K:12-16
    Web of Science | Medline

  6. 6

    Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in “active“ coronary artery disease. Am J Cardiol 1990;65:168-172
    CrossRef | Web of Science | Medline

  7. 7

    de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J 1982;47:239-243
    CrossRef | Web of Science | Medline

  8. 8

    Pietila K, Harmoinen A, Hermens W, Simoons ML, Van de Werf F, Verstraete M. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J 1993;14:915-919
    CrossRef | Web of Science | Medline

  9. 9

    Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424
    Free Full Text | Web of Science | Medline

  10. 10

    Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-641
    Free Full Text | Web of Science | Medline

  11. 11

    Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-547
    Web of Science | Medline

  12. 12

    Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985;153:9-13
    CrossRef | Web of Science | Medline

  13. 13

    Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-135
    Free Full Text | Web of Science | Medline

  14. 14

    Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-1149
    Free Full Text | Web of Science | Medline

  15. 15

    Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy adults: implications for reference interval and epidemiologic methods. Clin Chem 1997;43:52-58
    Web of Science | Medline

  16. 16

    Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991;325:373-381
    Free Full Text | Web of Science | Medline

  17. 17

    Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993;270:2195-2199
    CrossRef | Web of Science | Medline

  18. 18

    Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risks of future venous thromboembolism. Circulation (in press).

  19. 19

    Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993;341:1165-1168
    CrossRef | Web of Science | Medline

  20. 20

    Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236-2240
    Web of Science | Medline

  21. 21

    Buja LM. Does atherosclerosis have an infectious etiology? Circulation 1996;94:872-873
    Web of Science | Medline

  22. 22

    Grayston JT. Chlamydia in atherosclerosis. Circulation 1993;87:1408-1409
    Web of Science | Medline

  23. 23

    Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-278
    Web of Science | Medline

  24. 24

    Thom DH, Grayston JT, Siscovick DS, Wang S-P, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72
    CrossRef | Web of Science | Medline

  25. 25

    Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA 1990;263:2204-2207
    CrossRef | Web of Science | Medline

  26. 26

    Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-439
    CrossRef | Web of Science | Medline

  27. 27

    Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-714[Erratum, BMJ 1995;311:985.]
    CrossRef | Web of Science | Medline

  28. 28

    Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 1992;35:982-984
    CrossRef | Web of Science | Medline

  29. 29

    Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-877
    Web of Science | Medline

  30. 30

    Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-520
    Web of Science | Medline

  31. 31

    Vane J. The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action. Drugs 1987;33:Suppl 1:18-27
    CrossRef | Web of Science | Medline

  32. 32

    van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44
    CrossRef | Web of Science | Medline

  33. 33

    Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-1363
    Web of Science | Medline

Citing Articles (2272)

Citing Articles

  1. 1

    Shmeylan A. Al Harbi, Hani M. Tamim, Hasan M. Al-Dorzi, Musharaf Sadat, Yaseen M. Arabi. (2016) Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study. BMC Pharmacology and Toxicology 17
    CrossRef

  2. 2

    Clementina Mesaros, Ian A. Blair. (2016) Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease. Clinical Proteomics 13:1
    CrossRef

  3. 3

    Yugandhar V. Gowrisankar, Michelle A. Clark. (2016) Angiotensin II induces interleukin-6 expression in astrocytes: Role of reactive oxygen species and NF-κB. Molecular and Cellular Endocrinology 437, 130-141
    CrossRef

  4. 4

    Regina Rückerl, Alexandra Schneider, Regina Hampel, Susanne Breitner, Josef Cyrys, Ute Kraus, Jianwei Gu, Jens Soentgen, Wolfgang Koenig, Annette Peters. (2016) Association of novel metrics of particulate matter with vascular markers of inflammation and coagulation in susceptible populations –results from a panel study. Environmental Research 150, 337-347
    CrossRef

  5. 5

    Alberto J. Lorenzatti, Brenda M. Retzlaff. (2016) Unmet needs in the management of atherosclerotic cardiovascular disease: Is there a role for emerging anti-inflammatory interventions?. International Journal of Cardiology 221, 581-586
    CrossRef

  6. 6

    Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez. (2016) Ivabradine and the anti-inflammatory effects in patients with ischemic heart disease. International Journal of Cardiology 221, 627-628
    CrossRef

  7. 7

    Robin P. Choudhury, Jacqueline S. Birks, Venkatesh Mani, Luca Biasiolli, Matthew D. Robson, Philippe L. L’Allier, Marc-Alexandre Gingras, Nadia Alie, Mary Ann McLaughlin, Craig T. Basson, Alison D. Schecter, Eric C. Svensson, Yiming Zhang, Denise Yates, Jean-Claude Tardif, Zahi A. Fayad. (2016) Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance. Journal of the American College of Cardiology 68:16, 1769-1780
    CrossRef

  8. 8

    Yang Peng, Bin Dong, Zhiqiang Wang. (2016) Overall and Gender-specific Associations between C-reactive Protein and Stroke Occurrence: A Cross-sectional Study in US. Journal of Stroke 18:3, 355-357
    CrossRef

  9. 9

    Charles C. Esenwa, Mitchell S. Elkind. (2016) Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nature Reviews Neurology 12:10, 594-604
    CrossRef

  10. 10

    Shiro Sugiura, Tsuyoshi Ito, Norihisa Koyama, Noriko Sasaki, Hiroshi Ikai, Yuichi Imanaka. (2016) Asymptomatic C-reactive protein elevation in neutropenic children. Pediatrics International
    CrossRef

  11. 11

    Finnian R. Mc Causland, Brian Claggett, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Reshma Kewalramani, Andrew S. Levey, John J.V. McMurray, Patrick Parfrey, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Toto, Marc A. Pfeffer. (2016) C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases
    CrossRef

  12. 12

    Farah Z. Dawood, Suzanne Judd, Virginia J. Howard, Nita A. Limdi, James F. Meschia, Mary Cushman, George Howard, David M. Herrington, Elsayed Z. Soliman. (2016) High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study). The American Journal of Cardiology
    CrossRef

  13. 13

    Magdalena Krintus, Marek Kozinski, Tomasz Fabiszak, Magdalena Kuligowska-Prusinska, Ewa Laskowska, Lieselotte Lennartz, Lena Nowak-Los, Jacek Kubica, Grazyna Sypniewska. (2016) Impact of lipid markers and high-sensitivity C-reactive protein on the value of the 99th percentile upper reference limit for high-sensitivity cardiac troponin I. Clinica Chimica Acta
    CrossRef

  14. 14

    Raquel López-Mejías, Fernanda Genre, Sara Remuzgo-Martínez, Carlos González-Juanatey, Montserrat Robustillo-Villarino, Javier Llorca, Alfonso Corrales, Esther Vicente, José A. Miranda-Filloy, César Magro, Beatriz Tejera-Segura, Marco A. Ramírez Huaranga, Trinitario Pina, Ricardo Blanco, Juan J. Alegre-Sancho, Enrique Raya, Verónica Mijares, Begoña Ubilla, María D. Mínguez Sánchez, Carmen Gómez-Vaquero, Alejandro Balsa, Dora Pascual-Salcedo, Francisco J. López-Longo, Patricia Carreira, Isidoro González-Álvaro, Luis Rodríguez-Rodríguez, Benjamín Fernández-Gutiérrez, Iván Ferraz-Amaro, Santos Castañeda, Javier Martín, Miguel A. González-Gay. (2016) Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis. Scientific Reports 6, 31979
    CrossRef

  15. 15

    Laurie Wideman, Douglas J. Oberlin, Sevil Sönmez, Jeffrey Labban, Michael Kenneth Lemke, Yorghos Apostolopoulos. (2016) Obesity indices are predictive of elevated C-reactive protein in long-haul truck drivers. American Journal of Industrial Medicine 59:8, 665-675
    CrossRef

  16. 16

    L. D. Horvei, G. Grimnes, K. Hindberg, E. B. Mathiesen, I. Njølstad, T. Wilsgaard, J. Brox, S. K. Braekkan, J.-B. Hansen. (2016) C-reactive protein, obesity, and the risk of arterial and venous thrombosis. Journal of Thrombosis and Haemostasis 14:8, 1561-1571
    CrossRef

  17. 17

    Esmé Jansen van Vuren, Leoné Malan, Marike Cockeran, Jacobus D. Scheepers, Woudri Oosthuizen, Nicolaas T. Malan. (2016) Fibrosis and coronary perfusion – a cardiovascular disease risk in an African male cohort: The SABPA study. Clinical and Experimental Hypertension 38:5, 482-488
    CrossRef

  18. 18

    Yong-Soo Baek, Tae-Hoon Kim, Jae-Sun Uhm, Jong-Yun Kim, Hui-Nam Pak, Moon-Hyoung Lee, Boyoung Joung. (2016) Prevalence and the clinical outcome of atrial fibrillation in patients with Autoimmune Rheumatic Disease. International Journal of Cardiology 214, 4-9
    CrossRef

  19. 19

    Y-Y Zhang, X-Z Tong, W-H Xia, W-L Xie, B-B Yu, B Zhang, L Chen, J Tao. (2016) Increased plasma neopterin levels are associated with reduced endothelial function and arterial elasticity in hypertension. Journal of Human Hypertension 30:7, 436-441
    CrossRef

  20. 20

    Ruba S. Deeb, David P. Hajjar. (2016) Repair Mechanisms in Oxidant-Driven Chronic Inflammatory Disease. The American Journal of Pathology 186:7, 1736-1749
    CrossRef

  21. 21

    Rene Cortese, Chunling Zhang, Riyue Bao, Jorge Andrade, Abdelnaby Khalyfa, Babak Mokhlesi, David Gozal. (2016) DNA Methylation Profiling of Blood Monocytes in Patients With Obesity Hypoventilation Syndrome. Chest 150:1, 91-101
    CrossRef

  22. 22

    Paulo H.N. Harada, Nancy R. Cook, David E. Cohen, Nina P. Paynter, Lynda Rose, Paul M Ridker. (2016) Relation of Alanine Aminotransferase Levels to Cardiovascular Events and Statin Efficacy. The American Journal of Cardiology 118:1, 49-55
    CrossRef

  23. 23

    Gijs W.D. Landman, Nanne Kleefstra, Klaas H. Groenier, Stephan J.L. Bakker, Geert H. Groeneveld, Henk J.G. Bilo, Kornelis J.J. van Hateren. (2016) Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27). Atherosclerosis 250, 46-51
    CrossRef

  24. 24

    Alexandra C. H. Nowakowski, Katelyn Y. Graves. (2016) Exploring Black-White Differences in the Relationship Between Inflammation and Timing of Menopause. Journal of Racial and Ethnic Health Disparities
    CrossRef

  25. 25

    Clinical Applications of Aspirin. 2016:, 263-446.
    CrossRef

  26. 26

    Dimitris Tousoulis, Evangelos Oikonomou, Evangelos K. Economou, Filippo Crea, Juan Carlos Kaski. (2016) Inflammatory cytokines in atherosclerosis: current therapeutic approaches. European Heart Journal 37:22, 1723-1732
    CrossRef

  27. 27

    David Mansouri, Arfon G. Powell, James H. Park, Donald C. McMillan, Paul G. Horgan. (2016) Long-Term Follow-Up of Patients Undergoing Resection of TNM Stage I Colorectal Cancer: An Analysis of Tumour and Host Determinants of Outcome. World Journal of Surgery 40:6, 1485-1491
    CrossRef

  28. 28

    Gerben Hulsegge, Gerrie-Cor M. Herber-Gast, Annemieke M.W. Spijkerman, H. Susan, J. Picavet, Yvonne T. van der Schouw, Stephan J.L. Bakker, Ron T. Gansevoort, Martijn E.T. Dollé, Henriette A. Smit, W.M. Monique Verschuren. (2016) Obesity and Age-Related Changes in Markers of Oxidative Stress and Inflammation Across Four Generations. Obesity 24:6, 1389-1396
    CrossRef

  29. 29

    Kenneth E. Izuora, Echezona E. Ezeanolue, Michael F. Neubauer, Civon L. Gewelber, Gayle L. Allenback, Guogen Shan, Guillermo E. Umpierrez. (2016) Changes in Inflammatory and Bone Turnover Markers After Periodontal Disease Treatment in Patients With Diabetes. The American Journal of the Medical Sciences 351:6, 589-594
    CrossRef

  30. 30

    Satoshi Kurose, Junji Iwasaka, Hiromi Tsutsumi, Yutaka Yamanaka, Hiromi Shinno, Yaeko Fukushima, Kyoko Higurashi, Masaru Imai, Izuru Masuda, Shinichi Takeda, Chuichi Kawai, Yutaka Kimura. (2016) Effect of exercise-based cardiac rehabilitation on non-culprit mild coronary plaques in the culprit coronary artery of patients with acute coronary syndrome. Heart and Vessels 31:6, 846-854
    CrossRef

  31. 31

    Michael J Kraakman, Dragana Dragoljevic, Helene L Kammoun, Andrew J Murphy. (2016) Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis. Clinical & Translational Immunology 5:5, e84
    CrossRef

  32. 32

    Rishi J. Desai, Robert J. Glynn, Shirley Wang, Joshua J. Gagne. (2016) Performance of Disease Risk Score Matching in Nested Case-Control Studies: A Simulation Study. American Journal of Epidemiology 183:10, 949-957
    CrossRef

  33. 33

    Mandana Izadpanah, Mostafa Mohammadi, Hossein Khalili, Mohammad Ali Faramarzi. (2016) Comparing effects of different routes of heparin administration on the serum biomarkers of thrombosis. Journal of Comparative Effectiveness Research 5:3, 249-257
    CrossRef

  34. 34

    Sandeep Kumar Vashist, A.G. Venkatesh, E. Marion Schneider, Christopher Beaudoin, Peter B. Luppa, John H.T. Luong. (2016) Bioanalytical advances in assays for C-reactive protein. Biotechnology Advances 34:3, 272-290
    CrossRef

  35. 35

    Peter C. Westman, Michael J. Lipinski, Dror Luger, Ron Waksman, Robert O. Bonow, Edwin Wu, Stephen E. Epstein. (2016) Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. Journal of the American College of Cardiology 67:17, 2050-2060
    CrossRef

  36. 36

    André Barbisan de Souza, Rogério T. P. Okawa, Cléverson O. Silva, Maurício G. Araújo. (2016) Short-term changes on C-reactive protein (CRP) levels after non-surgical periodontal treatment in systemically healthy individuals. Clinical Oral Investigations
    CrossRef

  37. 37

    Judith Favereau. (2016) On the analogy between field experiments in economics and clinical trials in medicine. Journal of Economic Methodology 23:2, 203-222
    CrossRef

  38. 38

    E E A Arts, C D Popa, A A Den Broeder, R Donders, A Sandoo, T Toms, S Rollefstad, E Ikdahl, A G Semb, G D Kitas, P L C M Van Riel, J Fransen. (2016) Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Annals of the Rheumatic Diseases 75:4, 674-680
    CrossRef

  39. 39

    Jorge L. Gamboa, Jessica K. Devin, Claudia E. Ramirez, Chang Yu, Hui Nian, Rhonda H. Lee, Nancy J. Brown. (2016) Comparative effects of immediate-release and extended-release aspirin on basal and bradykinin-stimulated excretion of thromboxane and prostacyclin metabolites. Pharmacology Research & Perspectives 4:2, e00221
    CrossRef

  40. 40

    Ching-Yuan Cheng, Diana Yu-Wung Yeh, Cheng-Li Lin, Chia-Hung Kao. (2016) Risk of Stroke in Patients With Spontaneous Pneumothorax. Medicine 95:16, e3375
    CrossRef

  41. 41

    Yangming Wang, Noriko Sugita, Akihiro Yoshihara, Masanori Iwasaki, Hideo Miyazaki, Kazutoshi Nakamura, Hiromasa Yoshie. (2016) PPARγ gene polymorphism, C-reactive protein level, BMI and periodontitis in post-menopausal Japanese women. Gerodontology 33:10.1111/ger.2016.33.issue-1, 44-51
    CrossRef

  42. 42

    Rui-rui Yang, Bo-cheng Lu, Tao Li, Yi-feng Du, Xiang Wang, Yan-xia Jia. (2016) The relationship between high-sensitivity C-reactive protein at admission and post stroke depression: a 6-month follow-up study. International Journal of Geriatric Psychiatry 31:10.1002/gps.v31.3, 231-239
    CrossRef

  43. 43

    Jane E S Thompson, Wayne Smith, Lisa J Ware, Carina M C Mels, Johannes M van Rooyen, Hugo W Huisman, Leone Malan, Nico T Malan, Leandi Lammertyn, Aletta E Schutte. (2016) Masked hypertension and its associated cardiovascular risk in young individuals: the African-PREDICT study. Hypertension Research 39, 158-165
    CrossRef

  44. 44

    Osmar Antonio Centurión. (2016) Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions. Cardiovascular Revascularization Medicine 17, 119-128
    CrossRef

  45. 45

    Laily Najafi, Mojtaba Malek, Ameneh Ebrahim Valojerdi, Mohammad E. Khamseh. (2016) Acute phase proteins and diabetes microvascular complications. International Journal of Diabetes in Developing Countries 36, 10-17
    CrossRef

  46. 46

    Monalisa Debnath, Shruti Agrawal, Aruna Agrawal, G.P. Dubey. (2016) Metaflammatory responses during obesity: Pathomechanism and treatment. Obesity Research & Clinical Practice 10:2, 103-113
    CrossRef

  47. 47

    C. Corinaldesi, L. Di Luigi, A. Lenzi, C. Crescioli. (2016) Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications. Journal of Endocrinological Investigation 39, 143-151
    CrossRef

  48. 48

    Phillip Vlisides, George A. Mashour. (2016) Perioperative stroke. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 63, 193-204
    CrossRef

  49. 49

    Paul M Ridker. (2016) A Test in Context. Journal of the American College of Cardiology 67:6, 712-723
    CrossRef

  50. 50

    Fang Emily Deng, Nitin Shivappa, YiFan Tang, Joshua R. Mann, James R. Hebert. (2016) Association between diet-related inflammation, all-cause, all-cancer, and cardiovascular disease mortality, with special focus on prediabetics: findings from NHANES III. European Journal of Nutrition
    CrossRef

  51. 51

    Tatjana Rundek, Ralph L. Sacco. . Prognosis after Stroke. 2016:, 234-252.e10.
    CrossRef

  52. 52

    Gabriella Passacquale, Paolo Di Giosia, Albert Ferro. (2016) The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials. Cardiovascular Research 109, 9-23
    CrossRef

  53. 53

    Tushar P. Patel, Komal Rawal, Ashim K. Bagchi, Gauri Akolkar, Nathalia Bernardes, Danielle da Silva Dias, Sarita Gupta, Pawan K. Singal. (2016) Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart Failure Reviews 21, 11-23
    CrossRef

  54. 54

    Gabriela Cobo, Abdul Rashid Qureshi, Bengt Lindholm, Peter Stenvinkel. (2016) C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care. Seminars in Dialysis 29:10.1111/sdi.2016.29.issue-1, 7-14
    CrossRef

  55. 55

    K. Schrör. (2016) Why we should not skip aspirin in cardiovascular prevention. Hämostaseologie 36, 33-43
    CrossRef

  56. 56

    Gniesha Dinwiddie, Ruth Zambrana, Lauren Doamekpor, Lenny Lopez. (2016) The Impact of Educational Attainment on Observed Race/Ethnic Disparities in Inflammatory Risk in the 2001–2008 National Health and Nutrition Examination Survey. International Journal of Environmental Research and Public Health 13, 42
    CrossRef

  57. 57

    Roger Bartrop, Thomas Buckley, Geoffrey H. Tofler. . Bereavement and the Risk of Cardiovascular Disease. 2016:, 229-246.
    CrossRef

  58. 58

    Yu-Lin Ko, Lung-An Hsu, Semon Wu, Ming-Sheng Teng, Hsin-Hua Chou. (2016) CRP and SAA1 Haplotypes Are Associated with Both C-Reactive Protein and Serum Amyloid A Levels: Role of Suppression Effects. Mediators of Inflammation 2016, 1-12
    CrossRef

  59. 59

    Shuming Li, Tong Shen, Yongshan Liang, Bo Bai, Ying Zhang. (2016) Miniscalpel-Needle Treatment Is Effective for Work-Related Neck and Shoulder Musculoskeletal Disorders. Evidence-Based Complementary and Alternative Medicine 2016, 1-9
    CrossRef

  60. 60

    Yongjing Zhou, Wei Han, Dandan Gong, Changfeng Man, Yu Fan. (2016) Hs-CRP in stroke: A meta-analysis. Clinica Chimica Acta 453, 21-27
    CrossRef

  61. 61

    R. De Caterina, E. D'Ugo, P. Libby. (2016) Inflammation and thrombosis – testing the hypothesis with anti-inflammatory drug trials. Thrombosis and Haemostasis 116:5
    CrossRef

  62. 62

    Yildiz Tutuncu, Ilhan Satman, Selda Celik, Nevin Dinccag, Kubilay Karsidag, Aysegul Telci, Sema Genc, Halim Issever, Jaakko Tuomilehto, Beyhan Omer. (2016) A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria. Journal of Diabetes Research 2016, 1-9
    CrossRef

  63. 63

    Joaquin De Haro, Silvia Bleda, Francisco Acin. (2016) C-reactive protein predicts aortic aneurysmal disease progression after endovascular repair. International Journal of Cardiology 202, 701-706
    CrossRef

  64. 64

    Leonardo De Luca, Fabrizio Tomai. . Biomarkers of Coronary Plaque Composition and Vulnerability. 2016:, 897-913.
    CrossRef

  65. 65

    Christophe Bauters, Gautier Bauters. (2016) Cœur et pollution particulaire. La Presse Médicale 45:1, 73-77
    CrossRef

  66. 66

    Matthew Y. H. Tang, Ho Cheung Shum. (2016) One-step immunoassay of C-reactive protein using droplet microfluidics. Lab Chip
    CrossRef

  67. 67

    Shokoufeh Hajsadeghi, Mandana Chitsazan, Mitra Chitsazan, Negar Salehi, Ahmad Amin, Majid Maleki, Nima Babaali, Seifollah Abdi, Maryam Mohsenian. (2015) Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention. Research in Cardiovascular Medicine 5
    CrossRef

  68. 68

    Aaron A. Phillips, Andrei V. Krassioukov. (2015) Contemporary Cardiovascular Concerns after Spinal Cord Injury: Mechanisms, Maladaptations, and Management. Journal of Neurotrauma 32, 1927-1942
    CrossRef

  69. 69

    Waqas T. Qureshi, Jamal S. Rana, Joseph Yeboah, Usama bin Nasir, Mouaz H. Al-Mallah. (2015) Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium. Current Cardiology Reports 17
    CrossRef

  70. 70

    Gabriela Querejeta Roca, Amil M. Shah. (2015) Sleep Disordered Breathing: Hypertension and Cardiac Structure and Function. Current Hypertension Reports 17
    CrossRef

  71. 71

    Ping-Hsien Chiu, Chen-Hsun Weng, Ruey-Jen Yang. (2015) Preconcentration and Separation of Mixed-Species Samples Near a Nano-Junction in a Convergent Microchannel. Sensors 15, 30704-30715
    CrossRef

  72. 72

    Julia Aulin, Agneta Siegbahn, Ziad Hijazi, Michael D. Ezekowitz, Ulrika Andersson, Stuart J. Connolly, Kurt Huber, Paul A. Reilly, Lars Wallentin, Jonas Oldgren. (2015) Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. American Heart Journal 170:6, 1151-1160
    CrossRef

  73. 73

    Xuehan Zhang, Nisha Bansal, Alan S. Go, Chi-yuan Hsu. (2015) Gastrointestinal symptoms, inflammation and hypoalbuminemia in chronic kidney disease patients: a cross-sectional study. BMC Nephrology 16:1
    CrossRef

  74. 74

    Toshihiro Onohara, Kentaro Inoue, Tadashi Furuyama, Tomokazu Ohno. (2015) Preoperative Cardiovascular Assessment and Late Cardiovascular Events after Elective Abdominal Aortic Aneurysm Repair. Annals of Vascular Surgery 29:8, 1533-1542
    CrossRef

  75. 75

    Ph. Courtet, I. Jaussent, C. Genty, A.M. Dupuy, S Guillaume, D. Ducasse, E. Olié. (2015) Increased CRP levels may be a trait marker of suicidal attempt. European Neuropsychopharmacology 25:10, 1824-1831
    CrossRef

  76. 76

    Wenche S. Borgnakke. (2015) Does Treatment of Periodontal Disease Influence Systemic Disease?. Dental Clinics of North America 59:4, 885-917
    CrossRef

  77. 77

    Wioleta Stolarek, Michał Kasprzak, Karolina Obońska, Małgorzata Ostrowska, Michał Wiciński, Aldona Kubica, Jacek Kubica, Grzegorz Grześk. (2015) Acetylsalicylic acid resistance risk factors in patients with myocardial infarction. Pharmacological Reports 67:5, 952-958
    CrossRef

  78. 78

    Lewis Winning, Christopher C. Patterson, Kathy M. Cullen, Kathryn A. Stevenson, Fionnuala T. Lundy, Frank Kee, Gerard J. Linden. (2015) The association between subgingival periodontal pathogens and systemic inflammation. Journal of Clinical Periodontology 42:10.1111/jcpe.2015.42.issue-9, 799-806
    CrossRef

  79. 79

    James MacNamara, Danny J Eapen, Arshed Quyyumi, Laurence Sperling. (2015) Novel biomarkers for cardiovascular risk assessment: current status and future directions. Future Cardiology 11, 597-613
    CrossRef

  80. 80

    David del Val Martin, Marcelo Sanmartín Fernández, Jose Luís Zamorano Gómez. (2015) Biomarkers in acute coronary syndrome. IJC Metabolic & Endocrine 8, 20-23
    CrossRef

  81. 81

    Karsten Schrör, Bernhard H. Rauch. (2015) Aspirin and lipid mediators in the cardiovascular system. Prostaglandins & Other Lipid Mediators 121, 17-23
    CrossRef

  82. 82

    C.M. Nguyen, J.W.M. Kim, V.H. Quan, B.H. Nguyen, S.D. Tran. (2015) Periodontal associations in cardiovascular diseases: The latest evidence and understanding. Journal of Oral Biology and Craniofacial Research 5:3, 203-206
    CrossRef

  83. 83

    Lawrence A. Potempa, Zhen-Yu Yao, Shang-Rong Ji, János G. Filep, Yi Wu. (2015) Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification. Biophysics Reports 1, 18-33
    CrossRef

  84. 84

    Yujie Shi, Jian Zhang, Chen Tan, Wei Xu, Qi Sun, Junxia Li. (2015) Genetic Association Studies Reporting on Variants in the C-Reactive Protein Gene and Coronary Artery Disease. Medicine 94:32, e1131
    CrossRef

  85. 85

    Sofia Vladimirovna Miklishanskaya, Tatyana N. Vlasik, Gregory I. Kheimets, Valeriy V. Kukharchuk. (2015) The possibility of reducing the Lp-PLA2 mass level using simvastatin monotherapy and combination therapy with ezetimibe. Cor et Vasa 57:4, e257-e264
    CrossRef

  86. 86

    Andreas Edsfeldt, Helena Grufman, Giuseppe Asciutto, Mihaela Nitulescu, Ana Persson, Marie Nilsson, Jan Nilsson, Isabel Gonçalves. (2015) Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques. Atherosclerosis 241:2, 443-449
    CrossRef

  87. 87

    Seung Hwan Moon, Young Seok Cho, Tae Soo Noh, Joon Young Choi, Byung-Tae Kim, Kyung-Han Lee. (2015) Carotid FDG Uptake Improves Prediction of Future Cardiovascular Events in Asymptomatic Individuals. JACC: Cardiovascular Imaging 8:8, 949-956
    CrossRef

  88. 88

    Arash Azizi, Fatemeh Sarlati, Mohsen Bidi, Leila Mansouri, Seyed Mohammad Mehdi Azaminejad, Vahid Rakhshan. (2015) Effects of smoking severity and moderate and severe periodontitis on serum C-reactive protein levels: an age- and gender-matched retrospective cohort study. Biomarkers 20, 306-312
    CrossRef

  89. 89

    Karl J Neff, Patrick K O’Donohoe, Carel W le Roux. (2015) Anti-inflammatory effects of gastric bypass surgery and their association with improvement in metabolic profile. Expert Review of Endocrinology & Metabolism 10, 435-446
    CrossRef

  90. 90

    I. Kralova Lesna, J. Rychlikova, L. Vavrova, S. Vybiral. (2015) Could Human cold adaptation decrease the risk of cardiovascular disease?. Journal of Thermal Biology
    CrossRef

  91. 91

    Peter Alagona, Tariq Ali Ahmad. (2015) Cardiovascular Disease Risk Assessment and Prevention. Medical Clinics of North America 99:4, 711-731
    CrossRef

  92. 92

    Miguel Cainzos-Achirica, Kieran Eissler, Michael J. Blaha, Roger S. Blumenthal, Seth S. Martin. (2015) Tools for Cardiovascular Risk Assessment in Clinical Practice. Current Cardiovascular Risk Reports 9
    CrossRef

  93. 93

    Eitan Kugler, Eytan Cohen, Elad Goldberg, Yuval Nardi, Amos Levi, Irit Krause, Moshe Garty, Ilan Krause. (2015) C reactive protein and long-term risk for chronic kidney disease: a historical prospective study. Journal of Nephrology 28, 321-327
    CrossRef

  94. 94

    Polona Mlakar, Barbara Salobir, Nusret Čobo, Janja Strašek, Marija Prezelj, Ana Debevc, Borut Jug, Marjeta Terčelj, Mišo Šabovič. (2015) The effect of cardioprotective diet rich with natural antioxidants on chronic inflammation and oxidized LDL during cardiac rehabilitation in patients after acute myocardial infarction. IJC Heart & Vasculature 7, 40-48
    CrossRef

  95. 95

    Lini Dong, Xiaobing Qu, Zhi Gao Hu, Xiaoli Peng, Yanjiao Wang, Qin Miao, Xiangyu Zhang. (2015) Lipoprotein-associated Phospholipase A2 is Associated with Angiographic Coronary Artery Disease and Coronary Artery Risk Factors in the Elderly. International Journal of Gerontology 9:2, 82-86
    CrossRef

  96. 96

    S. Ramm, B. Morissey, B. Hernandez, C. Rooney, S.R. Pennington, A. Mally. (2015) Application of a discovery to targeted LC–MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS/diclofenac co-administration. Toxicology 331, 100-111
    CrossRef

  97. 97

    C. H. Im, N. R. Kim, J. W. Kang, J. H. Kim, J. Y. Kang, G. B. Bae, E. J. Nam, Y. M. Kang. (2015) Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis. Rheumatology 54, 808-815
    CrossRef

  98. 98

    C. M. Rhee, G. A. Brent, C. P. Kovesdy, O. P. Soldin, D. Nguyen, M. J. Budoff, S. M. Brunelli, K. Kalantar-Zadeh. (2015) Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients. Nephrology Dialysis Transplantation 30, 724-737
    CrossRef

  99. 99

    Earl S. Ford, Timothy J. Cunningham, David M. Mannino. (2015) Inflammatory markers and mortality among US adults with obstructive lung function. Respirology 20:10.1111/resp.2015.20.issue-4, 587-593
    CrossRef

  100. 100

    Hung-Chih Pan, Wayne H.-H. Sheu, Wen-Jane Lee, Wen-Lieng Lee, Ying-Chieh Liao, Kuo-Yang Wang, I-Te Lee, Jun-Sing Wang, Kae-Woei Liang. (2015) Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study). Clinica Chimica Acta 445, 93-100
    CrossRef

  101. 101

    Chong-hui Wang, Shu-yang Zhang, Quan Fang, Zhu-jun Shen, Zhong-jie Fan, Xiao-feng Jin, Yong Zeng, Zhen-yu Liu, Hong-zhi Xie. (2015) Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction. The American Journal of the Medical Sciences 349:5, 413-420
    CrossRef

  102. 102

    Beverly Teter. . Fats and Cardiovascular Disease: The Good, the Bad, and the Ugly. 2015:, 15-30.
    CrossRef

  103. 103

    Michael N. Oda. (2015) High-density lipoprotein cholesterol. Current Opinion in Endocrinology & Diabetes and Obesity 22, 133-141
    CrossRef

  104. 104

    E. E. A. Arts, C. Popa, A. A. Den Broeder, A. G. Semb, T. Toms, G. D. Kitas, P. L. van Riel, J. Fransen. (2015) Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases 74, 668-674
    CrossRef

  105. 105

    Viviana Brito, Andrea Alcaraz, Federico Augustovski, Andrés Pichón-Riviere, Sebastián García-Martí, Ariel Bardach, Agustín Ciapponi, Analía Lopez, Daniel Comandé. (2015) Proteína C ultrasensible como factor independiente de riesgo en población con y sin antecedentes cardiovasculares. Archivos de Cardiología de México 85, 124-135
    CrossRef

  106. 106

    H.F. Jelinek, K. Khalaf, C. Robinson, S. McDonald, E. Butkowski, H.A. Al-Aubaidy, T. Wild. (2015) Oxidative stress and inflammation associated with decreased fibrinolysis as an early marker for peripheral vascular disease stratification: A clinical study. Wound Medicine 8, 24-30
    CrossRef

  107. 107

    Dileep Unnikrishnan, Jonathan Jun, Vsevolod Polotsky. (2015) Inflammation in sleep apnea: An update. Reviews in Endocrine and Metabolic Disorders 16, 25-34
    CrossRef

  108. 108

    Anna Jalkanen, Tommi Kauko, Janne O. Koskinen, Matti E. Waris, Laura Airas. (2015) Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis. Neurological Sciences 36, 441-447
    CrossRef

  109. 109

    Irfan Zeb, Matthew Budoff. (2015) Coronary Artery Calcium Screening: Does it Perform Better than Other Cardiovascular Risk Stratification Tools?. International Journal of Molecular Sciences 16, 6606-6620
    CrossRef

  110. 110

    Kenneth Izuora, Echezona Ezeanolue, Karen Schlauch, Michael Neubauer, Civon Gewelber, Guillermo Umpierrez. (2015) Impact of periodontal disease on outcomes in diabetes. Contemporary Clinical Trials 41, 93-99
    CrossRef

  111. 111

    R. David Doron, C. Marcelo Muñoz. (2015) MARCADORES CARDIACOS Y RIESGO CARDIOVASCULAR. Revista Médica Clínica Las Condes 26:2, 133-141
    CrossRef

  112. 112

    Nikolas Itaru Wada, Lisa P. Jacobson, Joseph B. Margolick, Elizabeth Crabb Breen, Bernard Macatangay, Sudhir Penugonda, Otoniel Martínez-Maza, Jay H. Bream. (2015) The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS 29, 463-471
    CrossRef

  113. 113

    Oliver Dörr, Christoph Liebetrau, Helge Möllmann, Felix Mahfoud, Sebastian Ewen, Luise Gaede, Christian Troidl, Jedrzej Hoffmann, Nikolai Busch, Gerald Laux, Jens Wiebe, Timm Bauer, Christian Hamm, Holger Nef. (2015) Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension. Clinical Research in Cardiology 104, 175-184
    CrossRef

  114. 114

    Singh-baniya Bibek, Yong Xie, Jia-jia Gao, Zhi Wang, Jing-feng Wang, Deng-feng Geng. (2015) Role of Pre-procedural C-reactive Protein Level in the Prediction of Major Adverse Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention: a Meta-analysisof Longitudinal Studies. Inflammation 38, 159-169
    CrossRef

  115. 115

    Lauren E. Wong, Anne R. Bass. (2015) Postoperative Risk of Venous Thromboembolism in Rheumatic Disease Patients. Current Rheumatology Reports 17
    CrossRef

  116. 116

    Peifeng Hu, Elizabeth H. Herningtyas, Varsha Kale, Eileen M. Crimmins, Arun R. Risbud, Heather McCreath, Jinkook Lee, John Strauss, Jennifer C. O’Brien, David E. Bloom, Teresa E. Seeman. (2015) External Quality Control for Dried Blood Spot-Based C-Reactive Protein Assay: Experience from the Indonesia Family Life Survey and the Longitudinal Aging Study in India. Biodemography and Social Biology 61, 111-120
    CrossRef

  117. 117

    Daniel Y. Li, W.H. Wilson Tang. . Cardiovascular Biomarker Assessment Across Glycemic Status. 2015:, 245-268.
    CrossRef

  118. 118

    T. S. Ellingsen, J. Lappegård, T. Skjelbakken, S. K. Brækkan, J.-B. Hansen. (2015) Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population. Thrombosis and Haemostasis 113, 193-200
    CrossRef

  119. 119

    Didier Ducloux, Cécile Courivaud, Jamal Bamoulid, Vincent Bisaccia, Caroline Roubiou, Thomas Crepin, Béatrice Gaugler, Caroline Laheurte, Jean-Michel Rebibou, Jean-Marc Chalopin, Philippe Saas. (2015) Alloimmune Responses and Atherosclerotic Disease After Kidney Transplantation. Transplantation 99, 220-225
    CrossRef

  120. 120

    Christian A. Gleissner, Christian Erbel, Julia Haeussler, Mohammadreza Akhavanpoor, Gabriele Domschke, Fabian Linden, Andreas O. Doesch, Göran Conradson, Sebastian J. Buss, Nina P. Hofmann, Gitsios Gitsioudis, Hugo A. Katus, Grigorios Korosoglou. (2015) Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease. Clinical Research in Cardiology 104, 13-22
    CrossRef

  121. 121

    S. Bag, J.-C. Tseng, J. Rochford. (2015) A BODIPY-luminol chemiluminescent resonance energy-transfer (CRET) cassette for imaging of cellular superoxide. Org. Biomol. Chem. 13, 1763-1767
    CrossRef

  122. 122

    Claudia Schuette, Daniel Steffens, Marco Witkowski, Caroline Stellbaum, Peter Bobbert, Heinz-Peter Schultheiss, Ursula Rauch. (2015) The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study. Cardiovascular Diabetology 14, 15
    CrossRef

  123. 123

    Eduardo Ticona, Marta E. Bull, Jaime Soria, Kenneth Tapia, Jillian Legard, Sheila M. Styrchak, Corey Williams, Caroline Mitchell, Alberto L.A. Rosa, Robert W. Coombs, Lisa M. Frenkel. (2015) Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy. AIDS 29:13, 1617
    CrossRef

  124. 124

    T. Hohlfeld, K. Schrör. (2015) Antiinflammatory effects of aspirin in ACS: relevant to its cardiocoronary actions?. Thrombosis and Haemostasis 114, 469-477
    CrossRef

  125. 125

    K. A. L. Müller, M. Chatterjee, D. Rath, T. Geisler. (2015) Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD. Thrombosis and Haemostasis 114, 498-518
    CrossRef

  126. 126

    Jacob Allen, Yi Sun, Jeffrey A. Woods. . Exercise and the Regulation of Inflammatory Responses. 2015:, 337-354.
    CrossRef

  127. 127

    Filip Málek, Dagmar Vondráková, Oxana Komendová, Dana Říhová, Jana Vránová, Lenka Sedláčková, Táňa Andreasová, Petr Neužil. (2015) Correlation of Ceruloplasmin with Biomarkers of Cardiac Remodelling and Myofibrosis in Patients with Acute Decompensated Heart Failure Referred to a Tertiary Nurse Lead Heart Failure Clinic. Open Journal of Nursing 05, 971-975
    CrossRef

  128. 128

    Junya Ota, Chie Fukaya, Shunsuke Kasai, Mayako Akamatsu, Satoru Morikawa, Junko Tagomori, Toru Eguchi, Yoshifumi Saisho, Toshihide Kawai, Hiroshi Ito, Taneaki Nakagawa. (2015) Investigation of serum antibody titers for periodontopathic bacteria in diabetic patients. Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology) 56, 414-422
    CrossRef

  129. 129

    Dawod Sharif, Mahmoud Hammoud, Amal Sharif-Rasslan, Edward Abinader, Majed Odeh. (2015) Very Early C-Reactive Protein Levels after Acute Myocardial Infarction Predict Early Outcome and Late Prognosis. International Journal of Clinical Medicine 06, 547-553
    CrossRef

  130. 130

    Michele Barone, Maria Teresa Viggiani, Annabianca Amoruso, Serafina Schiraldi, Annapaola Zito, Fiorella Devito, Francesca Cortese, Michele Gesualdo, Natale Brunetti, Alfredo Di Leo, Pietro Scicchitano, Marco Matteo Ciccone. (2015) Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection. Gastroenterology Research and Practice 2015, 1-7
    CrossRef

  131. 131

    Enrico Ammirati, Francesco Moroni, Giuseppe Danilo Norata, Marco Magnoni, Paolo G. Camici. (2015) Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis. Mediators of Inflammation 2015, 1-15
    CrossRef

  132. 132

    Paola Ballotari, Sofia Chiatamone Ranieri, Ferdinando Luberto, Stefania Caroli, Marina Greci, Paolo Giorgi Rossi, Valeria Manicardi. (2015) Sex Differences in Cardiovascular Mortality in Diabetics and Nondiabetic Subjects: A Population-Based Study (Italy). International Journal of Endocrinology 2015, 1-10
    CrossRef

  133. 133

    T.N. Kathyayani, A. Harinatha Reddy, B. Sri Lakshmi, B. Venkatappa. (2015) Neuro-endocrine immune networks leading to HIV-associated cardiovascular abnormalities: Role of leptin. HIV & AIDS Review 14:3, 53-60
    CrossRef

  134. 134

    N. C. Olson, M. Cushman, P. L. Lutsey, L. A. McClure, S. Judd, R. P. Tracy, A. R. Folsom, N. A. Zakai. (2014) Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. Journal of Thrombosis and Haemostasis 12:10.1111/jth.2014.12.issue-12, 1993-2001
    CrossRef

  135. 135

    Rosaria Greco, Cristina Tassorelli, Antonina Stefania Mangione, Giovanna Levandis, Michelangelo Certo, Giuseppe Nappi, Giacinto Bagetta, Fabio Blandini, Diana Amantea. (2014) Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia. European Journal of Pharmacology 744, 91-97
    CrossRef

  136. 136

    Amit Kumar Shrivastava, Harsh Vardhan Singh, Arun Raizada, Sanjeev Kumar Singh. (2014) C-reactive protein, inflammation and coronary heart disease. The Egyptian Heart Journal
    CrossRef

  137. 137

    K. Sarat Chandra, Manish Bansal, Tiny Nair, S.S. Iyengar, Rajeev Gupta, Subhash C. Manchanda, P.P. Mohanan, V. Dayasagar Rao, C.N. Manjunath, J.P.S. Sawhney, Nakul Sinha, A.K. Pancholia, Sundeep Mishra, Ravi R. Kasliwal, Saumitra Kumar, Unni Krishnan, Sanjay Kalra, Anoop Misra, Usha Shrivastava, Seema Gulati. (2014) Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart Journal 66, S1-S51
    CrossRef

  138. 138

    Caie Yang, Zhiqiang Sun, Yunpeng Li, Junping Ai, Qiyu Sun, Yaping Tian. (2014) The correlation between serum lipid profile with carotid intima-media thickness and plaque. BMC Cardiovascular Disorders 14:1
    CrossRef

  139. 139

    Robert H Eckel, Marc-Andre Cornier. (2014) Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Medicine 12:1
    CrossRef

  140. 140

    Reagan L. Ross, Adam W. Beck. (2014) Fibrinogen and catheter-directed thrombolysis. Seminars in Vascular Surgery 27:3-4, 182-195
    CrossRef

  141. 141

    B. Suh, S. Park, D. W. Shin, J. M. Yun, B. Keam, H.- K. Yang, E. Ahn, H. Lee, J. H. Park, B. Cho. (2014) Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Annals of Oncology 25, 2260-2266
    CrossRef

  142. 142

    Ming Hui Chen, Lauren H. Blackington, Jing Zhou, Tammy F. Chu, Kimberlee Gauvreau, Karen J. Marcus, David C. Fisher, Lisa R. Diller, Andrea K. Ng. (2014) Blood pressure is associated with occult cardiovascular disease in prospectively studied Hodgkin lymphoma survivors after chest radiation. Leukemia & Lymphoma 55, 2477-2483
    CrossRef

  143. 143

    Jesse Lieberman, David Goff, Flora Hammond, Pamela Schreiner, H. James Norton, Michael Dulin, Xia Zhou, Lyn Steffen. (2014) Dietary intake and adherence to the 2010 Dietary Guidelines for Americans among individuals with chronic spinal cord injury: A pilot study. The Journal of Spinal Cord Medicine 37, 751-757
    CrossRef

  144. 144

    Youdi He, Ning Ma, Chen Xing, Xiaoqian Wang, He Xiao, Mingke Zheng, Gencheng Han, Guojiang Chen, Chunmei Hou, Beifen Shen, Yan Li, Zhenyu Jiang, Renxi Wang, Wenli Hu. (2014) Novel IL-6-secreting γδT cells increased in patients with atherosclerotic cerebral infarction. Molecular Medicine Reports
    CrossRef

  145. 145

    A Ross Eckard, CT Longenecker, Y Jiang, SM Debanne, D Labbato, N Storer, GA McComsey. (2014) Lipoprotein-associated phospholipase A 2 and cardiovascular disease risk in HIV infection. HIV Medicine 15:10.1111/hiv.2014.15.issue-9, 537-546
    CrossRef

  146. 146

    Nida Nadeem, Jayne V. Woodside, Charlotte E. Neville, Damian O. McCall, David McCance, David Edgar, Ian S. Young, Jane McEneny. (2014) Serum amyloid A-related inflammation is lowered by increased fruit and vegetable intake, while high-sensitive C-reactive protein, IL-6 and E-selectin remain unresponsive. British Journal of Nutrition 112, 1129-1136
    CrossRef

  147. 147

    Rossella Marcucci, Serafina Valente, Anna Maria Gori, Marco Chiostri, Rita Paniccia, Betti Giusti, Vanessa Cau, Chiara Lazzeri, Gian Franco Gensini, Rosanna Abbate. (2014) Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients. Thrombosis Research 134, 884-888
    CrossRef

  148. 148

    Magdalena Krintus, Marek Kozinski, Jacek Kubica, Grazyna Sypniewska. (2014) Critical appraisal of inflammatory markers in cardiovascular risk stratification. Critical Reviews in Clinical Laboratory Sciences 51, 263-279
    CrossRef

  149. 149

    H. Montaudié, C. Albert-Sabonnadière, E. Acquacalda, E. Fontas, A. Danré, C. Roux, J.P. Ortonne, J.P. Lacour, L. Euller-Ziegler, T. Passeron. (2014) Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study. Journal of the European Academy of Dermatology and Venereology 28:10.1111/jdv.2014.28.issue-9, 1186-1191
    CrossRef

  150. 150

    Hugo del Castillo-Carnevali, Vivencio Barrios Alonso, José Luis Zamorano Gómez. (2014) Antiagregación: resistencia a fármacos tradicionales y papel de los nuevos antiplaquetarios. Medicina Clínica 143, 222-229
    CrossRef

  151. 151

    Hidetoshi Takahashi, Shin Iinuma, Masaru Honma, Hajime Iizuka. (2014) Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease. The Journal of Dermatology, n/a-n/a
    CrossRef

  152. 152

    Enrica Golia, Giuseppe Limongelli, Francesco Natale, Fabio Fimiani, Valeria Maddaloni, Ivana Pariggiano, Renatomaria Bianchi, Mario Crisci, Ludovica D’Acierno, Roberto Giordano, Gaetano Di Palma, Marianna Conte, Paolo Golino, Maria Giovanna Russo, Raffaele Calabrò, Paolo Calabrò. (2014) Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target. Current Atherosclerosis Reports 16
    CrossRef

  153. 153

    May A. Beydoun, Michael A. Nalls, J. Atilio Canas, Michele K. Evans, Alan B. Zonderman. (2014) Gene polymorphisms and gene scores linked to low serum carotenoid status and their associations with metabolic disturbance and depressive symptoms in African-American adults. British Journal of Nutrition 112, 992-1003
    CrossRef

  154. 154

    Alparslan Turan, Brian D. Hesler, Jing You, Leif Saager, Martin Grady, Ryu Komatsu, Andrea Kurz, Daniel I. Sessler. (2014) The Association of Serum Vitamin D Concentration with Serious Complications After Noncardiac Surgery. Anesthesia & Analgesia 119, 603-612
    CrossRef

  155. 155

    André J. Tremblay, Benoît Lamarche, Carolyn F. Deacon, S. John Weisnagel, Patrick Couture. (2014) Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes. Metabolism 63, 1141-1148
    CrossRef

  156. 156

    Paul S. Bhella, Jeffrey L. Hastings, Naoki Fujimoto, Shigeki Shibata, Graeme Carrick-Ranson, M. Dean Palmer, Kara N. Boyd, Beverley Adams-Huet, Benjamin D. Levine. (2014) Impact of Lifelong Exercise “Dose” on Left Ventricular Compliance and Distensibility. Journal of the American College of Cardiology 64:12, 1257-1266
    CrossRef

  157. 157

    J. Dwivedi, S. Sutcliffe, L. Easterbrook, C. Woods, G.P. Maguire. (2014) Predicting Coronary Heart Disease in Remote Settings: A Prospective, Cross-sectional Observational Study. Heart, Lung and Circulation 23, 737-742
    CrossRef

  158. 158

    Magdalena Herová, Mattia Schmid, Claudio Gemperle, Christa Loretz, Martin Hersberger. (2014) Low dose aspirin is associated with plasma chemerin levels and may reduce adipose tissue inflammation. Atherosclerosis 235, 256-262
    CrossRef

  159. 159

    Shikhar Agarwal, Haala Rokadia, Todd Senn, Venu Menon. (2014) Burden of Cardiovascular Disease in Chronic Obstructive Pulmonary Disease. American Journal of Preventive Medicine 47, 105-114
    CrossRef

  160. 160

    Michael V. Fedewa, Bhibha M. Das, Ronald L. Forehand, Ellen M. Evans. (2014) Area-Level Socioeconomic Status, Adiposity, Physical Activity, and Inflammation in Young Adults, 2013. Preventing Chronic Disease 11
    CrossRef

  161. 161

    Trygve Sørdahl Hall, Tobias Erik Herrscher, Petr Jarolim, Morten Wang Fagerland, Torstein Jensen, Stefan Agewall, Dan Atar, Jonas Hallén. (2014) Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea. Sleep Medicine 15, 762-768
    CrossRef

  162. 162

    M. M. Azuma, R. O. Samuel, J. E. Gomes-Filho, E. Dezan-Junior, L. T. A. Cintra. (2014) The role of IL-6 on apical periodontitis: a systematic review. International Endodontic Journal 47:10.1111/iej.2014.47.issue-7, 615-621
    CrossRef

  163. 163

    Huseyin Korkmaz, Fatih Sahin, Suleyman H. Ipekci, Tuncer Temel, Levent Kebapcilar. (2014) Increased pulse wave velocity and relationship with inflammation, insulin, and insulin resistance in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 26, 725-732
    CrossRef

  164. 164

    Jennifer K. Bendall, Gillian Douglas, Eileen McNeill, Keith M. Channon, Mark J. Crabtree. (2014) Tetrahydrobiopterin in Cardiovascular Health and Disease. Antioxidants & Redox Signaling 20, 3040-3077
    CrossRef

  165. 165

    S. C. Kim, J. Liu, D. H. Solomon. (2014) The risk of atrial fibrillation in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 73, 1091-1095
    CrossRef

  166. 166

    E. Kozarov, T. Padro, L. Badimon. (2014) View of statins as antimicrobials in cardiovascular risk modification. Cardiovascular Research 102, 362-374
    CrossRef

  167. 167

    J. Liu, J. Yuen, S. Kang. (2014) Sleep duration, C-reactive protein and risk of incident coronary heart disease – results from the Framingham Offspring Study. Nutrition, Metabolism and Cardiovascular Diseases 24, 600-605
    CrossRef

  168. 168

    Kai-Ting Chang, Hsu-Shien Shu, Chun-Yuan Chu, Wen-Hsien Lee, Po-Chao Hsu, Ho-Ming Su, Tsung-Hsien Lin, Wen-Chol Voon, Wen-Ter Lai, Sheng-Hsiung Sheu. (2014) Association between C-reactive protein, corrected QT interval and presence of QT prolongation in hypertensive patients. The Kaohsiung Journal of Medical Sciences 30, 310-315
    CrossRef

  169. 169

    Yali Zhang, Leping Zhao, Jianzhang Wu, Xin Jiang, Lili Dong, Fengli Xu, Peng Zou, Yuanrong Dai, Xiaoou Shan, Shulin Yang, Guang Liang. (2014) Synthesis and Evaluation of a Series of Novel Asymmetrical Curcumin Analogs for the Treatment of Inflammation. Molecules 19, 7287-7307
    CrossRef

  170. 170

    P. M. Ridker, T. F. Luscher. (2014) Anti-inflammatory therapies for cardiovascular disease. European Heart Journal
    CrossRef

  171. 171

    Alessandro Mor, Philip Omotosho, Alfonso Torquati. (2014) Cardiovascular risk in obese diabetic patients is significantly reduced one year after gastric bypass compared to one year of diabetes support and education. Surgical Endoscopy
    CrossRef

  172. 172

    Amirhossein Sahebkar. (2014) Are Curcuminoids Effective C-Reactive Protein-Lowering Agents in Clinical Practice? Evidence from a Meta-Analysis. Phytotherapy Research 28:10.1002/ptr.v28.5, 633-642
    CrossRef

  173. 173

    Arti Shah, Alka M. Kanaya. (2014) Diabetes and Associated Complications in the South Asian Population. Current Cardiology Reports 16
    CrossRef

  174. 174

    Andrew J. Sinnamon, Elizabeth M. Sonnenberg, Edmund K. Bartlett, Chelsey K. Meise, Grace J. Wang, Rachel R. Kelz. (2014) The influence of socioeconomic factors on gender disparities in lower extremity bypass. Journal of Surgical Research 188, 537-544
    CrossRef

  175. 175

    Po-yuan Wu, Cheng-Li Lin, Fung-Chang Sung, Tzu-Chieh Chou, Yuan-Teh Lee. (2014) Increased risk of cardiovascular events in patients with herpes zoster: A population-based study. Journal of Medical Virology 86:10.1002/jmv.v86.5, 772-777
    CrossRef

  176. 176

    Jung Hye Sung, Jae Eun Lee, Tandaw E. Samdarshi, Harsha S. Nagarajarao, Jason K. Taylor, Khushboo K. Agrawal, Herman A. Taylor, Ervin R. Fox. (2014) C-reactive protein and subclinical cardiovascular disease among African−Americans. Journal of Cardiovascular Medicine 15:5, 371-376
    CrossRef

  177. 177

    Ingy M. Hashad, Mohamed F. Abdel Rahman, Sahar M. Abdel-Maksoud, Khalda S. Amr, Laila K. Effat, Gamal M. Shaban, Mohamed Z. Gad. (2014) C242T polymorphism of NADPH oxidase p22phox gene reduces the risk of coronary artery disease in a random sample of Egyptian population. Molecular Biology Reports 41, 2281-2286
    CrossRef

  178. 178

    Stacy A. Voils, Rhonda M. Cooper-DeHoff. (2014) Association between high sensitivity C-reactive protein and metabolic syndrome in subjects completing the National Health and Nutrition Examination Survey (NHANES) 2009–10. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 8, 88-90
    CrossRef

  179. 179

    S. Mitchell Harman. (2014) Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum. Fertility and Sterility 101, 887-897
    CrossRef

  180. 180

    Celestina Barbosa-Leiker, Virginia Roper, Sterling McPherson, Ming Lei, Bruce Wright, Trynke Hoekstra, Marylynne Kostick. (2014) Cross-sectional and Longitudinal Relationships between Perceived Stress and C-reactive Protein in Men and Women. Stress and Health 30:10.1002/smi.v30.2, 158-165
    CrossRef

  181. 181

    Jesse Lieberman, David Goff, Jr, Flora Hammond, Pamela Schreiner, H. Norton, Michael Dulin, Xia Zhou, Lyn Steffen. (2014) Dietary Intake Relative to Cardiovascular Disease Risk Factors in Individuals With Chronic Spinal Cord Injury: A Pilot Study. Topics in Spinal Cord Injury Rehabilitation 20, 127-136
    CrossRef

  182. 182

    David Heber, Susanne Henning. . Biomarkers of Inflammation and the Western Diet. 2014:, 53-66.
    CrossRef

  183. 183

    Anagha Sen, Patrick Most, Karsten Peppel. (2014) Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunction. FEBS Letters 588, 906-914
    CrossRef

  184. 184

    P. M. Ridker. (2014) Targeting inflammatory pathways for the treatment of cardiovascular disease. European Heart Journal 35, 540-543
    CrossRef

  185. 185

    Jaelim Cho, Yoon Jung Choi, Mina Suh, Jungwoo Sohn, Hyunsoo Kim, Seong-Kyung Cho, Kyoung Hwa Ha, Changsoo Kim, Dong Chun Shin. (2014) Air pollution as a risk factor for depressive episode in patients with cardiovascular disease, diabetes mellitus, or asthma. Journal of Affective Disorders 157, 45-51
    CrossRef

  186. 186

    Polona Mlakar, Barbara Salobir, Nusret Čobo, Borut Jug, Marjeta Terčelj, Mišo Šabovič. (2014) The Effect of Short-Term Cardiac Rehabilitation After Acute Myocardial Infarction on High-Sensitivity C-Reactive Protein. Metabolic Syndrome and Related Disorders 12, 149-155
    CrossRef

  187. 187

    Maria Giulia Marini, Chiara Sonnino, Marco Previtero, Luigi M. Biasucci. (2014) Targeting Inflammation: Impact on Atherothrombosis. Journal of Cardiovascular Translational Research 7, 9-18
    CrossRef

  188. 188

    Enrico Vizzardi, Eleftheria Trichaki, Ivano Bonadei, Edoardo Sciatti, Francesca Salghetti, Riccardo Raddino, Marco Metra. (2014) Elastic Aortic Properties in Patients with X Syndrome. Heart, Lung and Circulation 23, 114-118
    CrossRef

  189. 189

    Alaa A. Sabry, Eid M. Elshafey, Khalid Alsaran, Medhat Shalaby, Sherrine Alsherbeiny, Mohamed Abdelkader. (2014) The level of C-reactive protein in chronic hemodialysis patients: A comparative study between patients with noninfected catheters and arteriovenous fistula in two large Gulf hemodialysis centers. Hemodialysis International, n/a-n/a
    CrossRef

  190. 190

    Stephen T. Sinatra, Beverly B. Teter, Jonny Bowden, Mark C. Houston, Miguel A. Martinez-Gonzalez. (2014) The Saturated Fat, Cholesterol, and Statin Controversy A Commentary. Journal of the American College of Nutrition 33, 79-88
    CrossRef

  191. 191

    Ehimare Akhabue, Jeffrey Thiboutot, Jeh-wei Cheng, Stamatios Lerakis, Timothy J. Vittorio, Georgios Christodoulidis, Kathleen M. Grady, Constantine E. Kosmas. (2014) New and Emerging Risk Factors for Coronary Heart Disease. The American Journal of the Medical Sciences 347:2, 151-158
    CrossRef

  192. 192

    Ulrich Müller. . Immunologie. 2014:, 63-103.
    CrossRef

  193. 193

    Robert J. Myerburg, Agustin Castellanos. . Sudden Cardiac Death in Adults. 2014:, 981-991.
    CrossRef

  194. 194

    Jörg Eberhard, Meike Stiesch, Arno Kerling, Christoph Bara, Christine Eulert, Denise Hilfiker-Kleiner, Andres Hilfiker, Eva Budde, Johann Bauersachs, Momme Kück, Axel Haverich, Anette Melk, Uwe Tegtbur. (2014) Moderate and severe periodontitis are independent risk factors associated with low cardiorespiratory fitness in sedentary non-smoking men aged between 45 and 65 years. Journal of Clinical Periodontology 41:10.1111/jcpe.2013.41.issue-1, 31-37
    CrossRef

  195. 195

    Michael A. Seidman, Richard N. Mitchell, James R. Stone. . Pathophysiology of Atherosclerosis. 2014:, 221-237.
    CrossRef

  196. 196

    Stephanie McCarty, William Frishman. (2014) Interleukin 1β. Cardiology in Review 22, 176-181
    CrossRef

  197. 197

    Georgios Christodoulidis, Timothy J. Vittorio, Marat Fudim, Stamatios Lerakis, Constantine E. Kosmas. (2014) Inflammation in Coronary Artery Disease. Cardiology in Review 22, 279-288
    CrossRef

  198. 198

    Bo Bae Kim, Won Joo Im, Ju Young Byun, Hyung Min Kim, Min-Gon Kim, Yong-Beom Shin. (2014) Label-free CRP detection using optical biosensor with one-step immobilization of antibody on nitrocellulose membrane. Sensors and Actuators B: Chemical 190, 243-248
    CrossRef

  199. 199

    S Yilmaz, G Celik, SE Esmen. (2014) Assessment of arterial stiffness in patients with inactive and active Behçet’s disease. Scandinavian Journal of Rheumatology 43, 63-69
    CrossRef

  200. 200

    Jianmin Fan, Wen Zhang, Qiming Liu. (2014) Human Cytomegalovirus-Encoded miR-US25-1 Aggravates the Oxidised Low Density Lipoprotein-Induced Apoptosis of Endothelial Cells. BioMed Research International 2014, 1-13
    CrossRef

  201. 201

    Tomofumi Misaka, Satoshi Suzuki, Nobuo Sakamoto, Takayoshi Yamaki, Koichi Sugimoto, Hiroyuki Kunii, Kazuhiko Nakazato, Shu-ichi Saitoh, Tatsuya Sawamura, Toshiyuki Ishibashi, Yasuchika Takeishi. (2014) Significance of Soluble Lectin-Like Oxidized LDL Receptor-1 Levels in Systemic and Coronary Circulation in Acute Coronary Syndrome. BioMed Research International 2014, 1-7
    CrossRef

  202. 202

    Michael Torzewski, Ahmed Bilal Waqar, Jianglin Fan. (2014) Animal Models of C-Reactive Protein. Mediators of Inflammation 2014, 1-7
    CrossRef

  203. 203

    Juan Salazar, María Sofía Martínez, Mervin Chávez, Alexandra Toledo, Roberto Añez, Yaquelín Torres, Vanessa Apruzzese, Carlos Silva, Joselyn Rojas, Valmore Bermúdez. (2014) C-Reactive Protein: Clinical and Epidemiological Perspectives. Cardiology Research and Practice 2014, 1-10
    CrossRef

  204. 204

    Christos Rammos, Ulrike B. Hendgen-Cotta, Julia Pohl, Matthias Totzeck, Peter Luedike, Volker T. Schulze, Malte Kelm, Tienush Rassaf. (2014) Modulation of Circulating Macrophage Migration Inhibitory Factor in the Elderly. BioMed Research International 2014, 1-8
    CrossRef

  205. 205

    Junzhen Wu, Shijin Xia, Bill Kalionis, Wenbin Wan, Tao Sun. (2014) The Role of Oxidative Stress and Inflammation in Cardiovascular Aging. BioMed Research International 2014, 1-13
    CrossRef

  206. 206

    Frederik Strang, Heribert Schunkert. (2014) C-Reactive Protein and Coronary Heart Disease: All Said—Is Not It?. Mediators of Inflammation 2014, 1-7
    CrossRef

  207. 207

    Sophie J Crinion, Walter T McNicholas. (2013) Sleep-related disorders in chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine, 1-10
    CrossRef

  208. 208

    Thomas Buckley, Geoffrey Tofler, Holly G. Prigerson. (2013) Posttraumatic Stress Disorder as a Risk Factor for Cardiovascular Disease: A Literature Review and Proposed Mechanisms. Current Cardiovascular Risk Reports 7, 506-513
    CrossRef

  209. 209

    Mahesh J. Patel, Michael A. Blazing. (2013) Inflammation and Atherosclerosis: Disease Modulating Therapies. Current Treatment Options in Cardiovascular Medicine 15, 681-695
    CrossRef

  210. 210

    Livia S. A. Augustin. (2013) Glycaemic index in chronic disease. Nutrafoods 12, 117-125
    CrossRef

  211. 211

    Benjamin I. Goldstein, L. Trevor Young. (2013) Toward Clinically Applicable Biomarkers in Bipolar Disorder: Focus on BDNF, Inflammatory Markers, and Endothelial Function. Current Psychiatry Reports 15
    CrossRef

  212. 212

    Yacov Shacham, Yan Topilsky, Eran Leshem-Rubinow, Yaron Arbel, Eyal Ben Assa, Gad Keren, Arie Roth, Arie Steinvil. (2013) Association between C-reactive protein level and echocardiography assessed left ventricular function in first ST-segment elevation myocardial infarction patients who underwent primary coronary intervention. Journal of Cardiology
    CrossRef

  213. 213

    Yu-Jen Su, Shang-Chih Liao, Ben-Chung Cheng, Jyh-Chang Hwang, Jin-Bor Chen. (2013) Increasing high-sensitive C-reactive protein level predicts peritonitis risk in chronic peritoneal dialysis patients. BMC Nephrology 14:1
    CrossRef

  214. 214

    KunYing Zhang, YinHui Li, XuYang Cheng, Li Liu, WenYing Bai, WeiYa Guo, LeiYun Wu, Li Zuo. (2013) Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients. BMC Nephrology 14:1
    CrossRef

  215. 215

    Chiranjib Chakraborty, Alok Agrawal. (2013) Computational Analysis of C-Reactive Protein for Assessment of Molecular Dynamics and Interaction Properties. Cell Biochemistry and Biophysics 67, 645-656
    CrossRef

  216. 216

    Daniel P. Potaczek. (2013) Links between allergy and cardiovascular or hemostatic system. International Journal of Cardiology
    CrossRef

  217. 217

    Michael Fiechter, Jelena R. Ghadri, Milosz Jaguszewski, Asim Siddique, Severin Vogt, Raphael B. Haller, Robin Halioua, Armin Handzic, Philipp A. Kaufmann, Roberto Corti, Thomas F. Lüscher, Christian Templin. (2013) Impact of inflammation on adverse cardiovascular events in patients with acute coronary syndromes. Journal of Cardiovascular Medicine 14:11, 807-814
    CrossRef

  218. 218

    Paolo Calabro, Enrica Golia, Valeria Maddaloni, Giuseppe Limongelli, Brunella Ziello, Fabio Fimiani, Ilaria Jane Romano, Mario Crisci, Maria Giovanna Russo, Edward T.H. Yeh, Raffaele Calabro. . Obesity, Inflammation, and Vascular Disease: Novel Insight in the Role of Adipose Tissue. 2013:, 311-326.
    CrossRef

  219. 219

    Ayman A. Hussein, John S. Gottdiener, Traci M. Bartz, Nona Sotoodehnia, Christopher DeFilippi, Vincent See, Rajat Deo, David Siscovick, Phyllis K. Stein, Donald Lloyd-Jones. (2013) Inflammation and sudden cardiac death in a community-based population of older adults: The Cardiovascular Health Study. Heart Rhythm 10, 1425-1432
    CrossRef

  220. 220

    Na Wu, Bin Xu, Ying Xiang, Long Wu, Yao Zhang, Xiangyu Ma, Shifei Tong, Maoqing Shu, Zhiyuan Song, Yafei Li, Li Zhong. (2013) Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis. International Journal of Cardiology 169, 62-72
    CrossRef

  221. 221

    E. J. Heyer, J. L. Mergeche, S. S. Bruce, E. S. Connolly. (2013) Inflammation and Cognitive Dysfunction in Type 2 Diabetic Carotid Endarterectomy Patients. Diabetes Care 36, 3283-3286
    CrossRef

  222. 222

    Wolfgang Koenig. (2013) High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy. International Journal of Cardiology 168, 5126-5134
    CrossRef

  223. 223

    Omayma Alshaarawy, Motao Zhu, Alan Ducatman, Baqiyyah Conway, Michael E. Andrew. (2013) Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in men. Environmental Research 126, 98-104
    CrossRef

  224. 224

    Tawfiq Almadi, Ian Cathers, Chin Moi Chow. (2013) Associations among work-related stress, cortisol, inflammation, and metabolic syndrome. Psychophysiology 50:10.1111/psyp.2013.50.issue-9, 821-830
    CrossRef

  225. 225

    H. Grufman, I. Gonçalves, A. Edsfeldt, M. Nitulescu, A. Persson, M. Nilsson, J. Nilsson. (2013) Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques. Journal of Internal Medicine, n/a-n/a
    CrossRef

  226. 226

    Gjin Ndrepepa, Siegmund Braun, Salvatore Cassese, Massimiliano Fusaro, Lamin King, Adnan Kastrati, Roland Schmidt. (2013) C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention. Cardiovascular Revascularization Medicine 14, 264-269
    CrossRef

  227. 227

    Suganthi Remya, Anitha Madhusoodhanan Chikku, Raveendran Saraswathy Renjith, Sakunthala Arunima, Thankappan Rajamohan. (2013) Coconut kernel protein in diet protects the heart by beneficially modulating endothelial nitric oxide synthase, tumor necrosis factor-alpha, and nuclear factor-kappaB expressions in experimental myocardial infarction. Journal of Food and Drug Analysis 21:3, 325-331
    CrossRef

  228. 228

    A. N. Kiani, H. Fang, L. S. Magder, M. Petri. (2013) Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology
    CrossRef

  229. 229

    Wiebke Fenske, Thanos Athanasiou, Leanne Harling, Christiane Drechsler, Ara Darzi, Hutan Ashrafian. (2013) Obesity-related cardiorenal disease: the benefits of bariatric surgery. Nature Reviews Nephrology 9, 539-551
    CrossRef

  230. 230

    Dimitris Tousoulis, Emmanuel Androulakis, Nikolaos Papageorgiou. . C-Reactive Protein in Cardiovascular Disease. 2013:, 3-18.
    CrossRef

  231. 231

    M L Vetter, T A Wadden, C Vinnard, R H Moore, Z Khan, S Volger, D B Sarwer, L F Faulconbridge. (2013) Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. International Journal of Obesity 37, S38-S43
    CrossRef

  232. 232

    Daniel H. Solomon, Jeffrey R. Curtis, Kenneth G. Saag, Joyce Lii, Lang Chen, Leslie R. Harrold, Lisa J. Herrinton, David J. Graham, Mary K. Kowal, Bindee Kuriya, Liyan Liu, Marie R. Griffin, James D. Lewis, Jeremy A. Rassen. (2013) Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs. The American Journal of Medicine 126, 730.e9-730.e17
    CrossRef

  233. 233

    J. Guo, L. Yu, J. Zhang, N. Chen, M. Zhou, L. He. (2013) CRP gene polymorphism predicts post-stroke functional outcome in Han Chinese. Acta Neurologica Scandinavica, n/a-n/a
    CrossRef

  234. 234

    Brendan M. Everett, Aruna D. Pradhan, Daniel H. Solomon, Nina Paynter, Jean MacFadyen, Elaine Zaharris, Milan Gupta, Michael Clearfield, Peter Libby, Ahmed A.K. Hasan, Robert J. Glynn, Paul M. Ridker. (2013) Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis. American Heart Journal 166, 199-207.e15
    CrossRef

  235. 235

    Sara R. Schoenfeld, Shanthini Kasturi, Karen H. Costenbader. (2013) The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Seminars in Arthritis and Rheumatism 43, 77-95
    CrossRef

  236. 236

    G. L. Renju, G. Muraleedhara Kurup, C. H. Saritha Kumari. (2013) Effect of lycopene from Chlorella marina on high cholesterol-induced oxidative damage and inflammation in rats. Inflammopharmacology
    CrossRef

  237. 237

    Victoria P Tan, Alvin Chung, Bryan P Yan, Peter R Gibson. (2013) Venous and arterial disease in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 28:10.1111/jgh.2013.28.issue-7, 1095-1113
    CrossRef

  238. 238

    Naoko Nishitani, Hisataka Sakakibara. (2013) Association between body mass index and high-sensitivity C-reactive protein in male Japanese. Obesity Research & Clinical Practice 7, e297-e300
    CrossRef

  239. 239

    Marc S Penn, Andrea B Klemes. (2013) Multimarker approach for identifying and documenting mitigation of cardiovascular risk. Future Cardiology 9, 497-506
    CrossRef

  240. 240

    Seung Joo Kang, Donghee Kim, Hyo Eun Park, Goh Eun Chung, Seung Ho Choi, Su-Yeon Choi, Whal Lee, Joo Sung Kim, Sang-Heon Cho. (2013) Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis. Atherosclerosis
    CrossRef

  241. 241

    Neil A. Harrison, Ella Cooper, Valerie Voon, Ken Miles, Hugo D. Critchley. (2013) Central autonomic network mediates cardiovascular responses to acute inflammation: Relevance to increased cardiovascular risk in depression?. Brain, Behavior, and Immunity 31, 189-196
    CrossRef

  242. 242

    Marc Y. Donath, Élise Dalmas, Nadine S. Sauter, Marianne Böni-Schnetzler. (2013) Inflammation in Obesity and Diabetes: Islet Dysfunction and Therapeutic Opportunity. Cell Metabolism 17, 860-872
    CrossRef

  243. 243

    Hirofumi Soejima, Hisao Ogawa, Takeshi Morimoto, Masafumi Nakayama, Sadanori Okada, Mio Sakuma, Shiro Uemura, Masao Kanauchi, Naofumi Doi, Hideaki Jinnouchi, Seigo Sugiyama, Masako Waki, Yoshihiko Saito. (2013) Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein level: Subanalysis from the JPAD Trial. Journal of Cardiology
    CrossRef

  244. 244

    Muhammad Saleh Salga, Hapipah Mohd Ali, Mahmood Ameen Abdulla, Siddig Ibrahim Abdelwahab, Manal Mohamed ElhassanTaha, Umar Yagoub. (2013) Synthesis and gastroprotective activities of some zinc (II) complexes derived from (E)-2-(1-(2-(piperazin-1-yl)ethylimino)ethyl)phenol and (E)-4-(1-(2-(piperazin-1-yl)ethylimino)ethyl)benzene-1,3-diol Schiff bases against aspirin induced ulceration. Arabian Journal of Chemistry
    CrossRef

  245. 245

    Jeffrey L. Anderson, Cynthia D. Adams, Elliott M. Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin, A. Michael Lincoff, Eric D. Peterson, Pierre Theroux, Nanette K. Wenger, R. Scott Wright. (2013) 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 61:23, e179-e347
    CrossRef

  246. 246

    D. Mehta, T. Klengel, K. N. Conneely, A. K. Smith, A. Altmann, T. W. Pace, M. Rex-Haffner, A. Loeschner, M. Gonik, K. B. Mercer, B. Bradley, B. Muller-Myhsok, K. J. Ressler, E. B. Binder. (2013) Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. Proceedings of the National Academy of Sciences 110, 8302-8307
    CrossRef

  247. 247

    Stephen P. Glasser, Martha K. Hovater, Daniel T. Lackland, Mary Cushman, George Howard, Virginia J. Howard. (2013) Primary Prophylactic Aspirin Use and Incident Stroke: Reasons for Geographic and Racial Differences in Stroke Study. Journal of Stroke and Cerebrovascular Diseases 22, 500-507
    CrossRef

  248. 248

    Wei C. Lau, James B. Froehlich, Elizabeth S. Jewell, Daniel G. Montgomery, Kristina M. Eng, Theresa A. Shields, Peter K. Henke, Kim A. Eagle. (2013) Impact of Adding Aspirin to Beta-Blocker and Statin in High-Risk Patients Undergoing Major Vascular Surgery. Annals of Vascular Surgery 27, 537-545
    CrossRef

  249. 249

    Omair Yousuf, Bibhu D. Mohanty, Seth S. Martin, Parag H. Joshi, Michael J. Blaha, Khurram Nasir, Roger S. Blumenthal, Matthew J. Budoff. (2013) High-sensitivity C-reactive Protein and Cardiovascular Disease: A Resolute Belief or an Elusive Link?. Journal of the American College of Cardiology
    CrossRef

  250. 250

    Giuseppe Murdaca, Francesca Spanò, Paola Cagnati, Francesco Puppo. (2013) Free radicals and endothelial dysfunction: Potential positive effects of TNF-α inhibitors. Redox Report 18, 95-99
    CrossRef

  251. 251

    Kanako Shimizu, Kana Shimomura, Yoshiaki Tokuyama, Kenzo Sakurai, Kenji Isahaya, Satoshi Takaishi, Bunta Kato, Noriko Usuki, Takahiro Shimizu, Koji Yamada, Yasuhiro Hasegawa. (2013) Association between Inflammatory Biomarkers and Progression of Intracranial Large Artery Stenosis after Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 22, 211-217
    CrossRef

  252. 252

    Dong Gyu Lee, Kwang Sun Ryu, Mohamed Bashir, Jang-Whan Bae, Keun Ho Ryu. (2013) Discovering Medical Knowledge using Association Rule Mining in Young Adults with Acute Myocardial Infarction. Journal of Medical Systems 37
    CrossRef

  253. 253

    Augustin N. Zeba, Hélène F. Delisle, Clémentine Rossier, Genevieve Renier. (2013) Association of high-sensitivity C-reactive protein with cardiometabolic risk factors and micronutrient deficiencies in adults of Ouagadougou, Burkina Faso. British Journal of Nutrition 109, 1266-1275
    CrossRef

  254. 254

    D Sharma, P DasMahapatra, C Fernandez, W Chen, S R Srinivasan, J Xu, G S Berenson. (2013) The association of c-reactive protein with arterial compliance in asymptomatic young adults: the bogalusa heart study. Journal of Human Hypertension 27, 256-260
    CrossRef

  255. 255

    Wen Ni Tiong, Edmund Ui Hang Sim, Alan Yean Yip Fong, Tiong Kiam Ong. (2013) Early detection of C-reactive protein and von Willebrand factor levels in Malaysian patients with acute coronary syndrome. Journal of Cardiovascular Disease Research 4, 3-6
    CrossRef

  256. 256

    V. Anantharaman, Swee Han Lim. (2013) Treatment of NSTEMI (Non-ST Elevation Myocardial Infarction). Current Emergency and Hospital Medicine Reports 1, 18-28
    CrossRef

  257. 257

    Ralph B. D'Agostino, Michael J. Pencina, Joseph M. Massaro, Sean Coady. (2013) Cardiovascular Disease Risk Assessment: Insights from Framingham. Global Heart 8, 11-23
    CrossRef

  258. 258

    Janna A. van Diepen, Jimmy F.P. Berbée, Louis M. Havekes, Patrick C.N. Rensen. (2013) Interactions between inflammation and lipid metabolism: Relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis
    CrossRef

  259. 259

    C. Courivaud, J. Bamoulid, J.-M. Chalopin, E. Gaiffe, P. Tiberghien, P. Saas, D. Ducloux. (2013) Cytomegalovirus Exposure and Cardiovascular Disease in Kidney Transplant Recipients. Journal of Infectious Diseases
    CrossRef

  260. 260

    Marinez Farana Matos, Dayse Maria Lourenço, Cristina Mary Orikaza, Christiane Pereira Gouveia, Vânia Maris Morelli. (2013) Abdominal Obesity and the Risk of Venous Thromboembolism Among Women: A Potential Role of Interleukin-6. Metabolic Syndrome and Related Disorders 11, 29-34
    CrossRef

  261. 261

    D Conen. (2013) Inflammation, blood pressure and cardiovascular disease: heading east. Journal of Human Hypertension 27, 71-71
    CrossRef

  262. 262

    Kazutaka Saito, Kazunori Kihara. (2013) Role of C-reactive protein in urological cancers: A useful biomarker for predicting outcomes. International Journal of Urology 20:10.1111/iju.2013.20.issue-2, 161-171
    CrossRef

  263. 263

    Khalid Al Saran, Alaa Sabry, Medhat Shalaby, Sherrine Al Sherbeiny, Mohamed Abdelkader. (2013) Level of C-Reactive Protein in Chronic Hemodialysis Patients: A Comparative Study Between Patients With Non-Infected Catheters and Arteriovenous Fistula in a Large Saudi Hemodialysis Center. Therapeutic Apheresis and Dialysis 17:10.1111/tap.2013.17.issue-1, 35-39
    CrossRef

  264. 264

    Denee T. Mwendwa, Mana K. Ali, Regina C. Sims, Angela P. Cole, Michael W. Lipscomb, Shellie-Anne Levy, Clive O. Callender, Alfonso L. Campbell. (2013) Dispositional depression and hostility are associated with inflammatory markers of cardiovascular disease in African Americans. Brain, Behavior, and Immunity 28, 72-82
    CrossRef

  265. 265

    Thomas Gremmel, Thomas Perkmann, Daniela Seidinger, Renate Koppensteiner, Simon Panzer, Christoph W Kopp, Sabine Steiner. (2013) Differential Impact of Inflammation on Six Laboratory Assays Measuring Residual Arachidonic Acid-Inducible Platelet Reactivity During Dual Antiplatelet Therapy. Journal of Atherosclerosis and Thrombosis 20, 630-645
    CrossRef

  266. 266

    K. A. Krychtiuk, S. P. Kastl, W. S. Speidl, J. Wojta. (2013) Inflammation and coagulation in atherosclerosis. Hämostaseologie 33, 269-282
    CrossRef

  267. 267

    Sook Young Kim, Won Yu Kang, Jun Ho Shin, Bo Ram Youn, Il Hyung Jung, Dong In Nam, Chung Kang, Hong Ju An, Sang Seon Lee, Ho Yeong Song, Hoon Kang, Sang Cheol Cho, Sun Ho Hwang, Wan Kim. (2013) The Inflammation Markers According to the Presence of Coronary Artery Disease in Patients with Peripheral Artery Disease. Journal of Lipid and Atherosclerosis 2, 61
    CrossRef

  268. 268

    Tamio Teramoto, Jun Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, Takafumi Hiro, Kazuhiko Hirobe, Mami Iida, Shinji Kihara, Makoto Kinoshita, Chizuko Maruyama, Takao Ohta, Tomonori Okamura, Shizuya Yamashita, Masayuki Yokode, Koutaro Yokote. (2013) Cardiovascular Disease Risk Factors Other than Dyslipidemia. Journal of Atherosclerosis and Thrombosis 20, 733-742
    CrossRef

  269. 269

    Livia Puljak. (2013) Prognostic value of low and moderately elevated C-reactive protein in acute coronary syndrome: A 2-year follow-up study. Medical Science Monitor 19, 777-786
    CrossRef

  270. 270

    Daisuke Yamazaki, Masaru Ishida, Hiroyuki Watanabe, Kiyoshi Nobori, Yasunori Oguma, Yutaka Terata, Takashi Koyama, Kenji Iino, Toshimitsu Kosaka, Hiroshi Ito. (2013) Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe. Lipids in Health and Disease 12, 9
    CrossRef

  271. 271

    Suk Jae Kim, Gyeong Joon Moon, Oh Young Bang. (2013) Biomarkers for Stroke. Journal of Stroke 15, 27
    CrossRef

  272. 272

    Suk Min Seo, Sang Hong Baek, Hui Kyung Jeon, Seok-Min Kang, Dong-Soo Kim, Woo-Shik Kim, Hyung Seop Kim, Seung Woon Rha, Jong Seon Park, In Whan Seong, Young Keun Ahn, Jung Han Yoon, Tae Joon Cha. (2013) Correlations Between the Level of High-Sensitivity C-Reactive Protein and Cardiovascular Risk Factors in Korean Adults with Cardiovascular Disease or Diabetes Mellitus: The CALLISTO Study. Journal of Atherosclerosis and Thrombosis 20, 616-622
    CrossRef

  273. 273

    Junya Ota, Chie Fukaya, Shunsuke Kasai, Mayako Akamatsu, Satoru Morikawa, Junko Tagomori, Toru Eguchi, Yoshifumi Saisho, Toshihide Kawai, Hiroshi Ito, Taneaki Nakagawa. (2013) Relationship between periodontal disease and diabetic complications. Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology) 54, 336-345
    CrossRef

  274. 274

    R. di Giuseppe, M.B. Donati, G. de Gaetano, L. Iacoviello. . The Role of Dark Chocolate on Inflammation. 2013:, 371-378.
    CrossRef

  275. 275

    Cangel Pui-yee Chan, Timothy Hudson Rainer. . Pathophysiological Roles and Clinical Importance of Biomarkers in Acute Coronary Syndrome. 2013:, 23-63.
    CrossRef

  276. 276

    Jared L. Zeff, Pamela Snider, Stephen P. Myers, Zora DeGrandpre. . A Hierarchy of Healing: The Therapeutic Order. 2013:, 18-33.
    CrossRef

  277. 277

    S Masiha, J Sundström, L Lind. (2013) Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. Journal of Human Hypertension 27, 13-17
    CrossRef

  278. 278

    Zana Sllamniku-Dalipi, Hasan Mehmeti, Fatmir Dragidella, Ferit Koçani, Metush Disha, Kastriot Meqa, Luljeta Begolli, Gramos Begolli. (2013) Elevated levels of inflammatory cytokines and high-sensitivity C-reactive protein in periodontitis patients in Kosovo: A pilot study. Open Journal of Stomatology 03, 32-38
    CrossRef

  279. 279

    Christoph Liebetrau Liebetrau. (2013) High Sensitivity CRP Predicts Long-Term Mortality in Patients with Atrial Fibrillation and Evident Acute Coronary Syndrome. International Journal of Clinical Medicine 04, 137-144
    CrossRef

  280. 280

    Etty Grad, Haim D. Danenberg. (2013) C-reactive protein and atherothrombosis: Cause or effect?. Blood Reviews 27, 23-29
    CrossRef

  281. 281

    Deborah French, Alan H.B. Wu. . Cardiac Markers. 2013:, 817-831.
    CrossRef

  282. 282

    Yifei Xu, Haiyan Lin, Ying Zhou, Gang Cheng, Geng Xu. (2013) Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients. Mediators of Inflammation 2013, 1-7
    CrossRef

  283. 283

    Sung-Goo Kang, Woo Chul Chung, Sang-Wook Song, Kyu Re Joo, Hyewon Lee, Donghoon Kang, Joune Seup Lee, Kang-Moon Lee. (2013) Risk of Atherosclerosis and Helicobacter pylori Infection according to CD14 Promotor Polymorphism in Healthy Korean Population. Gastroenterology Research and Practice 2013, 1-8
    CrossRef

  284. 284

    Qinghua Shang, Hanjay Wang, Siming Li, Hao Xu. (2013) The Effect of Sodium Tanshinone IIA Sulfate and Simvastatin on Elevated Serum Levels of Inflammatory Markers in Patients with Coronary Heart Disease: A Study Protocol for a Randomized Controlled Trial. Evidence-Based Complementary and Alternative Medicine 2013, 1-8
    CrossRef

  285. 285

    Charlotte Strandhave, My Svensson, Henrik Krarup, Jeppe Hagstrup Christensen. (2013) Haptoglobin Genotype and Risk Markers of Cardiovascular Disease in Patients with Chronic Kidney Disease. International Journal of Nephrology 2013, 1-7
    CrossRef

  286. 286

    Nikolaos A. Chrysanthakopoulos, Panagiotis A. Chrysanthakopoulos. (2013) Clinically Classified Periodontitis and Its Association in Patients with Preexisting Coronary Heart Disease. Journal of Oral Diseases 2013, 1-9
    CrossRef

  287. 287

    Heriberto Rodríguez-Hernández, Luis E. Simental-Mendía, Gabriela Rodríguez-Ramírez, Miguel A. Reyes-Romero. (2013) Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation. International Journal of Endocrinology 2013, 1-11
    CrossRef

  288. 288

    Bruna M. Mazetto, Fernanda L. Orsi, Aline Barnabé, Érich V. De Paula, Mariane C. Flores-Nascimento, Joyce M. Annichino-Bizzacchi. (2012) Increased ADAMTS13 activity in patients with venous thromboembolism. Thrombosis Research 130, 889-893
    CrossRef

  289. 289

    Giuseppe Pasquale, Stefano Urbinati, Enrica Perugini, Simona Gambetti. (2012) Interactions Between Cardiovascular and Cerebrovascular Disease. Current Treatment Options in Neurology 14, 557-593
    CrossRef

  290. 290

    Christopher D. Owens. (2012) Statins and other agents for vascular inflammation. Journal of Vascular Surgery 56, 1799-1806
    CrossRef

  291. 291

    Ahmed A. Wafa, Eid M. Daoud, Gamal F. Gomaa. (2012) The role of flow-mediated dilatation and high sensitive C-reactive protein in paroxysmal atrial fibrillation. The Egyptian Heart Journal 64, 211-217
    CrossRef

  292. 292

    Nadzeya Kuzniatsova, Eduard Shantsila, Andrew Blann, Gregory Y. H. Lip. (2012) A contemporary viewpoint on ‘aspirin resistance’. Annals of Medicine 44, 773-783
    CrossRef

  293. 293

    Arzu Didem Yalcin, Saadet Gumuslu, Gizem Esra Parlak, Atil Bisgin, Mustafa Yildiz, Aysegül Kargi, Reginald M. Gorczynski. (2012) Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis. Immunopharmacology and Immunotoxicology 34, 1047-1053
    CrossRef

  294. 294

    Eva Skaleric, Milan Petelin, Boris Gaspirc, Uros Skaleric. (2012) Periodontal inflammatory burden correlates with C-reactive protein serum level. Acta Odontologica Scandinavica 70, 520-528
    CrossRef

  295. 295

    Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel, Dorairaj Prabhakaran. (2012) Polypill (fixed-dose combination) in the prevention of cardiovascular disease: rationale and clinical data. Clinical Investigation 2, 1213-1229
    CrossRef

  296. 296

    Doroteia Silva, António Pais de Lacerda. (2012) High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease. Revista Portuguesa de Cardiologia (English Edition) 31, 733-745
    CrossRef

  297. 297

    Jean-Pierre Després. (2012) Abdominal Obesity and Cardiovascular Disease: Is Inflammation the Missing Link?. Canadian Journal of Cardiology 28, 642-652
    CrossRef

  298. 298

    Qingdi Zhu, Dieter Trau. (2012) Multiplex detection platform for tumor markers and glucose in serum based on a microfluidic microparticle array. Analytica Chimica Acta 751, 146-154
    CrossRef

  299. 299

    R. Elhage, H.-G. Ljunggren, G. K. Hansson. (2012) Proatherogenic role of interleukin-18: effects on inflammation and action on vascular cells: AUTHORS' RETROSPECTIVE. Cardiovascular Research 96, 176-180
    CrossRef

  300. 300

    P. Artemiou, N. Charokopos, E. Rouska, F. Sabol, I. Chrysogonidis, V. Tsavdaridou, G. Paschalidis. (2012) C-Reactive protein/interleukin-6 ratio as marker of the size of the uncomplicated thoracic aortic aneurysms. Interactive CardioVascular and Thoracic Surgery 15, 871-877
    CrossRef

  301. 301

    M L Jones, C J Martoni, S Prakash. (2012) Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. European Journal of Clinical Nutrition 66, 1234-1241
    CrossRef

  302. 302

    Sirin Yaemsiri, Souvik Sen, Lesley Tinker, Wayne Rosamond, Sylvia Wassertheil-Smoller, Ka He. (2012) Trans fat, aspirin, and ischemic stroke in postmenopausal women. Annals of Neurology 72:10.1002/ana.v72.5, 704-715
    CrossRef

  303. 303

    Nao Fukui, Yoshihiro Shimazaki, Takashi Shinagawa, Yoshihisa Yamashita. (2012) Periodontal Status and Metabolic Syndrome in Middle-Aged Japanese. Journal of Periodontology 83:11, 1363-1371
    CrossRef

  304. 304

    Maivel H. Ghattas, Dina M. Abo-Elmatty, Azza Z. El-Eraki. (2012) C-reactive protein 1059G/C gene polymorphism, C-reactive protein levels and acute myocardial infarction. Journal of Cardiovascular Medicine 13:11, 716-719
    CrossRef

  305. 305

    Carlo Patrono. . Aspirin. 2012:, 12-25.
    CrossRef

  306. 306

    Domenico Prisco, Caterina Cenci, Elena Silvestri, Giacomo Emmi, Tommaso Barnini, Carlo Tamburini. (2012) The risk stratification in atrial fibrillation. Internal and Emergency Medicine 7, 233-240
    CrossRef

  307. 307

    Susan P. Bell, Jennifer L. Giuseffi, Daniel E. Forman. (2012) Cardiovascular Biomarkers and Their Utility in the Older Adult. Current Cardiovascular Risk Reports 6, 397-403
    CrossRef

  308. 308

    Paul A Monach. (2012) Repeating tests: different roles in research studies and clinical medicine. Biomarkers in Medicine 6, 691-703
    CrossRef

  309. 309

    Peng-cheng Xu, Jian Hao, Xiao-wei Yang, Dong-yuan Chang, Min Chen, Ming-hui Zhao. (2012) C-reactive protein enhances the respiratory burst of neutrophils-induced by antineutrophil cytoplasmic antibody. Molecular Immunology 52, 148-154
    CrossRef

  310. 310

    Jung-Yoon Yang, Ji-Sook Nam, Hee-Jeong Choi. (2012) Association between high-sensitivity C-reactive protein with arterial stiffness in healthy Korean adults. Clinica Chimica Acta 413, 1419-1423
    CrossRef

  311. 311

    Aytekin Guven, Fatma Tolun, Mustafa Caliskan, Ozgur Ciftci, Haldun Muderrisoglu. (2012) C-reactive protein and nitric oxide level in patients with white coat hypertension. Blood Pressure 21, 281-285
    CrossRef

  312. 312

    Meng-Yueh Chien, Peilin Lee, Yuan-Feen Tsai, Pan-Chyr Yang, Ying-Tai Wu. (2012) C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea. Sleep and Breathing 16, 629-637
    CrossRef

  313. 313

    Mandar S. Joshi, Liyue Tong, Angela C. Cook, Brandon L. Schanbacher, Hong Huang, Bing Han, Leona W. Ayers, John Anthony Bauer. (2012) Increased myocardial prevalence of C-reactive protein in human coronary heart disease: direct effects on microvessel density and endothelial cell survival. Cardiovascular Pathology 21, 428-435
    CrossRef

  314. 314

    Jen-Chieh Tseng, Andrew L. Kung. (2012) In Vivo Imaging of Inflammatory Phagocytes. Chemistry & Biology 19, 1199-1209
    CrossRef

  315. 315

    Robert K McNamara, Francis E Lotrich. (2012) Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?. Expert Review of Neurotherapeutics 12, 1143-1161
    CrossRef

  316. 316

    Nitin K. Gupta, James A. de Lemos, Colby R. Ayers, Shuaib M. Abdullah, Darren K. McGuire, Amit Khera. (2012) The Relationship Between C-Reactive Protein and Atherosclerosis Differs on the Basis of Body Mass Index. Journal of the American College of Cardiology 60:13, 1148-1155
    CrossRef

  317. 317

    Hasan Kayahan, Ismail Sari, Nesat Cullu, Fahize Yuksel, Serdal Demir, Mesut Akarsu, Yigit Goktay, Belkis Unsal, Hale Akpinar. (2012) Evaluation of Early Atherosclerosis in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 57, 2137-2143
    CrossRef

  318. 318

    An H. Bui, Marc P. Bonaca, Marc S. Sabatine, Kausik K. Ray, Nader Rifai, Christopher P. Cannon, David A. Morrow. (2012) Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial. Journal of Thrombosis and Thrombolysis 34, 222-228
    CrossRef

  319. 319

    Antonio Abbate, Benjamin W. Tassell, Giuseppe G. L. Biondi-Zoccai. (2012) Blocking Interleukin-1 as a Novel Therapeutic Strategy for Secondary Prevention of Cardiovascular Events. BioDrugs 26, 217-233
    CrossRef

  320. 320

    Jade S. Hiramoto, Christopher D. Owens, Ji Min Kim, John Boscardin, Michael Belkin, Mark A. Creager, Michael S. Conte. (2012) Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts. Journal of Vascular Surgery 56, 387-395
    CrossRef

  321. 321

    Hani Jneid, Jeffrey L. Anderson, R. Scott Wright, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Theodore G. Ganiats, A. Michael Lincoff, Eric D. Peterson, George J. Philippides, Pierre Theroux, Nanette K. Wenger, James Patrick Zidar. (2012) 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update). Journal of the American College of Cardiology 60:7, 645-681
    CrossRef

  322. 322

    A. P. Doumatey, G. Chen, F. Tekola Ayele, J. Zhou, M. Erdos, D. Shriner, H. Huang, J. Adeleye, W. Balogun, O. Fasanmade, T. Johnson, J. Oli, G. Okafor, A. Amoah, B. A. Eghan, K. Agyenim-Boateng, J. Acheampong, C. Adebamowo, N. P. Gerry, M. F. Christman, A. Adeyemo, C. N. Rotimi. (2012) C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans. Human Molecular Genetics 21, 3063-3072
    CrossRef

  323. 323

    Benjamin T. Bikman. (2012) A role for sphingolipids in the pathophysiology of obesity-induced inflammation. Cellular and Molecular Life Sciences 69, 2135-2146
    CrossRef

  324. 324

    M. Girndt. (2012) Klinische Probleme der Urämie. Der Internist 53, 817-822
    CrossRef

  325. 325

    Jan Van der Heyden, Frank J. Wolters, Nathalie Garin, Snezana Andrejevic Blant, Marc Inglin, E.T. Bal, Jan-Maarten Suttorp. (2012) The role of embolic protection devices during carotid stenting prior to cardiac surgery in asymptomatic patients: Empty filters?. Catheterization and Cardiovascular Interventions 80:10.1002/ccd.v80.1, 112-119
    CrossRef

  326. 326

    Yaron Arbel, Edo Y. Birati, Itzhak Shapira, Yan Topilsky, Michal Wirguin, Jonathan Canaani. (2012) T-Wave Amplitude Is Related to Physical Fitness Status. Annals of Noninvasive Electrocardiology 17, 214-218
    CrossRef

  327. 327

    Joaquin De Haro, Francisco Acin, Silvia Bleda, Cesar Varela, Francisco J. Medina, Leticia Esparza. (2012) Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels. Journal of Vascular Surgery 56, 45-52
    CrossRef

  328. 328

    Shikhar Agarwal. (2012) Red cell distribution width, inflammatory markers and cardiorespiratory fitness: Results from the National Health and Nutrition Examination Survey. Indian Heart Journal 64, 380-387
    CrossRef

  329. 329

    Salim S. Virani, Lisa Pompeii, Andrew E. Lincoln, Reginald E. Dunn, Andrew M. Tucker, Vijay Nambi, Khurram Nasir, Robert A. Vogel, Jeffrey L. Boone, Arthur J. Roberts, Christie M. Ballantyne. (2012) Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis 222, 551-556
    CrossRef

  330. 330

    Naoko Takaoka, Kenichi Tsujita, Koichi Kaikita, Shinji Tayama, Seiji Hokimoto, Seigo Sugiyama, Hisao Ogawa. (2012) Subsequent silent plaque rupture of nonculprit lesion in a patient with acute myocardial infarction. International Journal of Cardiology 157, e60-e62
    CrossRef

  331. 331

    Cora Stefanie Weber, Kristina Orth-Gomér, Frank Zimmermann-Viehoff, Frank Holger Perschel, Hans Christian Deter. (2012) C-reaktives Protein bei Frauen mit koronarer Herzkrankheit und Zusammenhänge mit Depressivität. Zeitschrift für Psychosomatische Medizin und Psychotherapie 58, 158-172
    CrossRef

  332. 332

    Mette Rauhe Mouridsen, Theodoros Intzilakis, Zeynep Binici, Olav Wendelboe Nielsen, Ahmad Sajadieh. (2012) Prognostic value of high sensitive C-reactive protein in subjects with silent myocardial ischemia. Journal of Electrocardiology 45, 260-264
    CrossRef

  333. 333

    Daniel Nelson, Rees Porta, Kelly Blair, Preston Carter, Matthew Martin. (2012) The duodenal switch for morbid obesity: modification of cardiovascular risk markers compared with standard bariatric surgeries. The American Journal of Surgery 203:5, 603-608
    CrossRef

  334. 334

    Peter Kan, Maxim Mokin, Travis M. Dumont, Kenneth V. Snyder, Adnan H. Siddiqui, Elad I. Levy, L. Nelson Hopkins. (2012) Cervical Carotid Artery Stenosis: Latest Update on Diagnosis and Management. Current Problems in Cardiology 37, 127-169
    CrossRef

  335. 335

    Woo-Keun Seo, Hung-Youl Seok, Ji Hyun Kim, Moon-Ho Park, Sung-Wook Yu, Kyungmi Oh, Seong-Beom Koh, Kun-Woo Park. (2012) C-Reactive Protein is a Predictor of Early Neurologic Deterioration in Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 21, 181-186
    CrossRef

  336. 336

    Brice Faraut, Karim Zouaoui Boudjeltia, Luc Vanhamme, Myriam Kerkhofs. (2012) Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Medicine Reviews 16, 137-149
    CrossRef

  337. 337

    Emilio Ortega, Rosa Gilabert, Isabel Nuñez, Montserrat Cofán, Aleix Sala-Vila, Eric de Groot, Emili Ros. (2012) White blood cell count is associated with carotid and femoral atherosclerosis. Atherosclerosis 221, 275-281
    CrossRef

  338. 338

    Paul Jellinger, Donald Smith, Adi Mehta, Om Ganda, Yehuda Handelsman, Helena Rodbard, Mark Shepherd, John Seibel. (2012) American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocrine Practice 18, 1-78
    CrossRef

  339. 339

    Mónica Acevedo, Ramón Corbalán, Sandra Braun, Jaime Pereira, Ilse González, Carlos Navarrete. (2012) Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis
    CrossRef

  340. 340

    E. Braunwald. (2012) Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. European Heart Journal 33, 430-432
    CrossRef

  341. 341

    Christian Stratz, Michael Amann, David D. Berg, David A. Morrow, Franz-Josef Neumann, Willibald Hochholzer. (2012) Novel biomarkers in cardiovascular disease. Cardiology in Review, 1
    CrossRef

  342. 342

    D. Shrikrishna, N. S. Hopkinson. (2012) Chronic obstructive pulmonary disease: consequences beyond the lung. Clinical Medicine 12, 71-74
    CrossRef

  343. 343

    K. Koike, Y. Yamamoto, N. Suzuki, R. Yamazaki, C. Yoshikawa, K. Takuma, K. Sugiura, M. Inoue. (2012) Efficacy of porcine placental extracts with hormone therapy for postmenopausal women with knee pain. Climacteric 15, 30-35
    CrossRef

  344. 344

    L. M. Biasucci, F. Bellocci, M. Landolina, R. Rordorf, A. Vado, E. Menardi, G. Giubilato, S. Orazi, M. Sassara, A. Castro, R. Massa, A. Kheir, G. Zaccone, C. Klersy, F. Accardi, F. Crea. (2012) Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study. European Heart Journal
    CrossRef

  345. 345

    Alan T. Remaley, Nader Rifai, G. Russell Warnick. . Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors. 2012:, 731-805.
    CrossRef

  346. 346

    Byung Kil Ha, Bong Gun Kim, Dong Hyun Kim, Soon Il Lee, Soon Myung Jung, Ja Young Park, Chang Won Lee, Sang Soo Kim, Bo Hyun Kim, In Ju Kim. (2012) Relationships between Brachial-Ankle Pulse Wave Velocity and Peripheral Neuropathy in Type 2 Diabetes. Diabetes & Metabolism Journal 36, 443
    CrossRef

  347. 347

    Razvan T. Dadu, Vijay Nambi, Christie M. Ballantyne, Jessica L. Slocum, Michael Heung, Subramaniam Pennathur, Wenjun Ju, Shahaan Smith, Matthias Kretzler. (2012) Developing and assessing cardiovascular biomarkers. Translational Research 159:4, 265
    CrossRef

  348. 348

    Sun-Hee Park, Peter Stenvinkel, Bengt Lindholm. (2012) Cardiovascular Biomarkers in Chronic Kidney Disease. Journal of Renal Nutrition 22, 120-127
    CrossRef

  349. 349

    Shu Meng, Lin Zhang, Lei Zhao, Yi-ru Fang, Tetsuya Fujimoto, Shun-ichiro Hirano, Hiroshi Inoue, Kenji Uchihashi, Yasuo Nishikawa, Ya-fei Wu. (2012) Effects of C-Reactive Protein on CC Chemokine Receptor 2-Mediated Chemotaxis of Monocytes. DNA and Cell Biology 31, 30-35
    CrossRef

  350. 350

    Peter P. Toth, Nicolas W. Shammas, Eric J. Dippel, Blair Foreman. . Cardiovascular Disease. 2012:, 478-549.
    CrossRef

  351. 351

    Doroteia Silva, António Pais de Lacerda. (2012) Proteína C reativa de alta sensibilidade como biomarcador de risco na doença coronária. Revista Portuguesa de Cardiologia 31:11, 733
    CrossRef

  352. 352

    Hanna Alastalo, Katri Räikkönen, Anu-Katriina Pesonen, Clive Osmond, David J.P. Barker, Kati Heinonen, Eero Kajantie, Johan G. Eriksson. (2012) Cardiovascular Morbidity and Mortality in Finnish Men and Women Separated Temporarily From Their Parents in Childhood—A Life Course Study. Psychosomatic Medicine 74, 583-587
    CrossRef

  353. 353

    Dariusz Kotlęga, Sylwester Ciećwież, Jolanta Turowska-Kowalska, Przemysław Nowacki. (2012) Patogenetyczne uzasadnienie stosowania statyn w profilaktyce udaru niedokrwiennego mózgu w świetle zapalnej teorii rozwoju miażdżycy. Neurologia i Neurochirurgia Polska 46, 176-183
    CrossRef

  354. 354

    P. Y. Hsue, S. G. Deeks, P. W. Hunt. (2012) Immunologic Basis of Cardiovascular Disease in HIV-Infected Adults. The Journal of Infectious Diseases 205:suppl 3, S375
    CrossRef

  355. 355

    Soghra Jarvandi, Nicholas O. Davidson, Donna B. Jeffe, Mario Schootman. (2012) Influence of Lifestyle Factors on Inflammation in Men and Women with Type 2 Diabetes: Results from the National Health and Nutrition Examination Survey, 1999–2004. Annals of Behavioral Medicine 44:3, 399
    CrossRef

  356. 356

    Jennifer L. Armstrong-Wells, Marilyn J. Manco-Johnson. . Hematology and Immunology. 2012:, 89-95.
    CrossRef

  357. 357

    Takeharu Asano, Ikuo Nakamura, Mari Okajima, Kenichi Yamanaka, Shinichi Asabe, Hiroyuki Miyatani, Katsuhiko Matsuura, Yukio Yoshida, Michio Imawari. (2012) A case of pseudoaneurysm formed 10 years after segmental liver resection for hepatocellular carcinoma. Kanzo 53, 55-63
    CrossRef

  358. 358

    Hiroyasu Iso, Hiroyuki Noda, Ai Ikeda, Kazumasa Yamagishi, Manami Inoue, Motoki Iwasaki, Shoichiro Tsugane. (2012) The Impact of C-Reactive Protein on Risk of Stroke, Stroke Subtypes, and Ischemic Heart Disease in Middle-Aged Japanese: the Japan Public Health Center-Based Study. Journal of Atherosclerosis and Thrombosis
    CrossRef

  359. 359

    Francesco Versaci, Bernhard Reimers, Francesco Prati, Achille Gaspardone, Costantino Del Giudice, Andrea Pacchioni, Alessandro Mauriello, Claudio Cortese, Paolo Nardi, Anna De Fazio, Giovanni Alfonso Chiariello, Igino Proietti, Luigi Chiariello. (2012) Prediction of Cardiovascular Events by Inflammatory Markers in Patients Undergoing Carotid Stenting. Mayo Clinic Proceedings 87, 50-58
    CrossRef

  360. 360

    Jennifer G. Robinson, Catherine Rahilly-Tierney, Elizabeth Lawler, J. Michael Gaziano. (2012) Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men. Journal of Clinical Lipidology 6, 58-65
    CrossRef

  361. 361

    Matthias Hermann, Dieter Fischer, Michael M. Hoffmann, Theo Gasser, Kurt Quitzau, Thomas Meinertz, Thomas Münzel, Thomas F. Lüscher. (2012) CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease – IVUS substudy of the ENCORE trials. Atherosclerosis 220, 172-176
    CrossRef

  362. 362

    Elizabeth Dean, Rasmus Gormsen Hansen. (2012) Prescribing Optimal Nutrition and Physical Activity as “First-Line” Interventions for Best Practice Management of Chronic Low-Grade Inflammation Associated with Osteoarthritis: Evidence Synthesis. Arthritis 2012, 1-28
    CrossRef

  363. 363

    Vincenzo Panichi, Alessia Scatena, Massimiliano Migliori, Valentina Marchetti, Sabrina Paoletti, Sara Beati. (2012) Biomarkers of Chronic Inflammatory State in Uremia and Cardiovascular Disease. International Journal of Inflammation 2012, 1-6
    CrossRef

  364. 364

    Yuxiang Dai, Junbo Ge. (2012) Clinical Use of Aspirin in Treatment and Prevention of Cardiovascular Disease. Thrombosis 2012, 1-7
    CrossRef

  365. 365

    M. S. Ahmed, A. B. Jadhav, A. Hassan, Qing H. Meng. (2012) Acute Phase Reactants as Novel Predictors of Cardiovascular Disease. ISRN Inflammation 2012, 1-18
    CrossRef

  366. 366

    Ertuğrul Kurtoğlu, Hasan Korkmaz, Erdal Aktürk, Mücahid Yılmaz, Yakup Altaş, Ahmet Uçkan. (2012) Association of Mitral Annulus Calcification with High-Sensitivity C-Reactive Protein, Which Is a Marker of Inflammation. Mediators of Inflammation 2012, 1-6
    CrossRef

  367. 367

    Wolfgang Lösche, Janina Boettel, Björn Kabisch, Johannes Winning, Ralf A. Claus, Michael Bauer. (2012) Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?. Thrombosis 2012, 1-8
    CrossRef

  368. 368

    Gabriele Demetz, Ilka Ott. (2012) The Interface between Inflammation and Coagulation in Cardiovascular Disease. International Journal of Inflammation 2012, 1-8
    CrossRef

  369. 369

    Zhong-Xuan Ye, Po-Hsun Huang, Hsin-Bang Leu, Tao-Cheng Wu, Shing-Jong Lin, Jaw-Wen Chen. (2011) The Role of High Sensitivity C-Reactive Protein and Coronary Artery Calcium as Predictors of the Long-term Prognosis in Men with Coronary Artery Disease. Journal of Experimental & Clinical Medicine
    CrossRef

  370. 370

    DOMINIC A. M. J. THEUNS, TIM SMITH, TAMAS SZILI-TOROK, AGNES MUSKENS-HEEMSKERK R. N., PETTER JANSE, LUC JORDAENS. (2011) Prognostic Role of High-Sensitivity C-Reactive Protein and B-Type Natriuretic Peptide in Implantable Cardioverter-Defibrillator Patients. Pacing and Clinical Electrophysiology, no-no
    CrossRef

  371. 371

    Eugene Joseph Kucharz. (2011) Chronic inflammation-enhanced atherosclerosis: Can we consider it as a new clinical syndrome?. Medical Hypotheses
    CrossRef

  372. 372

    Fernanda G.C. Signoretti, Marcos S. Endo, Brenda P.F.A. Gomes, Francisco Montagner, Fernanda B. Tosello, Rogério C. Jacinto. (2011) Persistent Extraradicular Infection in Root-filled Asymptomatic Human Tooth: Scanning Electron Microscopic Analysis and Microbial Investigation after Apical Microsurgery. Journal of Endodontics 37, 1696-1700
    CrossRef

  373. 373

    Kamran I Muhammad, Thomas Morledge, Ravish Sachar, Annette Zeldin, Kathy Wolski, Deepak L Bhatt. (2011) Treatment with ω-3 fatty acids reduces serum C-reactive protein concentration. Clinical Lipidology 6, 723-729
    CrossRef

  374. 374

    Jeannette Y. Wick, Guido R. Zanni. (2011) C-Reactive Protein: The Evolution of a Laboratory Test. The Consultant Pharmacist 26, 929-933
    CrossRef

  375. 375

    Flor de la C. Heres-Álvarez, Amalia Peix-González. (2011) La proteína C reactiva como blanco terapéutico en la prevención cardiovascular: ¿ficción o realidad?. Revista Española de Cardiología Suplementos 11, 30-35
    CrossRef

  376. 376

    Thomas Gremmel, Cihan Ay, Daniela Seidinger, Ingrid Pabinger, Simon Panzer, Renate Koppensteiner. (2011) Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb. Journal of Vascular Surgery 54, 48S-55S
    CrossRef

  377. 377

    Tanya G. Marsh, Rachel K. Straub, Fatima Villalobos, Mee Young Hong. (2011) Soy protein supports cardiovascular health by downregulating hydroxymethylglutaryl–coenzyme A reductase and sterol regulatory element-binding protein–2 and increasing antioxidant enzyme activity in rats with dextran sodium sulfate–induced mild systemic inflammation. Nutrition Research 31, 922-928
    CrossRef

  378. 378

    Arnon Blum, Snait Tamir, Keren Mualem, Rotem Shelly Ben-Shushan, Lital Keinan-Boker, Maya Paritsky. (2011) Endothelial Dysfunction Is Reversible in Helicobacter Pylori-Positive Subjects. The American Journal of Medicine 124, 1171-1174
    CrossRef

  379. 379

    Brian R. Weil, Jared J. Greiner, Christopher A. DeSouza, Brian L. Stauffer. (2011) Relation of C-Reactive Protein to Endothelial Fibrinolytic Function in Healthy Adults. The American Journal of Cardiology 108, 1675-1679
    CrossRef

  380. 380

    Mario Di Napoli, Mitchell SV Elkind, Daniel Agustin Godoy, Puneetpal Singh, Francesca Papa, Aurel Popa-Wagner. (2011) Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Review of Cardiovascular Therapy 9, 1565-1584
    CrossRef

  381. 381

    Suthesh Sivapalaratnam, Rosienne Farrugia, Max Nieuwdorp, Cordelia F Langford, Rachel T van Beem, Stephanie Maiwald, Jaap Jan Zwaginga, Arief Gusnanto, Nicholas A Watkins, Mieke D Trip, Willem H Ouwehand. (2011) Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivoLPS infusion study. BMC Medical Genomics 4:1
    CrossRef

  382. 382

    Nicole Cristell, Domenico Cianflone, Alessandro Durante, Enrico Ammirati, Diego Vanuzzo, Michela Banfi, Giliola Calori, Azeem Latib, Filippo Crea, Giancarlo Marenzi, Monica De Metrio, Luciano Moretti, Hui Li, Neal G. Uren, Dayi Hu, Attilio Maseri. (2011) High-Sensitivity C-Reactive Protein Is Within Normal Levels at the Very Onset of First ST-Segment Elevation Acute Myocardial Infarction in 41% of Cases. Journal of the American College of Cardiology 58:25, 2654-2661
    CrossRef

  383. 383

    Elba Bandeira, Ana Paula Neves, Christiane Costa, Francisco Bandeira. (2011) Association Between Vascular Calcification and Osteoporosis in Men With Type 2 Diabetes. Journal of Clinical Densitometry
    CrossRef

  384. 384

    Maria Lukasik, Grzegorz Dworacki, Slawomir Michalak, Joanna Kufel-Grabowska, Jacek Golanski, Cezary Watala, Wojciech Kozubski. (2011) Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. Thrombosis Research 128, e73-e80
    CrossRef

  385. 385

    D. O. Dahle, G. Mjoen, B. Oqvist, H. Scharnagl, G. Weihrauch, T. Grammer, W. Marz, S. Abedini, G. E. Norby, I. Holme, B. Fellstrom, A. Jardine, H. Holdaas. (2011) Inflammation-associated graft loss in renal transplant recipients. Nephrology Dialysis Transplantation 26, 3756-3761
    CrossRef

  386. 386

    Motohiro Shimizu, Joji Ishikawa, Yuichirou Yano, Satoshi Hoshide, Kazuyuki Shimada, Kazuomi Kario. (2011) The relationship between the morning blood pressure surge and low-grade inflammation on silent cerebral infarct and clinical stroke events. Atherosclerosis 219, 316-321
    CrossRef

  387. 387

    Hua Zhou, Li Cui, GeYa Zhu, YaPing Jiang, XiaoXia Gao, Yun Zou, Min Yang, Hua Liu, Jia Di, Yin Zong, JiaRong Pan. (2011) Survival Advantage of Normal Weight in Peritoneal Dialysis Patients. Renal Failure 33, 964-968
    CrossRef

  388. 388

    Kazutaka Saito, Kazunori Kihara. (2011) C-reactive protein as a biomarker for urological cancers. Nature Reviews Urology
    CrossRef

  389. 389

    Sun Young Kim, Seok Kyo Seo, Young Mi Choi, Young Eun Jeon, Kyung Jin Lim, SiHyun Cho, Young Sik Choi, Byung Seok Lee. (2011) Effects of red ginseng supplementation on menopausal symptoms and cardiovascular risk factors in postmenopausal women. Menopause, 1
    CrossRef

  390. 390

    Tawfiq Almadi, Ian Cathers, Ayman M. Hamdan Mansour, Chin Moi Chow. (2011) The association between work stress and inflammatory biomarkers in Jordanian male workers. Psychophysiology, n/a-n/a
    CrossRef

  391. 391

    Ryo Yoshimoto, Yoshiko Fujita, Akemi Kakino, Shin Iwamoto, Tomohide Takaya, Tatsuya Sawamura. (2011) The Discovery of LOX-1, its Ligands and Clinical Significance. Cardiovascular Drugs and Therapy 25, 379-391
    CrossRef

  392. 392

    Georg Aue, Jay Nelson Lozier, Xin Tian, Ann M. Cullinane, Susan Soto, Leigh Samsel, Philip McCoy, Adrian Wiestner. (2011) Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia. American Journal of Hematology 86:10.1002/ajh.v86.10, 835-840
    CrossRef

  393. 393

    Akira Funayama, Tetsuro Shishido, Shunsuke Netsu, Mitsunori Ishino, Toshiki Sasaki, Shigehiko Katoh, Hiroki Takahashi, Takanori Arimoto, Takuya Miyamoto, Joji Nitobe, Tetsu Watanabe, Isao Kubota. (2011) Serum Pregnancy-Associated Plasma Protein A in Patients With Heart Failure. Journal of Cardiac Failure 17, 819-826
    CrossRef

  394. 394

    Odessa Addison, Paul C. LaStayo, Leland E. Dibble, Robin L. Marcus. (2011) Inflammation, Aging, and Adiposity. Journal of Geriatric Physical Therapy, 1
    CrossRef

  395. 395

    Ta-Chen Su, Ching-Fen Wu, Chang-Chuan Chan, Ming-Fong Chen. (2011) C-reactive protein and particulate matter predict plasma fibrinogen levels. International Journal of Cardiology
    CrossRef

  396. 396

    B. Chamarthi, G. H. Williams, V. Ricchiuti, N. Srikumar, P. N. Hopkins, J. M. Luther, X. Jeunemaitre, A. Thomas. (2011) Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans. American Journal of Hypertension 24, 1143-1148
    CrossRef

  397. 397

    Petrus M. van der Zee, Jan Hein Cornel, Radha Bholasingh, Johan C. Fischer, Jan P. van Straalen, Robbert J. De Winter. (2011) N-Terminal Pro B-Type Natriuretic Peptide Identifies Patients with Chest Pain at High Long-term Cardiovascular Risk. The American Journal of Medicine 124:10, 961-969
    CrossRef

  398. 398

    Paul M Ridker, Tom Thuren, Andrew Zalewski, Peter Libby. (2011) Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). American Heart Journal 162:4, 597-605
    CrossRef

  399. 399

    Nazri Mustaffa, Suhairi Ibrahim, Wan Zaidah Abdullah, Zurkurnai Yusof. (2011) Add-on rosiglitazone therapy improves plasminogen activity and high-density lipoprotein cholesterol in type 2 diabetes mellitus. Blood Coagulation & Fibrinolysis 22, 512-520
    CrossRef

  400. 400

    Marinez F. Matos, Dayse M. Lourenço, Cristina M. Orikaza, João A.H. Bajerl, Maria A.E. Noguti, Vânia M. Morelli. (2011) The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: A case-control study. Thrombosis Research 128, 216-220
    CrossRef

  401. 401

    T. Wurster, K. Stellos, T. Geisler, P. Seizer, M. E. Andia, A. Schuster, A. E. May, A. Melms, M. Gawaz, B. Bigalke. (2011) Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?. European Journal of Neurology, no-no
    CrossRef

  402. 402

    V. Vermeeren, L. Grieten, N. Vanden Bon, N. Bijnens, S. Wenmackers, S.D. Janssens, K. Haenen, P. Wagner, L. Michiels. (2011) Impedimetric, diamond-based immmunosensor for the detection of C-reactive protein. Sensors and Actuators B: Chemical 157, 130-138
    CrossRef

  403. 403

    Toshiki Fukui, Kazuhiro Yamauchi, Mie Maruyama, Tadashi Yasuda, Masakazu Kohno, Youichi Abe. (2011) Significance of measuring oxidative stress in lifestyle-related diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects. Hypertension Research 34, 1041-1045
    CrossRef

  404. 404

    Kerstyn C. Zalesin, Barry A. Franklin, Wendy M. Miller, Eric D. Peterson, Peter A. McCullough. (2011) Impact of Obesity on Cardiovascular Disease. Medical Clinics of North America 95, 919-937
    CrossRef

  405. 405

    Michael H. Davidson, Christie M. Ballantyne, Terry A. Jacobson, Vera A. Bittner, Lynne T. Braun, Alan S. Brown, W.Virgil Brown, William C. Cromwell, Ronald B. Goldberg, James M. McKenney, Alan T. Remaley, Allan D. Sniderman, Peter P. Toth, Sotirios Tsimikas, Paul E. Ziajka, Kevin C. Maki, Mary R. Dicklin. (2011) Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists. Journal of Clinical Lipidology 5, 338-367
    CrossRef

  406. 406

    XiaoFei Li, Miranda C. Kramer, Chris M. van der Loos, Karel T. Koch, Onno J. de Boer, José P.S. Henriques, Jan Baan, Marije M. Vis, Jan J. Piek, Jan G.P. Tijssen, Robbert J. de Winter, Allard C. van der Wal. (2011) A pattern of disperse plaque microcalcifications identifies a subset of plaques with high inflammatory burden in patients with acute myocardial infarction. Atherosclerosis 218, 83-89
    CrossRef

  407. 407

    Qi Yu, Yan Lin, Peigang Yang, Yanli Wang, Sihai Zhao, Penghui Yang, Jianglin Fan, Enqi Liu. (2011) C-reactive protein is associated with the progression of acute embolic stroke in rabbit model. Journal of Thrombosis and Thrombolysis
    CrossRef

  408. 408

    Osamu Saiki, Makihiko Kuhara, Nozomi Kikuchi, Sanshirou Shiraishi, Hiroshi Uda. (2011) Evaluation of Lasting High Levels of CRP among the Patients with Metabolic Syndrome. Inflammation
    CrossRef

  409. 409

    Markus H. Schafer, Kenneth F. Ferraro. (2011) Distal and variably proximal causes: Education, obesity, and health. Social Science & Medicine
    CrossRef

  410. 410

    S. Yamamoto, Y. Zuo, J. Ma, P. G. Yancey, T. E. Hunley, M. Motojima, A. B. Fogo, M. F. Linton, S. Fazio, I. Ichikawa, V. Kon. (2011) Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrology Dialysis Transplantation 26, 2491-2497
    CrossRef

  411. 411

    Emmanuela Quental Callou de Sá, Francisco Carleial Feijó de Sá, Rebeca de Souza e Silva, Kelly Cristina de Oliveira, Alexis Dourado Guedes, Fausto Feres, Ieda Therezinha do Nascimento Verreschi. (2011) Endogenous oestradiol but not testosterone is related to coronary artery disease in men. Clinical Endocrinology 75:10.1111/cen.2011.75.issue-2, 177-183
    CrossRef

  412. 412

    H. Kaneko, T. Anzai, T. Nagai, A. Anzai, T. Takahashi, Y. Mano, K. Morimoto, Y. Maekawa, H. Itoh, T. Yoshikawa, S. Ogawa, K. Fukuda. (2011) Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling. Cardiovascular Research 91, 546-555
    CrossRef

  413. 413

    Stacy A. Brethauer, Helen M. Heneghan, Shai Eldar, Patrick Gatmaitan, Hazel Huang, Sangeeta Kashyap, Heather L. Gornik, John P. Kirwan, Philip R. Schauer. (2011) Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surgical Endoscopy 25, 2650-2659
    CrossRef

  414. 414

    Regina Rückerl, Alexandra Schneider, Susanne Breitner, Josef Cyrys, Annette Peters. (2011) Health effects of particulate air pollution: A review of epidemiological evidence. Inhalation Toxicology 23, 555-592
    CrossRef

  415. 415

    Tim J. McDonald, Beverley M. Shields, Jane Lawry, Katharine R. Owen, Anna L. Gloyn, Sian Ellard, Andrew T. Hattersley. (2011) High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes: Figure 1. Diabetes Care 34, 1860-1862
    CrossRef

  416. 416

    Ya-Ching Chang, Wei-Ming Wu, Lung-An Hsu. (2011) Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese. Molecular Biology Reports
    CrossRef

  417. 417

    Hanen Belfki, Samir Ben Ali, Souha Bougatef, Decy Ben Ahmed, Najet Haddad, Awatef Jmal, Monia Abdennebi, Habiba Ben Romdhane. (2011) Association Between C-Reactive Protein and Type 2 Diabetes in a Tunisian Population. Inflammation
    CrossRef

  418. 418

    Hee-Jin Hwang, Sang-Woo Lee, Sang-Hwan Kim. (2011) Relationship between bilirubin and C-reactive protein. Clinical Chemistry and Laboratory Medicine, ---
    CrossRef

  419. 419

    Elsie M. Taveras, Sheryl L. Rifas-Shiman, Janet W. Rich-Edwards, Christos S. Mantzoros. (2011) Maternal short sleep duration is associated with increased levels of inflammatory markers at 3 years postpartum. Metabolism 60, 982-986
    CrossRef

  420. 420

    Meriam Messedi, Makram Frigui, Khaireddine Ben Mahfoudh, Hanen Feki, Salma Triki Ben Mahfoudh, Jameleddine Mnif, Zouhir Bahloul, Fatma Ayadi. (2011) Intima-media Thickness of Carotid Artery in Patients with Behçet’s Disease. Archives of Medical Research 42, 398-404
    CrossRef

  421. 421

    T. Vepsalainen, M. Soinio, J. Marniemi, S. Lehto, A. Juutilainen, M. Laakso, T. Ronnemaa. (2011) Physical Activity, High-Sensitivity C-Reactive Protein, and Total and Cardiovascular Disease Mortality in Type 2 Diabetes. Diabetes Care 34, 1492-1496
    CrossRef

  422. 422

    Choy-Lye Chei, Kazumasa Yamagishi, Akihiko Kitamura, Masahiko Kiyama, Hironori Imano, Tetsuya Ohira, Renzhe Cui, Takeshi Tanigawa, Tomoko Sankai, Yoshinori Ishikawa, Shinichi Sato, Hiroyasu Iso. (2011) C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 217, 187-193
    CrossRef

  423. 423

    Xian Li, Michele L. Shaffer, Sol M. Rodríguez-Colón, Fan He, Edward O. Bixler, Alexandros N. Vgontzas, Deborah L. Wolbrette, Chuntao Wu, Richard W. Ball, Duanping Liao. (2011) Systemic inflammation and circadian rhythm of cardiac autonomic modulation. Autonomic Neuroscience 162, 72-76
    CrossRef

  424. 424

    Kae-Woei Liang, I-Chen Tsai, Wen-Jane Lee, I-Te Lee, Wen-Lieng Lee, Shih-Yi Lin, Chu-Jen Wan, Chia-Po Fu, Chih-Tai Ting, Wayne H-H Sheu. (2011) MRI Measured Epicardial Adipose Tissue Thickness at the Right AV Groove Differentiates Inflammatory Status in Obese Men With Metabolic Syndrome. Obesity
    CrossRef

  425. 425

    M.Y. Hrira, W. Mnif, M. Kerkeni, Z. Jaidane, A. Kasab, S. Ferchichi, S. Laradi, F. Addad, H. Ben Limam, A. Miled. (2011) C-réactive protéine ultrasensible et facteurs de risque cardiovasculaire dans une population tunisienne. Immuno-analyse & Biologie Spécialisée 26, 107-112
    CrossRef

  426. 426

    Miraj Mondal, Rathindra Nath Sarkar, Amitava Chakroborty, Ashutosh Dey, Sibaji Phaujdar, Sattik Siddhanta, Siwalik Banerjee. (2011) Atherosclerosis in an Indian cohort of rheumatoid arthritis with low disease activity and its correlation with inflammatory markers. Indian Journal of Rheumatology 6, 61-67
    CrossRef

  427. 427

    Rae-Chi Huang, Nicholas de Klerk, Trevor A. Mori, John P. Newnham, Fiona J. Stanley, Louis I. Landau, Wendy H. Oddy, Beth Hands, Lawrence J. Beilin. (2011) Differential relationships between anthropometry measures and cardiovascular risk factors in boys and girls. International Journal of Pediatric Obesity 6, e271-e282
    CrossRef

  428. 428

    Patricia K. Tithof, Sean M. Richards, Mona A. Elgayyar, Fu-Minn Menn, Vijay M. Vulava, Larry McKay, John Sanseverino, Gary Sayler, Dawn E. Tucker, Christina C. Leslie, Kim P. Lu, Kenneth S. Ramos. (2011) Activation of group IVC phospholipase A2 by polycyclic aromatic hydrocarbons induces apoptosis of human coronary artery endothelial cells. Archives of Toxicology 85, 623-634
    CrossRef

  429. 429

    Hideo Nakarai, Akiko Yamashita, Mikimasa Takagi, Masataka Adachi, Masaharu Sugiyama, Haruhiko Noda, Masafumi Katano, Ryuji Yamakawa, Keiji Nakayama, Hitomi Takumiya, Yoshikatsu Nakai, Ataru Taniguchi, Fusanori Nishimura. (2011) Periodontal disease and hypertriglyceridemia in Japanese subjects: potential association with enhanced lipolysis. Metabolism 60, 823-829
    CrossRef

  430. 430

    Xiang Ying Ouyang, Wen Mei Xiao, Yi Chu, Shuang Ying Zhou. (2011) Influence of periodontal intervention therapy on risk of cardiovascular disease. Periodontology 2000 56:10.1111/prd.2011.56.issue-1, 227-257
    CrossRef

  431. 431

    Kwan Leung Chan, Jean G. Dumesnil, James Tam, Andy Ni, Koon Teo. (2011) Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis. American Heart Journal 161, 1133-1139
    CrossRef

  432. 432

    Dong-Hyun Choi, Kyung Woo Park, Han-Mo Yang, Hae-Young Lee, Jin-Shik Park, Hyun-Jai Kang, Yong-Jin Kim, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim. (2011) Renal dysfunction and high levels of hsCRP are additively associated with hard endpoints after percutaneous coronary intervention with drug eluting stents. International Journal of Cardiology 149, 174-181
    CrossRef

  433. 433

    Yueh-Hsiu Mathilda Chiu, Donna Spiegelman, Douglas W. Dockery, Eric Garshick, S. Katharine Hammond, Thomas J. Smith, Jaime E. Hart, Francine Laden. (2011) Secondhand Smoke Exposure and Inflammatory Markers in Nonsmokers in the Trucking Industry. Environmental Health Perspectives 119, 1294-1300
    CrossRef

  434. 434

    Matthew R. Evans, Agustín Escalante, Daniel F. Battafarano, Gregory L. Freeman, Daniel H. O'Leary, Inmaculada del Rincón. (2011) Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis & Rheumatism 63, 1211-1220
    CrossRef

  435. 435

    Alan D. Bell, André Roussin, Raymond Cartier, Wee Shian Chan, James D. Douketis, Anil Gupta, Maria E. Kraw, Thomas F. Lindsay, Michael P. Love, Neesh Pannu, Rémi Rabasa-Lhoret, Ashfaq Shuaib, Philip Teal, Pierre Théroux, Alexander G.G. Turpie, Robert C. Welsh, Jean-François Tanguay. (2011) The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines. Canadian Journal of Cardiology 27, S1-S59
    CrossRef

  436. 436

    I. Ouellet-Morin, A. Danese, B. Williams, L. Arseneault. (2011) Validation of a high-sensitivity assay for C-reactive protein in human saliva. Brain, Behavior, and Immunity 25, 640-646
    CrossRef

  437. 437

    Wanda Acampa, Maria D. Di Taranto, Alberto Morgante, Barbara Salvatore, Laura Evangelista, Francesca Ricci, Pierluigi Costanzo, Emma de Sisto, Pasquale P. Filardi, Mario Petretta, Giuliana Fortunato, Alberto Cuocolo. (2011) C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging. Scandinavian Journal of Clinical and Laboratory Investigation 71, 179-184
    CrossRef

  438. 438

    Jamie A. Bastek, Amy G. Brown, Lauren Anton, Sindhu K. Srinivas, Antonietta D'addio, Michal A. Elovitz. (2011) Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth. The Journal of Maternal-Fetal & Neonatal Medicine 24, 600-605
    CrossRef

  439. 439

    R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Theodore G. Ganiats, Hani Jneid, A. Michael Lincoff, Eric D. Peterson, George J. Philippides, Pierre Theroux, Nanette K. Wenger, James Patrick Zidar. (2011) 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline). Journal of the American College of Cardiology 57:19, 1920-1959
    CrossRef

  440. 440

    R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Theodore G. Ganiats, Hani Jneid, A. Michael Lincoff, Eric D. Peterson, George J. Philippides, Pierre Theroux, Nanette K. Wenger, James Patrick Zidar. (2011) 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 57:19, e215-e367
    CrossRef

  441. 441

    Giuseppe Sangiorgi, Alessandro Mauriello, Santi Trimarchi, Elena Bonanno, Luigi Giusto Spagnoli. . Atherogenesis and Inflammation. 2011:, 10-29.
    CrossRef

  442. 442

    Julianne Holt-Lunstad, Patrick R. Steffen, Jonathan Sandberg, Bryan Jensen. (2011) Understanding the connection between spiritual well-being and physical health: an examination of ambulatory blood pressure, inflammation, blood lipids and fasting glucose. Journal of Behavioral Medicine
    CrossRef

  443. 443

    J. V. Baker, J. D. Lundgren. (2011) Cardiovascular implications from untreated human immunodeficiency virus infection. European Heart Journal 32, 945-951
    CrossRef

  444. 444

    Lung-An Hsu, Yu-Lin Ko, Ming-Sheng Teng, Semon Wu, Hsin-Hua Chou, Pi-Yueh Chang, Hsien-Hsun Chang. (2011) Effect of obesity on the association between common variations in the HNF1A gene region and C-reactive protein level in Taiwanese. Clinica Chimica Acta 412, 725-729
    CrossRef

  445. 445

    T. ULRYCH, A. BÖHM, A. POLZIN, G. DAUM, R. M. NÜSING, G. GEISSLINGER, T. HOHLFELD, K. SCHRÖR, B. H. RAUCH. (2011) Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. Journal of Thrombosis and Haemostasis 9:10.1111/jth.2011.9.issue-4, 790-798
    CrossRef

  446. 446

    Charlotte E. Bolton, Wiebke Schumacher, John R. Cockcroft, Nicholas J. Timpson, George Davey Smith, John Gallacher, Anne Rumley, Gordon D. Lowe, Shah Ebrahim, Dennis J. Shale, Yoav Ben‑Shlomo. (2011) The CRP genotype, serum levels and lung function in men: the Caerphilly Prospective Study. Clinical Science 120, 347-355
    CrossRef

  447. 447

    Jean-Louis Vincent, Katia Donadello, Xavier Schmit. (2011) Biomarkers in the Critically Ill Patient: C-reactive Protein. Critical Care Clinics 27, 241-251
    CrossRef

  448. 448

    Stefano Volpato, Luigi Ferrucci, Paola Secchiero, Federica Corallini, Giovanni Zuliani, Renato Fellin, Jack M. Guralnik, Stefania Bandinelli, Giorgio Zauli. (2011) Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults. Atherosclerosis 215, 452-458
    CrossRef

  449. 449

    Giovanni Cimmino, Chiara D’Amico, Valentina Vaccaro, Margherita D’Anna, Paolo Golino. (2011) The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?. Expert Review of Cardiovascular Therapy 9, 517-523
    CrossRef

  450. 450

    Hidenori Nishida, Takeshi Horio, Yoshihiko Suzuki, Yoshio Iwashima, Takeshi Tokudome, Fumiki Yoshihara, Satoko Nakamura, Yuhei Kawano. (2011) Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: Comparison with C-reactive protein. Cytokine 53, 342-346
    CrossRef

  451. 451

    Alan D. Bell, André Roussin, Raymond Cartier, Wee Shian Chan, James D. Douketis, Anil Gupta, Maria E. Kraw, Thomas F. Lindsay, Michael P. Love, Neesh Pannu, Rémi Rabasa-Lhoret, Ashfaq Shuaib, Philip Teal, Pierre Théroux, A. Graham Turpie, Robert C. Welsh, Jean-François Tanguay. (2011) The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary. Canadian Journal of Cardiology 27, 208-221
    CrossRef

  452. 452

    A. Pejcic, L. J. Kesic, J. Milasin. (2011) C-reactive protein as a systemic marker of inflammation in periodontitis. European Journal of Clinical Microbiology & Infectious Diseases 30, 407-414
    CrossRef

  453. 453

    Shujuan Guo, Shu Meng, Bin Chen, Juan Liu, Li Gao, Yafei Wu. (2011) C-Reactive Protein Can Influence the Proliferation, Apoptosis, and Monocyte Chemotactic Protein-1 Production of Human Umbilical Vein Endothelial Cells. DNA and Cell Biology 30, 157-162
    CrossRef

  454. 454

    Ako Fukami, Sho-ichi Yamagishi, Hisashi Adachi, Takanori Matsui, Kuniko Yoshikawa, Kinuka Ogata, Akiko Kasahara, Eri Tsukagawa, Kanako Yokoi, Tsutomu Imaizumi. (2011) High White Blood Cell Count and Low Estimated Glomerular Filtration Rate Are Independently Associated With Serum Level of Monocyte Chemoattractant Protein-1 in a General Population. Clinical Cardiology 34, 189-194
    CrossRef

  455. 455

    Zhu-Zhi Wen, Dong-mei Jin, Ya-mei Zhang, Jing-Feng Wang, Deng-Feng Geng. (2011) Glucometabolic state in Chinese patients undergoing elective coronary angiography. Diabetes Research and Clinical Practice 91, 300-306
    CrossRef

  456. 456

    Jason N. Katz, Kamalkumar P. Kolappa, Richard C. Becker. (2011) Beyond Thrombosis. Chest 139, 658-668
    CrossRef

  457. 457

    Hyun-Jung Kim, Hyun-Syuk Yoo, Pan-Kyeom Kim, Mi-Ryung Kim, Hyup-Woo Lee, Chan-Wha Kim. (2011) Comparative analysis of serum proteomes of patients with cardiovascular disease. Clinical Biochemistry 44, 178-184
    CrossRef

  458. 458

    Adriano Caixeta, Gregg W. Stone, Roxana Mehran, Edwin A. Lee, Brent T. McLaurin, David A. Cox, Michel E. Bertrand, A. Michael Lincoff, Jeffrey W. Moses, Harvey D. White, E. Magnus Ohman, Tullio Palmerini, George Syros, Christos Kittas, Martin Fahy, W. Craig Hooper, Alexandra J. Lansky, George D. Dangas. (2011) Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. Journal of Thrombosis and Thrombolysis 31, 154-164
    CrossRef

  459. 459

    Francisco López-Jiménez, Mery Cortés-Bergoderi. (2011) Obesidad y corazón. Revista Española de Cardiología 64, 140-149
    CrossRef

  460. 460

    Mohsen Moohebati, Shirin Bidmeshgi, Mahmoud R. Azarpazhooh, Mahdi Hassanzadeh Daloee, Majid Ghayour-Mobarhan, Shima Tavallaie, Maral Amini, Akram Momenzadeh, Amirhossein Sahebkar, Roghayeh Paydar, Amir A. Rahsepar, Seyyed M.R. Parizadeh, Saeed Akhlaghi, Gordon A.A. Ferns. (2011) Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: A randomized, double-blind, placebo-controlled, cross-over trial. Clinical Biochemistry 44, 192-197
    CrossRef

  461. 461

    En-Zhi Jia, Zhen-Xia Xu, Zhi-Jian Yang, Tie-Bing Zhu, Lian-Sheng Wang, Ke-Jiang Cao, Wen-Zhu Ma. (2011) Severity of coronary atherosclerosis is an independent predictor of the left ventricular ejection fraction. Clinical and Experimental Pharmacology and Physiology 38:10.1111/cep.2011.38.issue-2, 109-112
    CrossRef

  462. 462

    Myung-A Kim, Chee Jeong Kim, Jae-Bin Seo, Woo-Yong Chung, Sang-Hyun Kim, Joo-Hee Zo, Eun Yeon Rho, Sue Shin, Jong Hyun Yoon. (2011) The Effect of Aspirin on C-Reactive Protein in Hypertensive Patients. Clinical and Experimental Hypertension 33, 47-52
    CrossRef

  463. 463

    Marina J. Harutyunyan, Anders B. Mathiasen, Per Winkel, Jens P. Gøtze, Jørgen Fischer Hansen, Per Hildebrandt, Gorm Boje Jensen, Jørgen Hilden, Christian M. Jespersen, Erik Kjøller, Hans J. Kolmos, Christian Gluud, Jens Kastrup, . (2011) High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Scandinavian Journal of Clinical and Laboratory Investigation 71, 52-62
    CrossRef

  464. 464

    Pavel Poredos, Mateja Kaja Jezovnik. (2011) In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction. Heart and Vessels
    CrossRef

  465. 465

    Elizabeth Windgassen, Luciana Funtowicz, Tisha Lunsford, Lucinda Harris, Sharon Mulvagh. (2011) C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians. Postgraduate Medicine 123, 114-119
    CrossRef

  466. 466

    Benjamín Rubio-Jurado, Paulina Iñiguez-Franco, Pedro A. Reyes, Gustavo Robles, Mario Salazar-Páramo, Guadalupe Zavala-Cerna, Carlos Riebeling, Arnulfo Nava. (2011) The Clinical Significance of Coagulation and the Inflammatory Response in Autoimmunity. Clinical Reviews in Allergy & Immunology
    CrossRef

  467. 467

    Tatjana Rundek, Ralph L. Sacco. . Prognosis after Stroke. 2011:, 219-241.
    CrossRef

  468. 468

    Oh Young Bang. (2011) Biomarkers of Stroke. Korean Journal of Stroke 13, 57
    CrossRef

  469. 469

    Vijay Nambi, Ariel Brautbar, Christie M. Ballantyne. . Novel Biomarkers and the Assessment of Cardiovascular Risk. 2011:, 54-63.
    CrossRef

  470. 470

    Kiwoong Yu, Cheolhwan Kim, Eunju Sung, Hocheol Shin, Hyewon Lee. (2011) Association of Serum Total Bilirubin with Serum High Sensitivity C-reactive Protein in Middle-aged Men. Korean Journal of Family Medicine 32, 327
    CrossRef

  471. 471

    Juan José Badimón, Carlos G. Santos-Gallego, Francisco Torres, Jesús Castillo, Juan Carlos Kaski. (2011) Nuevas herramientas en la estratificación del riesgo cardiovascular. Revista Española de Cardiología Suplementos 11, 21
    CrossRef

  472. 472

    Jessica L. Mega, Elliott M. Antman, Marc S. Sabatine. . Risk Stratification in Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction. 2011:, 181-193.
    CrossRef

  473. 473

    Kazuhisa Yamazaki, Koichi Tabeta, Takako Nakajima. (2011) Periodontitis as a Risk Factor for Atherosclerosis. Journal of Oral Biosciences 53, 221-232
    CrossRef

  474. 474

    Chih-Wei Chen, Chih-Ta Lin, Ying-Lung Lin, Tin-Kwang Lin, Chin-Lon Lin. (2011) Taiwanese Female Vegetarians Have Lower Lipoprotein-Associated Phospholipase A2 Compared with Omnivores. Yonsei Medical Journal 52, 13
    CrossRef

  475. 475

    Samir B. Damani, Eric J. Topol. . Molecular genetics of atherosclerosis and acute coronary syndromes. 2011:, 35-43.
    CrossRef

  476. 476

    Neil Ruparelia, Janet E Digby, Robin P Choudhury. (2011) Effects of niacin on atherosclerosis and vascular function. Current Opinion in Cardiology 26, 66-70
    CrossRef

  477. 477

    Emily G. Kurtz, Paul M. Ridker, Lynda M. Rose, Nancy R. Cook, Brendan M. Everett, Julie E. Buring, Kathryn M. Rexrode. (2011) Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes. Menopause 18, 23-29
    CrossRef

  478. 478

    May A Beydoun, Marie T Fanelli Kuczmarski, Youfa Wang, Marc A Mason, Michele K Evans, Alan B Zonderman. (2011) Receiver-operating characteristics of adiposity for metabolic syndrome: the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study. Public Health Nutrition 14, 77-92
    CrossRef

  479. 479

    Yongnian Ni, Ruirui Zhu, Serge Kokot. (2011) Competitive binding of small molecules with biopolymers: a fluorescence spectroscopy and chemometrics study of the interaction of aspirin and ibuprofen with BSA. The Analyst
    CrossRef

  480. 480

    Jay L. Bock. . Cardiac Injury, Atherosclerosis, and Thrombotic Disease. 2011:, 249-258.
    CrossRef

  481. 481

    E. Marc Jolicoeur, Christopher B. Granger. . Inflammation and Immunity as Targets for Drug Therapy in Acute Coronary Syndrome. 2011:, 271-288.
    CrossRef

  482. 482

    Kathleen Maksimowicz-McKinnon, Susan Manzi. . Heart. 2011:, 815-832.
    CrossRef

  483. 483

    John R Koethe, Meridith Blevins, Christopher Nyirenda, Edmond K Kabagambe, Bryan E Shepherd, C William Wester, Isaac Zulu, Janelle M Chiasera, Lloyd B Mulenga, Albert Mwango, Douglas C Heimburger. (2011) Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia. Journal of the International AIDS Society 14, 19
    CrossRef

  484. 484

    L Nibali, S Fedele, F D’Aiuto, N Donos. (2011) Interleukin-6 in oral diseases: a review : IL-6 and oral diseases. Oral Diseases, no
    CrossRef

  485. 485

    Anna L. Soares, Rashid S. Kazmi, Michelle A. Borges, Pedro W. Rosário, Ana P. Fernandes, Marinez O. Sousa, Bashir A. Lwaleed, Maria G. Carvalho. (2011) Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes : inflammatory reaction, endothelial perturbation or else?. Blood Coagulation & Fibrinolysis 22:7, 600
    CrossRef

  486. 486

    T.-N. Wang, M.-C. Lin, C.-C. Wu, M.-S. Huang, S. Y. Leung, C.-C. Huang, P.-S. Ho, Y.-C. Ko. (2011) Role of gender disparity of circulating high-sensitivity C-reactive protein concentrations and obesity on asthma in Taiwan. Clinical & Experimental Allergy 41:10.1111/cea.2010.41.issue-1, 72-77
    CrossRef

  487. 487

    Joseph S. Alpert, Allan S. Jaffe, Kristian Thygesen, Harvey D. White. . Biomarkers in Acute Ischemic Heart Disease. 2011:, 101-112.
    CrossRef

  488. 488

    Efser Oztas, Gulay Kurtay. (2011) Randomized, controlled study of the effects of raloxifene on high sensitivity C-reactive protein and serum lipids. Archives of Gynecology and Obstetrics 283, 71-77
    CrossRef

  489. 489

    Fan He, Michele L Shaffer, Xian Li, Sol Rodriguez-Colon, Deborah L Wolbrette, Ronald Williams, Wayne E Cascio, Duanping Liao. (2011) Individual-level PM2.5 exposure and the time course of impaired heart rate variability: the APACR Study. Journal of Exposure Science and Environmental Epidemiology 21, 65-73
    CrossRef

  490. 490

    Mark Nash, Kevin Dalal, Jasmine Martinez-Barrizonte, Diana Cardenas. (2011) Suppression of Proatherogenic Inflammatory Cytokines as a Therapeutic Countermeasure to CVD Risks Accompanying SCI. Topics in Spinal Cord Injury Rehabilitation 16, 14-32
    CrossRef

  491. 491

    Hem C. Jha, Pragya Srivastava, Jagdish Prasad, Aruna Mittal. (2011) Chlamydia pneumoniae Heat Shock Protein 60 Enhances Expression of ERK, TLR-4 and IL-8 in Atheromatous Plaques of Coronary Artery Disease Patients. Immunological Investigations 40, 206-222
    CrossRef

  492. 492

    Hale Turan, Bahriye Horasanli, Murat Ugur, Hande Arslan. (2011) Procalcitonin Levels in Migraine Patients. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 38:01, 124-128
    CrossRef

  493. 493

    Christopher S. Coffey, Folkert W. Asselbergs, Patricia R. Hebert, Hans L. Hillege, Qing Li, Jason H. Moore, Wiek H. van Gilst. (2011) The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels. Cardiology Research and Practice 2011, 1-8
    CrossRef

  494. 494

    John A. Morrison, Charles J. Glueck, Stephen R. Daniels, Ping Wang, Davis M. Stroop, Paul S. Horn. (2011) High-Sensitivity C Reactive Protein: Associations with Cardiovascular Risk Factors and Tracking in Female Adolescents and Young Adults. ISRN Pediatrics 2011, 1-9
    CrossRef

  495. 495

    Carmine Savoia, Lidia Sada, Luigi Zezza, Lorenzo Pucci, Francesco Maria Lauri, Alberto Befani, Alessandro Alonzo, Massimo Volpe. (2011) Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension. International Journal of Hypertension 2011, 1-8
    CrossRef

  496. 496

    Viviane Zorzanelli Rocha, Eduardo J. Folco. (2011) Inflammatory Concepts of Obesity. International Journal of Inflammation 2011, 1-14
    CrossRef

  497. 497

    Jamal Bamoulid, Cécile Courivaud, Marina Deschamps, Béatrice Gaugler, Pierre Tiberghien, Jean-Marc Chalopin, Philippe Saas, Didier Ducloux. (2011) The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients. Journal of Transplantation 2011, 1-6
    CrossRef

  498. 498

    Zeynep Ozturk, Byambaa Enkhmaa, Neil S. Shachter, Lars Berglund, Erdembileg Anuurad. (2010) Integrated Role of Two Apoliprotein E Polymorphisms on Apolipoprotein B Levels and Coronary Artery Disease in a Biethnic Population. Metabolic Syndrome and Related Disorders 8, 531-538
    CrossRef

  499. 499

    Giuseppe Lippi, Emmanuel J. Favaloro, Martina Montagnana, Massimo Franchini. (2010) C-reactive protein and venous thromboembolism: causal or casual association?. Clinical Chemistry and Laboratory Medicine 48, 1693-1701
    CrossRef

  500. 500

    Sharon M. L. Wallace, Kaisa M. Mäki-Petäjä, Joseph Cheriyan, Edward H. Davidson, Lynne Cherry, Carmel M. McEniery, Naveed Sattar, Ian B. Wilkinson, Rajesh K. Kharbanda. (2010) Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction. British Journal of Clinical Pharmacology 70:10.1111/bcp.2010.70.issue-6, 799-806
    CrossRef

  501. 501

    Hui Chen, Pei Zheng, Haihua Zhu, Jianhua Zhu, Lili Zhao, Nour Eddine Mokhtari, Jörg Eberhard, Markus Lins, Søren Jepsen. (2010) Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. Clinical Oral Investigations 14, 629-636
    CrossRef

  502. 502

    Kazutaka Saito, Kazunori Kihara. (2010) Role of C-reactive protein as a biomarker for renal cell carcinoma. Expert Review of Anticancer Therapy 10, 1979-1989
    CrossRef

  503. 503

    Caroline Berthillot, Dominique Stephan, Michel Chauvin, Gerald Roul. (2010) In-hospital complications after invasive strategy for the management of Non STEMI: women fare as well as men. BMC Cardiovascular Disorders 10:1
    CrossRef

  504. 504

    Jaana I Halonen, Antonella Zanobetti, David Sparrow, Pantel S Vokonas, Joel Schwartz. (2010) Associations between outdoor temperature and markers of inflammation: a cohort study. Environmental Health 9:1
    CrossRef

  505. 505

    Amy Z Fan, Ajay Yesupriya, Man-huei Chang, Meaghan House, Jing Fang, Renée Ned, Donald Hayes, Nicole F Dowling, Ali H Mokdad. (2010) Gene polymorphisms in association with emerging cardiovascular risk markers in adult women. BMC Medical Genetics 11:1
    CrossRef

  506. 506

    Ming-May Lai, Chia-Ing Li, Sharon LR Kardia, Chiu-Shong Liu, Wen-Yuan Lin, Yih-Dar Lee, Pei-Chia Chang, Cheng-Chieh Lin, Tsai-Chung Li. (2010) Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population. BMC Public Health 10:1
    CrossRef

  507. 507

    Aydin Nazmi, Ana V Diez-Roux, Nancy S Jenny, Michael Y Tsai, Moyses Szklo, Allison E Aiello. (2010) The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis. BMC Public Health 10:1
    CrossRef

  508. 508

    Omar Rana, Christopher D Byrne, Kim Greaves. (2010) Intensive Insulin Therapy in the Intensive Care Unit, Hypoglycemia, and Cardiovascular Mortality. Hospital Practice 38, 59-66
    CrossRef

  509. 509

    Rahul Rawat, Jean H. Humphrey, Kuda Mutasa, Robert Ntozini, Rebecca J. Stoltzfus. (2010) Short Communication: Predicting Adverse HIV-Related Outcomes in a Resource-Limited Setting: Use of the Inflammation Marker α 1 -Acid Glycoprotein. AIDS Research and Human Retroviruses 26, 1171-1174
    CrossRef

  510. 510

    A.R. Pradeep, R.G. Shiva Manjunath, Rahul Kathariya. (2010) Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levels. Journal of Investigative and Clinical Dentistry 1:10.1111/jicd.2010.1.issue-2, 133-138
    CrossRef

  511. 511

    Mitchell S. V. Elkind. (2010) Impact of innate inflammation in population studies. Annals of the New York Academy of Sciences 1207:10.1111/nyas.2010.1207.issue-1, 97-106
    CrossRef

  512. 512

    Jiangtao Yan, James K. Liao, Daowen Wang. (2010) Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients. Journal of Huazhong University of Science and Technology [Medical Sciences] 30, 643-647
    CrossRef

  513. 513

    Jessica R. Meendering, Britta N. Torgrimson, Nicole P. Miller, Paul F. Kaplan, Christopher T. Minson. (2010) A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation☆. Contraception 82, 366-372
    CrossRef

  514. 514

    Antonio J Vallejo Vaz, María L Miranda Guisado, Pablo Stiefel García-Junco, Encarnación Pamies Andreu, Salvador García Morillo, José Villar Ortiz. (2010) Differences in the prevalence of metabolic syndrome and levels of C-reactive protein after puerperium in women with hypertensive disorders during pregnancy. Hypertension Research 33, 1012-1017
    CrossRef

  515. 515

    Fumitaka Tanaka, Shinji Makita, Toshiyuki Onoda, Kozo Tanno, Masaki Ohsawa, Kazuyoshi Itai, Kiyomi Sakata, Masayuki Onodera, Yorihiko Koeda, Kazuko Kawarura, Yasuo Terayama, Yuki Yoshida, Akira Ogawa, Akira Okayama, Motoyuki Nakamura. (2010) Prehypertension Subtype With Elevated C-Reactive Protein: Risk of Ischemic Stroke in a General Japanese Population. American Journal of Hypertension 23, 1108-1113
    CrossRef

  516. 516

    Sandip K. Zalawadiya, Vikas Veeranna, Ashutosh Niraj, Jyotiranjan Pradhan, Luis Afonso. (2010) Red Cell Distribution Width and Risk of Coronary Heart Disease Events. The American Journal of Cardiology 106, 988-993
    CrossRef

  517. 517

    Duane A. Burnett, Harry R. Davis. . Atherosclerosis I: LDL Cholesterol Lowering. 2010.
    CrossRef

  518. 518

    Zhuang Liu, Meng Su, Shi-cheng Yu, Zhi-hua Yin, Bao-sen Zhou. (2010) Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China. Thoracic Cancer 1:10.1111/tca.2010.1.issue-3, 126-129
    CrossRef

  519. 519

    R. J. Bisoendial, S. M. Boekholdt, M. Vergeer, E. S. G. Stroes, J. J. P. Kastelein. (2010) C-reactive protein is a mediator of cardiovascular disease. European Heart Journal 31, 2087-2091
    CrossRef

  520. 520

    Roy Fried. (2010) Zoster Vaccine in Older Adults. Journal of the American Geriatrics Society 58, 1799-1800
    CrossRef

  521. 521

    John T. Wilkins, Donald M. Lloyd-Jones. (2010) Biomarkers for Coronary Heart Disease Clinical Risk Prediction: A Critical Appraisal. Preventive Cardiology 13, 160-165
    CrossRef

  522. 522

    Emmanouil K. Symvoulakis, Constantine I. Vardavas, Popi Fountouli, Aimilia Stavroulaki, Katerina M. Antoniou, George Duijker, Manolis N. Tzatzarakis, Katerina Sfiridaki, Eirini Bolonaki, Thanasis Alegakis, Aristidis M. Tsatsakis. (2010) Time interval from cigarette smoke exposure to blood donation and markers of inflammation: should a smoking cut-off be designated?. Xenobiotica 40, 613-620
    CrossRef

  523. 523

    Georgios Tsakos, Wael Sabbah, Aroon D Hingorani, Gopalakrishnan Netuveli, Nikos Donos, Richard G Watt, Francesco DʼAiuto. (2010) Is periodontal inflammation associated with raised blood pressure? Evidence from a National US survey. Journal of Hypertension, 1
    CrossRef

  524. 524

    Bilgen Balaforlu, Ipek Eskiyoruk, Burcu Kus, Mesut Tozar, Nural Bekiroglu, Mehmet Koc. (2010) Seasonal variation of C-reactive protein and atherosclerotic cardiovascular events in hemodialysis patients. Renal Failure 32, 825-831
    CrossRef

  525. 525

    J. K. MacLaine, A. B. M. Rabie, R. Wong. (2010) Does orthodontic tooth movement cause an elevation in systemic inflammatory markers?. The European Journal of Orthodontics 32, 435-440
    CrossRef

  526. 526

    D. Conen, P. M. Ridker, B. M. Everett, U. B. Tedrow, L. Rose, N. R. Cook, J. E. Buring, C. M. Albert. (2010) A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. European Heart Journal 31, 1730-1736
    CrossRef

  527. 527

    Filippo Graziani, Silvia Cei, Fabio La Ferla, Michele Vano, Mario Gabriele, Maurizio Tonetti. (2010) Effects of non-surgical periodontal therapy on the glomerular filtration rate of the kidney: an exploratory trial. Journal of Clinical Periodontology 37:10.1111/cpe.2010.37.issue-7, 638-643
    CrossRef

  528. 528

    Zhiqiang Wang, Wendy E. Hoy. (2010) C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians. Australian and New Zealand Journal of Public Health 34, S25-S29
    CrossRef

  529. 529

    L. Soares-Miranda, C. E. Negrao, L. M. Antunes-Correa, T. S. Nobre, P. Silva, R. Santos, S. Vale, J. Mota. (2010) High levels of C-reactive protein are associated with reduced vagal modulation and low physical activity in young adults. Scandinavian Journal of Medicine & Science in Sports, no-no
    CrossRef

  530. 530

    Petter Quist-Paulsen. (2010) Statins and inflammation: an update. Current Opinion in Cardiology 25, 399-405
    CrossRef

  531. 531

    Carla LoPinto-Khoury, Scott Mintzer. (2010) Antiepileptic Drugs and Markers of Vascular Risk. Current Treatment Options in Neurology 12, 300-308
    CrossRef

  532. 532

    Mukesh Singh, Sarabjeet Singh, Rohit Arora, Sandeep Khosla. (2010) Cardiac syndrome X: Current concepts. International Journal of Cardiology 142, 113-119
    CrossRef

  533. 533

    Turgay Celik, Atila Iyisoy, U.Cagdas Yuksel. (2010) Possible pathogenetic role of Helicobacter pylori infection in cardiac syndrome X. International Journal of Cardiology 142, 193-194
    CrossRef

  534. 534

    Tao Zhang, Tomoko Kurita-Ochiai, Tomomi Hashizume, Yuan Du, Sumito Oguchi, Masafumi Yamamoto. (2010) Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunology & Medical Microbiology 59:2, 143-151
    CrossRef

  535. 535

    Abhimanyu Beri, Tahmeed Contractor, Atul Khasnis, Ranjan Thakur. (2010) Statins and the Reduction of Sudden Cardiac Death. American Journal Cardiovascular Drugs 10, 155-164
    CrossRef

  536. 536

    Hongsheng Ren, Ming Li, Lili Feng, Jinjiao Jiang, Yijing Zhang, Yuanchao Zhang, Xinglei Zhu. (2010) Effects of Clopidogrel on Vascular Proliferation and Apoptosis in an Atherosclerotic Rabbit Model. Journal of Cardiovascular Pharmacology 55, 617-624
    CrossRef

  537. 537

    Gina Biasillo, Milena Leo, Roberta Della Bona, Luigi Marzio Biasucci. (2010) Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. Internal and Emergency Medicine 5, 225-233
    CrossRef

  538. 538

    D. Deepak, C. Daousi, M. Javadpour, D. Clark, Y. Perry, J. Pinkney, I.A. MacFarlane. (2010) The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency. Growth Hormone & IGF Research 20, 220-225
    CrossRef

  539. 539

    Kristen M. Beavers, Tina E. Brinkley, Barbara J. Nicklas. (2010) Effect of exercise training on chronic inflammation. Clinica Chimica Acta 411, 785-793
    CrossRef

  540. 540

    J. Pavlu, A. K. Kew, B. Taylor-Roberts, H. W. Auner, D. Marin, E. Olavarria, E. J. Kanfer, D. H. MacDonald, D. Milojkovic, A. Rahemtulla, K. Rezvani, J. M. Goldman, J. F. Apperley, R. M. Szydlo. (2010) Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase. Blood 115, 4018-4020
    CrossRef

  541. 541

    Willian Cruz, Sonia Fialho, Edelton Morato, Gláucio Castro, Adriana Zimmermann, Giovana Ribeiro, Fabrício Neves, Ivânio Pereira. (2010) Is there a link between inflammation and abnormal lipoprotein profile in Sjögren's syndrome?. Joint Bone Spine 77, 229-231
    CrossRef

  542. 542

    (2010) Diabetes mellitus y riesgo cardiovascular. Recomendaciones del grupo de trabajo Diabetes Mellitus y Enfermedad Cardiovascular de la Sociedad Española de Diabetes 2009. Endocrinología y Nutrición 57, 220-226
    CrossRef

  543. 543

    David Conen, Christine M. Albert. (2010) Sex Differences in Atrial Fibrillation and Its Complications. Current Cardiovascular Risk Reports 4, 237-243
    CrossRef

  544. 544

    George S. Abela. (2010) Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation. Journal of Clinical Lipidology 4, 156-164
    CrossRef

  545. 545

    Francesco US Mattace-Raso, Germaine C Verwoert, Albert Hofman, Jacqueline CM Witteman. (2010) Inflammation and incident-isolated systolic hypertension in older adults: the Rotterdam study. Journal of Hypertension 28, 892-895
    CrossRef

  546. 546

    J. Gustav Smith, Christopher Newton-Cheh. (2010) Genetic Loci Associated with C-Reactive Protein Levels and Risk Of Coronary Heart Disease. Current Cardiovascular Risk Reports 4, 178-180
    CrossRef

  547. 547

    P. M. Ridker. (2010) Psoriasis, inflammation, and vascular risk: a problem more than skin deep?. European Heart Journal 31, 902-904
    CrossRef

  548. 548

    R. P. Stowe, M. K. Peek, M. P. Cutchin, J. S. Goodwin. (2010) Plasma Cytokine Levels in a Population-Based Study: Relation to Age and Ethnicity. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 65A, 429-433
    CrossRef

  549. 549

    Amparo Galán, Antonio Curós, Vicente Valle. (2010) Biomarcadores de detección y predicción de síndrome coronario agudo. Medicina Clínica 134, 499-504
    CrossRef

  550. 550

    Ambareesh Bajpai, Abhinav Goyal, Laurence Sperling. (2010) Should We Measure C-reactive Protein on Earth or Just on JUPITER?. Clinical Cardiology 33:10.1002/clc.v33:4, 190-198
    CrossRef

  551. 551

    Peter S. Munk, Tor H. Melberg, Oyvind Skadberg, Jan T. Kvaløy, Alf I. Larsen. (2010) Variations in population-based levels of C-reactive protein, cardiovascular morbidity and all-cause mortality. International Journal of Cardiology 140, 247-249
    CrossRef

  552. 552

    Rosalind J. Wright. (2010) Perinatal stress and early life programming of lung structure and function. Biological Psychology 84, 46-56
    CrossRef

  553. 553

    Mi-Ri Kim, Jungil Hong. (2010) Analysis of chemical interactions of (−)-epigallocatechin-3-gallate, a major green tea polyphenol, with commonly-consumed over-thecounter drugs. Food Science and Biotechnology 19, 559-564
    CrossRef

  554. 554

    Aydin Nazmi, Isabel O. Oliveira, Bernardo L. Horta, Denise P. Gigante, Cesar G. Victora. (2010) Lifecourse socioeconomic trajectories and C-reactive protein levels in young adults: Findings from a Brazilian birth cohort. Social Science & Medicine 70, 1229-1236
    CrossRef

  555. 555

    Grace Casaclang-Verzosa, Marion E. Barnes, Gustavo Blume, James B. Seward, Bernard J. Gersh, Stephen S. Cha, Kent R. Bailey, Teresa S. M. Tsang. (2010) C-Reactive Protein, Left Atrial Volume, and Atrial Fibrillation: A Prospective Study in High-Risk Elderly. Echocardiography 27, 394-399
    CrossRef

  556. 556

    L. Takouli, D. Hadjiyannakos, P. Metaxaki, V. Sideris, V. Filiopoulos, A. Anogiati, D. Vlassopoulos. (2010) Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress. Renal Failure 32, 287-293
    CrossRef

  557. 557

    Michael R. Bleavins, Claudio Carini, Malle Jurima-Romet, Ramin Rahbari. . Biomarkers. 2010.
    CrossRef

  558. 558

    Daisuke Ekuni, Takaaki Tomofuji, Koichiro Irie, Kenta Kasuyama, Michihiro Umakoshi, Tetsuji Azuma, Naofumi Tamaki, Toshihiro Sanbe, Yasumasa Endo, Tatsuo Yamamoto, Takashi Nishida, Manabu Morita. (2010) Effects of periodontitis on aortic insulin resistance in an obese rat model. Laboratory Investigation 90, 348-359
    CrossRef

  559. 559

    Jin Si, Yan Ge, Shougang Zhuang, Rujun Gong. (2010) Inhibiting nonmuscle myosin II impedes inflammatory infiltration and ameliorates progressive renal disease. Laboratory Investigation 90, 448-458
    CrossRef

  560. 560

    Rocco Antonio Montone, Giuseppe Ferrante, Marco Bacà, Giampaolo Niccoli. (2010) Predictive value of C-reactive protein after drug-eluting stent implantation. Future Cardiology 6, 167-179
    CrossRef

  561. 561

    Cedric Delhaye, Gabriel Maluenda, Kohei Wakabayashi, Itsik Ben-Dor, Gilles Lemesle, Sara D. Collins, Asmir I. Syed, Rebecca Torguson, Kimberly Kaneshige, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron Waksman. (2010) Long-Term Prognostic Value of Preprocedural C-Reactive Protein After Drug-Eluting Stent Implantation. The American Journal of Cardiology 105, 826-832
    CrossRef

  562. 562

    Nithya Sukumar, Ansu Basu. (2010) Treatment of erectile dysfunction in the older diabetic patient. Aging Health 6, 9-29
    CrossRef

  563. 563

    Umadevi Kandalam, Michelle A. Clark. (2010) Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes. Regulatory Peptides 159, 110-116
    CrossRef

  564. 564

    Shion Imoto, Kosuke Sakurai, Takeshi Sugimoto, Makoto Hashimoto, Katsuyasu Saigo, Shinya Akita, Nobuo Araki, Mariko Yamashita, Kiichiro Namura, Yoshihiro Bouike, Rika Taniguchi, Osamu Mabuchi. (2010) COMPARISON OF ATHEROSCLEROTIC RISK FACTORS BETWEEN DONORS WITH ASSOCIATED ACUTE NON-HEMOLYTIC TRANSFUSION REACTIONS AND DONORS WITHOUT ASSOCIATION. Japanese Journal of Transfusion and Cell Therapy 56, 697-701
    CrossRef

  565. 565

    Robert M. Califf. . Medical Management of Acute Coronary Syndromes. 2010:, 867-882.
    CrossRef

  566. 566

    Jung Min Lee, Hyun Woong Lee, Yoon Suk Hong, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Jae Seok Hwang, Hyungseop Kim. (2010) A Case of Acute Myocardial Infarction Occurred Immediately after Endoscopic Submucosal Dissection. The Korean Journal of Gastroenterology 56, 249
    CrossRef

  567. 567

    Peter G. Blake, Rita S. Suri. . Peritoneal Dialysis Prescription and Adequacy. 2010:, 432-445.
    CrossRef

  568. 568

    Paolo Calabrò, Enrica Golia, Lucia Riegler, Giuseppe Limongelli, Paolo Golino, Maria Giovanna Russo, Raffaele Calabrò. (2010) Inflammation: The Link Between Obesity and Cardiovascular Risk. Current Cardiovascular Risk Reports 4:2, 101
    CrossRef

  569. 569

    Charles N. Serhan. . Lipoxins and Aspirin-Triggered 15-epi-Lipoxins. 2010:, 1235-1242.
    CrossRef

  570. 570

    Atsushi Tanaka, Guillermo J. Tearney, Brett E. Bouma. (2010) Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography. Journal of Biomedical Optics 15, 011104
    CrossRef

  571. 571

    Matthias Frick, Herwig Antretter, Otmar Pachinger, Gerhard Pölzl. (2010) Biomarker zur Diagnose der zellulären Abstoßung nach Herztransplantation. Herz 35, 11-16
    CrossRef

  572. 572

    Susan M. Ordaz-Medina, Juana González-Plascencia, Fabiola Martín del Campo, Enrique Rojas-Campos, José L Montañez-Fernández, Francisco Espinoza-Gómez, Alfonso M. Cueto-Manzano. (2010) Is Systemic Inflammation of Hemodialysis Patients Improved With the Use of Enalapril? Results of a Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. ASAIO Journal 56, 37-41
    CrossRef

  573. 573

    Giovanni Guaraldi, Chiara Stentarelli, Stefano Zona, Gabriella Orlando, Federica Carli, Guido Ligabue, Antonella Lattanzi, Giacomo Zaccherini, Rosario Rossi, Maria Grazia Modena, Nikolaos Alexopoulos, Frank Palella, Paolo Raggi. (2010) Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis 208, 222-227
    CrossRef

  574. 574

    Tomoe KOMORIYA, Maho KIKUCHI, Yutaka TERASHIMA, Mayumi OKAMOTO, Masahiro OGAWA, Mituhiko MORIYAMA, Hideki KOHNO. (2010) Development of a Highly Sensitive Latex Reagent Directed against C-Reactive Protein (CRP) Using Epitope Analysis with Monoclonal Antibodies. Bioscience, Biotechnology, and Biochemistry 74, 292-297
    CrossRef

  575. 575

    Charles J. Everett, Dana E. King, Marty S. Player, Eric M. Matheson, Robert E. Post, Arch G. Mainous. (2010) Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein. Environmental Research 110, 79-82
    CrossRef

  576. 576

    Per Torger Skretteberg, Johan Bodegård, Sverre E. Kjeldsen, Gunnar Erikssen, Erik Thaulow, Leif Sandvik, Jan E. Erikssen. (2010) Interaction between inflammation and blood viscosity predicts cardiovascular mortality. Scandinavian Cardiovascular Journal 44, 107-112
    CrossRef

  577. 577

    Rachel E. Cowan, Mark S. Nash. (2010) Cardiovascular disease, SCI and exercise: unique risks and focused countermeasures. Disability and Rehabilitation 32, 2228-2236
    CrossRef

  578. 578

    Miki Sato, Shinichi Kako, Kumi Oshima, Ken Sato, Kiriko Terasako, Shun-Ichi Kimura, Hideki Nakasone, Shinya Okuda, Rie Yamazaki, Takakazu Higuchi, Junji Nishida, Yoshinobu Kanda. (2010) Prediction of infectious events by high-sensitivity C-reactive protein level before undergoing chemotherapy for acute myeloid leukaemia. Scandinavian Journal of Infectious Diseases 42, 97-101
    CrossRef

  579. 579

    Johannes Winning, Jens Neumann, Matthias Kohl, Ralf A. Claus, Konrad Reinhart, Michael Bauer, Wolfgang Lösche. (2010) Antiplatelet drugs and outcome in mixed admissions to an intensive care unit*. Critical Care Medicine 38, 32-37
    CrossRef

  580. 580

    (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet 375:9709, 132-140
    CrossRef

  581. 581

    E. Ramesh, P. Geraldine, P.A. Thomas. (2010) Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chemico-Biological Interactions 183:1, 125-132
    CrossRef

  582. 582

    Veena S. Rao, Natesha B. Kadarinarasimhiah, Shibu John, Sridhara Hebbagodi, Jayashree Shanker, Vijay V. Kakkar. (2010) Usefulness of C-Reactive Protein as a Marker for Prediction of Future Coronary Events in the Asian Indian Population: Indian Atherosclerosis Research Study. International Journal of Vascular Medicine 2010, 1-8
    CrossRef

  583. 583

    Allison E. Aiello, George A. Kaplan. (2009) Socioeconomic Position and Inflammatory and Immune Biomarkers of Cardiovascular Disease: Applications to the Panel Study of Income Dynamics. Biodemography and Social Biology 55, 178-205
    CrossRef

  584. 584

    Mayuko Akamatsu, Tetsuya Ogawa, Ayuko Fujiu, Nami Matsuda, Kosaku Nitta. (2009) Clinical assessment of atherosclerotic parameters and cardiac function in chronic hemodialysis patients. Clinical and Experimental Nephrology 13, 651-658
    CrossRef

  585. 585

    Vadivel Senthil Kumaran, Karpagavinayagam Arulmathi, Rajaguru Sundarapandiyan, Periandavan Kalaiselvi. (2009) Attenuation of the inflammatory changes and lipid anomalies by epigallocatechin-3-gallate in hypercholesterolemic diet fed aged rats. Experimental Gerontology 44, 745-751
    CrossRef

  586. 586

    Toshiko Uchida, Stephen D. Persell, David W. Baker. (2009) Update in General Internal Medicine. Journal of General Internal Medicine 24, 1327-1332
    CrossRef

  587. 587

    허금, Dong-Ho Park, Jun,Tae-Won, Wook Song, 김광준, 김권일. (2009) The Effect of Aerobic Gymnastic Exercise on Physical Fitness and Inflammatory Markers in Hemiplegic Disabled after Cerebral Stroke. Journal of adapted physical activity and exercise 17, 109-126
    CrossRef

  588. 588

    Mona Hashem Allam, Azza Farag Said, Ahmed Abd El Samie Omran, Dalia Mohammed Abd El-Reheim, Ahmed Hussein Kasem. (2009) High sensitivity C-reactive protein: Its correlation with sputum cell counts in bronchial asthma. Respiratory Medicine 103, 1878-1884
    CrossRef

  589. 589

    Chih-Wei Chen, Yen-Hsien Lee, Hung-Mei Chen, Ying-Lung Lin. (2009) High-sensitivity C-reactive Protein and Other Factors as Outcome Predictors in Acute Decompensated Heart Failure. Tzu Chi Medical Journal 21, 296-301
    CrossRef

  590. 590

    S. R. Williams, G. Pham-Kanter, S. A. Leitsch. (2009) Measures of Chronic Conditions and Diseases Associated With Aging in the National Social Life, Health, and Aging Project. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 64B, i67-i75
    CrossRef

  591. 591

    S. R. Williams, T. W. McDade. (2009) The Use of Dried Blood Spot Sampling in the National Social Life, Health, and Aging Project. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 64B, i131-i136
    CrossRef

  592. 592

    Nicoletta Vivona, Giulia Bivona, Davide Noto, Bruna Lo Sasso, Angelo B. Cefalù, Gaia Chiarello, Angelo Falletta, Marcello Ciaccio, Maurizio R. Averna. (2009) C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. Clinical Biochemistry 42, 1713-1718
    CrossRef

  593. 593

    Yukihiko Momiyama, Akito Kawaguchi, Ichiro Kajiwara, Reiko Ohmori, Katsutoshi Okada, Isao Saito, Masamitsu Konishi, Masakazu Nakamura, Shinichi Sato, Yoshihiro Kokubo, Toshifumi Mannami, Hisashi Adachi, Kazuomi Kario, Hiroyasu Iso, Fumitaka Ohsuzu, Motoo Tsushima. (2009) Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study. Atherosclerosis 207, 272-276
    CrossRef

  594. 594

    Xiu-ren Gao, Chandar M. Adhikari, Long-yun Peng, Xiao-gang Guo, Yuan-sheng Zhai, Xu-yu He, Li-Yuan Zhang, Jun Lin, Zhi-yi Zuo. (2009) Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome. Journal of Pharmacy and Pharmacology 61, 1505-1510
    CrossRef

  595. 595

    Walter T. McNicholas. (2009) Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine 180, 692-700
    CrossRef

  596. 596

    Nitin Mahajan, Namita Malik, Ajay Bahl, Yashpaul Sharma, Veena Dhawan. (2009) Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease. Molecular and Cellular Biochemistry 330, 201-209
    CrossRef

  597. 597

    Steffen U. Eisenhardt, Jonathon Habersberger, Karlheinz Peter. (2009) Monomeric C-Reactive Protein Generation on Activated Platelets: The Missing Link Between Inflammation and Atherothrombotic Risk. Trends in Cardiovascular Medicine 19, 232-237
    CrossRef

  598. 598

    Laura A. Colangelo, Brian Chiu, Peter Kopp, Kiang Liu, Susan M. Gapstur. (2009) Serum IGF-I and C-reactive protein in healthy black and white young men: The CARDIA male hormone study. Growth Hormone & IGF Research 19, 420-425
    CrossRef

  599. 599

    Ali A. Rizvi. (2009) Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts. The American Journal of the Medical Sciences 338:4, 310-318
    CrossRef

  600. 600

    Shuumarjav Uurtuya, Kazuhiko Kotani, Nobuyuki Taniguchi, Hiroaki Matsunaga, Hiroshi Kanai, Hideyuki Hasegawa, Kazuomi Kario, Shun Ishibashi, Kouichi Itoh. (2009) Relationship between upper limb peripheral artery stiffness using the radial artery and atherosclerotic parameters. Journal of Medical Ultrasonics 36, 129-135
    CrossRef

  601. 601

    Peter P. Toth. (2009) Statin therapy, inflammation, and risk for cardiovascular events: The light from JUPITER is illuminating. Current Atherosclerosis Reports 11, 323-325
    CrossRef

  602. 602

    Udaya S. Tantry, Elisabeth Mahla, Paul A. Gurbel. (2009) Aspirin Resistance. Progress in Cardiovascular Diseases 52, 141-152
    CrossRef

  603. 603

    Sebastián Hernández, Magdalena Vidal, Enric Pedrol. (2009) Evaluación del riesgo cardiovascular e intervención en los pacientes con VIH. Enfermedades Infecciosas y Microbiología Clínica 27, 40-47
    CrossRef

  604. 604

    Scott Mintzer, Richard T. Mattson. (2009) Should enzyme-inducing antiepileptic drugs be considered first-line agents?. Epilepsia 50:10.1111/epi.2009.50.issue-s8, 42-50
    CrossRef

  605. 605

    Gabriel Izbicki, Itsik Ben-Dor, David Shitrit, Danielle Bendayan, Thomas K. Aldrich, Ran Kornowski, Mordechai R. Kramer. (2009) The prevalence of coronary artery disease in end-stage pulmonary disease: Is pulmonary fibrosis a risk factor?. Respiratory Medicine 103, 1346-1349
    CrossRef

  606. 606

    Francisco AH Fonseca, Maria Cristina O Izar. (2009) Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study. Expert Review of Cardiovascular Therapy 7, 1041-1056
    CrossRef

  607. 607

    Giuseppe Marano, Desiree Harnic, Marzia Lotrionte, Giuseppe Biondi-Zoccai, Antonio Abbate, Enrico Romagnoli, Marianna Mazza. (2009) Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications. Expert Review of Cardiovascular Therapy 7, 1123-1147
    CrossRef

  608. 608

    Panagiota Pietri, Charalambos Vlachopoulos, Konstantinos Aznaouridis, Katerina Baou, Panagiotis Xaplanteris, Ioanna Dima, Gregory Vyssoulis, Christodoulos Stefanadis. (2009) Inflammatory status, arterial stiffness and central hemodynamics in hypertensive patients with metabolic syndrome. Artery Research 3:3, 115-121
    CrossRef

  609. 609

    Abayomi O. Akanji, Jude U. Ohaeri, Suhail Al-Shammri, Hasmukh R. Fatania. (2009) Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients. Psychiatry Research 169, 56-61
    CrossRef

  610. 610

    E. GRAD, M. GOLOMB, N. KOROUKHOV, J. A. LAWSON, C. LOTAN, G. A. FITZGERALD, H. D. DANENBERG. (2009) Aspirin reduces the prothrombotic activity of C-reactive protein. Journal of Thrombosis and Haemostasis 7:10.1111/jth.2009.7.issue-8, 1393-1400
    CrossRef

  611. 611

    Maqsood M. Elahi, Felino R. Cagampang, Dhea Mukhtar, Frederick W. Anthony, Sunil K. Ohri, Mark A. Hanson. (2009) Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. British Journal of Nutrition 102, 514
    CrossRef

  612. 612

    Robin Vos, Bart M. Vanaudenaerde, Stéphanie I. De Vleeschauwer, Anna Willems-Widyastuti, Hans Scheers, Dirk E. Van Raemdonck, Lieven J. Dupont, Geert M. Verleden. (2009) Circulating and Intrapulmonary C-Reactive Protein: A Predictor of Bronchiolitis Obliterans Syndrome and Pulmonary Allograft Outcome. The Journal of Heart and Lung Transplantation 28, 799-807
    CrossRef

  613. 613

    Hisao Ogawa, Sunao Kojima. (2009) Modern state of acute myocardial infarction in the interventional era: Observational case–control study—Japanese acute coronary syndrome study (JACSS). Journal of Cardiology 54, 1-9
    CrossRef

  614. 614

    Louai Razzouk, Paul Muntner, Sameer Bansilal, Annapoorna S. Kini, Ashish Aneja, Joshua Mozes, Oana Ivan, Madhavi Jakkula, Samin Sharma, Michael E. Farkouh. (2009) C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. American Heart Journal 158:2, 277-283
    CrossRef

  615. 615

    Jennifer E. Phillips, Anna L. Marsland, Janine D. Flory, Matthew F. Muldoon, Sheldon Cohen, Stephen B. Manuck. (2009) Parental education is related to C-reactive protein among female middle aged community volunteers. Brain, Behavior, and Immunity 23, 677-683
    CrossRef

  616. 616

    James K. Liao. (2009) Genetically elevated C-reactive protein and ischemic vascular disease. Current Atherosclerosis Reports 11, 245-245
    CrossRef

  617. 617

    PAUL M. RIDKER. (2009) Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). Journal of Thrombosis and Haemostasis 7:10.1111/jth.2009.7.issue-s1, 332-339
    CrossRef

  618. 618

    Guido Lastra, Adam Whaley-Connell. (2009) Diabetes: Aspirin and prevention of diabetes still a topic of debate. Nature Reviews Endocrinology 5, 365-366
    CrossRef

  619. 619

    M. Odette Gore, Darren K. McGuire. (2009) Cardiovascular disease and type 2 diabetes mellitus: Regulating glucose and regulating drugs. Current Cardiology Reports 11, 258-263
    CrossRef

  620. 620

    Jeffrey M Bloom. (2009) Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. The Lancet 374, 25-26
    CrossRef

  621. 621

    Janusz Szkodziński, Wojciech Romanowski, Bartosz Hudzik, Andrzej Kaszuba, Ewa Nowakowska-Zajdel, Ryszard Szkilnik, Barbara Pietrasińska, Barbara Zubelewicz-Szkodzińska. (2009) Effect of HMG-CoA (3-hydroxy-3-methyl-glutaryl-CoA) reductase inhibitors on the concentration of insulin-like growth factor-1 (IGF-1) in hypercholesterolemic patients. Pharmacological Reports 61, 654-664
    CrossRef

  622. 622

    Takako Nakajima, Kazuhisa Yamazaki. (2009) Periodontal disease and risk of atherosclerotic coronary heart disease. Odontology 97, 84-91
    CrossRef

  623. 623

    Nauder Faraday, Lisa R. Yanek, Dhananjay Vaidya, Brian Kral, Rehan Qayyum, J. Enrique Herrera-Galeano, Taryn F. Moy, Diane M. Becker, Lewis C. Becker. (2009) Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease. Thrombosis Research 124, 311-317
    CrossRef

  624. 624

    Michael A. Zimmerman, Sonia C. Flores. (2009) Autoimmune-Mediated Oxidative Stress and Endothelial Dysfunction: Implications of Accelerated Vascular Injury in Type I Diabetes. Journal of Surgical Research 155, 173-178
    CrossRef

  625. 625

    Xiao-Ming Mao, Hao Liu, Xiao-Jun Tao, Guo-Ping Yin, Qian Li, Shu-Kui Wang. (2009) Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes. Diabetes/Metabolism Research and Reviews 25:10.1002/dmrr.v25:5, 435-441
    CrossRef

  626. 626

    Tibor Fulop, Andrew D. Rule, Darren W. Schmidt, Heather J. Wiste, Kent R. Bailey, Iftikhar J. Kullo, Gary L. Schwartz, Thomas H. Mosley, Eric Boerwinkle, Stephen T. Turner. (2009) C-reactive protein among community-dwelling hypertensives on single-agent antihypertensive treatment. Journal of the American Society of Hypertension 3, 260-266
    CrossRef

  627. 627

    Cédric Delhaye, Arnaud Sudre, Gilles Lemesle, Sylvestre Maréchaux, Damien Broucqsault, Bernadette Hennache, Christophe Bauters, Jean-Marc Lablanche. (2009) Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention. Cardiovascular Revascularization Medicine 10, 144-150
    CrossRef

  628. 628

    James K. Liao. (2009) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. Current Atherosclerosis Reports 11, 243-244
    CrossRef

  629. 629

    Paul M. Ridker. (2009) Moving toward new statin guidelines in a post-JUPITER world: Principles to consider. Current Atherosclerosis Reports 11, 249-256
    CrossRef

  630. 630

    Virginia A Triant, James B Meigs, Steven K Grinspoon. (2009) Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction. JAIDS Journal of Acquired Immune Deficiency Syndromes 51, 268-273
    CrossRef

  631. 631

    Erdembileg Anuurad, Russell P. Tracy, Thomas A. Pearson, Kyoungmi Kim, Lars Berglund. (2009) Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 205, 290-295
    CrossRef

  632. 632

    Vincent E. Friedewald, Kenneth S. Kornman, James D. Beck, Robert Genco, Allison Goldfine, Peter Libby, Steven Offenbacher, Paul M. Ridker, Thomas E. Van Dyke, William C. Roberts. (2009) The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease††Published simultaneously in the Journal of Periodontology, the Official Journal of the American Academy of Periodontology.. The American Journal of Cardiology 104, 59-68
    CrossRef

  633. 633

    Kai M. Eggers, Bo Lagerqvist, Per Venge, Lars Wallentin, Bertil Lindahl. (2009) Prognostic Value of Biomarkers During and After Non–ST-Segment Elevation Acute Coronary Syndrome. Journal of the American College of Cardiology 54:4, 357-364
    CrossRef

  634. 634

    이건호. (2009) The Association between Serum GGT within Normal Range and Cardiovascular Risk Factors, Metabolic Syndrome of Premenopausal and Postmenopausal Women. JOURNAL OF THE KOREAN SOCIETY OF MATERNAL AND CHILD HEALTH 13:2, 171-181
    CrossRef

  635. 635

    Vincent E. Friedewald, Kenneth S. Kornman, James D. Beck, Robert Genco, Allison Goldfine, Peter Libby, Steven Offenbacher, Paul M. Ridker, Thomas E. Van Dyke, William C. Roberts. (2009) The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Journal of Periodontology 80:7, 1021-1032
    CrossRef

  636. 636

    Coman Tanasescu, Ciprian Jurcut, Ruxandra Jurcut, Carmen Ginghina. (2009) Vascular disease in rheumatoid arthritis: From subclinical lesions to cardiovascular risk. European Journal of Internal Medicine 20:4, 348-354
    CrossRef

  637. 637

    Viviane Z. Rocha, Peter Libby. (2009) Obesity, inflammation, and atherosclerosis. Nature Reviews Cardiology 6, 399-409
    CrossRef

  638. 638

    Alberto Dominguez-Rodriguez, Sima Samimi Fard, Pedro Abreu-Gonzalez, Francisco Bosa-Ojeda, Luciano Consuegra-Sanchez, Alejandro Jiménez-Sosa, Alejandro Sánchez Grande, Juan Carlos Kaski. (2009) Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the I f Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome—RIVIERA Trial Study Design and Rationale. Cardiovascular Drugs and Therapy 23, 243-247
    CrossRef

  639. 639

    Priscilla Y Hsue, Peter W Hunt, Amanda Schnell, S Craig Kalapus, Rebecca Hoh, Peter Ganz, Jeffrey N Martin, Steven G Deeks. (2009) Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 23, 1059-1067
    CrossRef

  640. 640

    Ming-Sheng Teng, Lung-An Hsu, Semon Wu, Hsien-Hsun Chang, Hsin-Hua Chou, Yu-Lin Ko. (2009) Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwanese: Interaction with obesity. Atherosclerosis 204, e64-e69
    CrossRef

  641. 641

    Sunna Snaedal, Olof Heimbürger, Abdul Rashid Qureshi, Anders Danielsson, Björn Wikström, Bengt Fellström, Ingela Fehrman-Ekholm, Juan Jesús Carrero, Anders Alvestrand, Peter Stenvinkel, Peter Bárány. (2009) Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient Survival. American Journal of Kidney Diseases 53, 1024-1033
    CrossRef

  642. 642

    Epaminondas Zakynthinos, Nikolitsa Pappa. (2009) Inflammatory biomarkers in coronary artery disease. Journal of Cardiology 53, 317-333
    CrossRef

  643. 643

    Stefan Renvert, Christel Lindahl, Ann-Marie Roos-Jansåker, Jan Lessem. (2009) Short-Term Effects of an Anti-Inflammatory Treatment on Clinical Parameters and Serum Levels of C-Reactive Protein and Proinflammatory Cytokines in Subjects With Periodontitis. Journal of Periodontology 80:6, 892-900
    CrossRef

  644. 644

    Ori Rogowski, Itzhak Shapira, Arie Steinvil, Shlomo Berliner. (2009) Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: Another feature of the atherogenic dysmetabolism. Metabolism 58, 661-667
    CrossRef

  645. 645

    Barry McDonnell, Stephen Hearty, Paul Leonard, Richard O'Kennedy. (2009) Cardiac biomarkers and the case for point-of-care testing. Clinical Biochemistry 42, 549-561
    CrossRef

  646. 646

    Henrik Brun, Henrik Holmstrøm, Erik Thaulow, Jan Kristian Damås, Arne Yndestad, Pål Aukrust, Thor Ueland. (2009) Patients with Pulmonary Hypertension Related to Congenital Systemic-to-Pulmonary Shunts are Characterized by Inflammation Involving Endothelial Cell Activation and Platelet-mediated Inflammation. Congenital Heart Disease 4:10.1111/chd.2009.4.issue-3, 153-159
    CrossRef

  647. 647

    Dustin Goei, Sanne E. Hoeks, Eric Boersma, Tamara A. Winkel, Martin Dunkelgrun, Willem-Jan Flu, Olaf Schouten, Jeroen J. Bax, Don Poldermans. (2009) Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Coronary Artery Disease 20, 219-224
    CrossRef

  648. 648

    W. C. Stephen, I. Janssen. (2009) Sarcopenic-obesity and cardiovascular disease risk in the elderly. The Journal of Nutrition, Health and Aging 13, 460-466
    CrossRef

  649. 649

    Shinji Makita, Motoyuki Nakamura, Kenyu Satoh, Fumitaka Tanaka, Toshiyuki Onoda, Kazuko Kawamura, Masaki Ohsawa, Kozo Tanno, Kazuyoshi Itai, Kiyomi Sakata, Akira Okayama, Yasuo Terayama, Yuki Yoshida, Akira Ogawa. (2009) Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis 204, 234-238
    CrossRef

  650. 650

    Kaoru Matsuura, Mizuho Imamaki, Atsushi Ishida, Hitoshi Shimura, Masaru Miyazaki. (2009) The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery. Heart and Vessels 24, 169-174
    CrossRef

  651. 651

    Adam M. Rogers, Michael G. Shlipak. (2009) C-Reactive Protein, Statins, and Cardiovascular Risk: What Can JUPITER Teach Us?. American Journal of Kidney Diseases 53, 737-740
    CrossRef

  652. 652

    Robert Skinner, Rachel Georgiou, Peter Thornton, Nancy Rothwell. (2009) Psychoneuroimmunology of Stroke. Immunology and Allergy Clinics of North America 29, 359-379
    CrossRef

  653. 653

    Saori Yoshii, Shinji Tsuboi, Ichizo Morita, Yuko Takami, Keiko Adachi, Junko Inukai, Koji Inagaki, Kinichiro Mizuno, Haruo Nakagaki. (2009) Temporal Association of Elevated C-Reactive Protein and Periodontal Disease in Men. Journal of Periodontology 80:5, 734-739
    CrossRef

  654. 654

    Glynn , Robert J. , Danielson , Eleanor , Fonseca , Francisco A.H. , Genest , Jacques , Gotto , Antonio M. Jr. , Kastelein , John J.P. , Koenig , Wolfgang , Libby , Peter , Lorenzatti , Alberto J. , MacFadyen , Jean G. , Nordestgaard , Børge G. , Shepherd , James , Willerson , James T. , Ridker , Paul M , . (2009) A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism. New England Journal of Medicine 360:18, 1851-1861
    Free Full Text

  655. 655

    N Goldenberg-Cohen, Y Cohen, Y Monselise, I Eldar, R Axer-Siegel, D Weinberger, M Kramer. (2009) C-reactive protein levels do not correlate with retinal artery occlusion but with atherosclerosis. Eye 23, 785-790
    CrossRef

  656. 656

    Srinivas Iyengar, LeRoy E. Rabbani. (2009) Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists. Journal of Thrombosis and Thrombolysis 27, 300-306
    CrossRef

  657. 657

    Mariana J. Kaplan. (2009) Management of cardiovascular disease risk in chronic inflammatory disorders. Nature Reviews Rheumatology 5, 208-217
    CrossRef

  658. 658

    A Belza, S Toubro, S Stender, A Astrup. (2009) Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects. International Journal of Obesity 33, 456-464
    CrossRef

  659. 659

    Chun-Yan Zhang, Liang-Jing Lu, Feng-Hua Li, Hong-Li Li, Yue-Ying Gu, Shun-le Chen, Chun-De Bao. (2009) Evaluation of Risk Factors That Contribute to High Prevalence of Premature Atherosclerosis in Chinese Premenopausal Systemic Lupus Erythematosus Patients. JCR: Journal of Clinical Rheumatology 15, 111-116
    CrossRef

  660. 660

    Dean G. Karalis. (2009) Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease. Mayo Clinic Proceedings 84, 345-352
    CrossRef

  661. 661

    Mariann Harangi, Peter Szodoray, György Paragh. (2009) Atherosclerosis: a complex interplay of inflammatory processes. Clinical Lipidology 4, 167-187
    CrossRef

  662. 662

    L. Karlsson, D. Bergqvist, J. Lindbäck, H. Pärsson. (2009) Expansion of Small-diameter Abdominal Aortic Aneurysms is Not Reflected by the Release of Inflammatory Mediators IL-6, MMP-9 and CRP in Plasma. European Journal of Vascular and Endovascular Surgery 37, 420-424
    CrossRef

  663. 663

    Macy Mei-sze Lui, Jamie Chung-mei Lam, Henry Ka-Fung Mak, Aimin Xu, Clara Ooi, David Chi-leung Lam, Judith Choi-wo Mak, Pek Lan Khong, Mary Sau-Man Ip. (2009) C-Reactive Protein Is Associated With Obstructive Sleep Apnea Independent of Visceral Obesity. Chest 135, 950-956
    CrossRef

  664. 664

    Yasuaki Hayashino, Charles H. Hennekens, Tobias Kurth. (2009) Aspirin Use and Risk of Type 2 Diabetes in Apparently Healthy Men. The American Journal of Medicine 122:4, 374-379
    CrossRef

  665. 665

    Hyun-Chul Kim, Soo-Keun Lee, Seung Woo Lee, Sang Won Jeong. (2009) A reactive polythiophene for protein immobilization. Polymers for Advanced Technologies 20:10.1002/pat.v20:3, 298-302
    CrossRef

  666. 666

    Fadi G. Hage, Alexander J. Szalai. (2009) The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk. Current Atherosclerosis Reports 11, 124-130
    CrossRef

  667. 667

    Jiangtao Yan, Rutai Hui, Daowen Wang. (2009) Elevated C-reactive protein levels predict worsening prognosis in Chinese patients with first-onset stroke. Frontiers of Medicine in China 3, 30-35
    CrossRef

  668. 668

    Karina W. Davidson, Joseph E. Schwartz, Susan A. Kirkland, Elizabeth Mostofsky, Daniel Fink, Duane Guernsey, Daichi Shimbo. (2009) Relation of Inflammation to Depression and Incident Coronary Heart Disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study). The American Journal of Cardiology 103, 755-761
    CrossRef

  669. 669

    Sa Rah Yoon, Oh Young Bang, Ji Man Hong, Wen Yu Li, Phil Hyu Lee, Bruce Ovbiagele. (2009) Non-conventional risk factors were associated with infarct patterns in ischemic stroke. Clinical Neurology and Neurosurgery 111, 134-139
    CrossRef

  670. 670

    K REIFENBERG, H LEHR, J FAN, T KOIKE, E WIESE, I KUPPER, T SAGBAN, S SCHAEFER, U ZAHRINGER, M TORZEWSKI. (2009) Endotoxin accelerates atherosclerosis independent of complement activation. Thrombosis Research 123, 653-658
    CrossRef

  671. 671

    JOSEPH E. DONNELLY, STEVEN N. BLAIR, JOHN M. JAKICIC, MELINDA M. MANORE, JANET W. RANKIN, BRYAN K. SMITH. (2009) Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults. Medicine & Science in Sports & Exercise 41, 459-471
    CrossRef

  672. 672

    Qiu-Li Zhang, Wolfgang Koenig, Elke Raum, Christa Stegmaier, Hermann Brenner, Dietrich Rothenbacher. (2009) Epidemiology of chronic kidney disease: Results from a population of older adults in Germany. Preventive Medicine 48, 122-127
    CrossRef

  673. 673

    S. I. VAN LEUVEN, R. S. BIRJMOHUN, R. FRANSSEN, R. J. BISOENDIAL, H. DE KORT, J. H. M. LEVELS, R. L. BASSER, J. C. M. MEIJERS, J. A. KUIVENHOVEN, J. J. KASTELEIN, E. S. STROES. (2009) ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans. Journal of Thrombosis and Haemostasis 7:10.1111/jth.2009.7.issue-2, 347-354
    CrossRef

  674. 674

    C.-Y. Chou, H.-L. Kuo, H.-H. Lin, J. S. Liu, Y.-L. Liu, C.-C. Huang. (2009) C-reactive protein predicts ischaemic stroke in haemodialysis patients. International Journal of Clinical Practice 63:10.1111/ijcp.2009.63.issue-2, 243-248
    CrossRef

  675. 675

    Karen E MacKenzie, Esko J Wiltshire, Alexia S Peña, Roger Gent, Craig Hirte, Lino Piotto, Jennifer J Couper. (2009) Hs-CRP is associated with weight, BMI, and female sex but not with endothelial function in children with type 1 diabetes. Pediatric Diabetes 10:10.1111/pdi.2009.10.issue-1, 44-51
    CrossRef

  676. 676

    Shu-Yuan Yao, Jian-Min Chu, Ke-Ping Chen, Min Tang, Pi-Hua Fang, Fang-Zheng Wang, Shu Zhang. (2009) Inflammation in Lone Atrial Fibrillation. Clinical Cardiology 32:10.1002/clc.v32:2, 94-98
    CrossRef

  677. 677

    Matteo Cesari, Stephen B. Kritchevsky, Hal H. Atkinson, Brenda W. Penninx, Mauro Di Bari, Russell P. Tracy, Marco Pahor. (2009) Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers. American Heart Journal 157, 334.e1-334.e8
    CrossRef

  678. 678

    S. Charriere, N. Rognant, F. Chiche, A. Cremer, G. Deray, M. Priou. (2009) Insuffisance rénale chronique et maladie cardiovasculaire. Annales de Cardiologie et d'Angéiologie 58, 40-52
    CrossRef

  679. 679

    Erdembileg Anuurad, Russell P. Tracy, Thomas A. Pearson, Laurel Beckett, Lars Berglund. (2009) Comparison of C-Reactive Protein and Metabolic Syndrome as Cardiovascular Risk Factors in African-Americans and European-Americans. The American Journal of Cardiology 103, 523-527
    CrossRef

  680. 680

    Milind Y Desai, Paul Schoenhagen. (2009) Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease. Expert Review of Cardiovascular Therapy 7, 197-204
    CrossRef

  681. 681

    KEITH A.A. FOX, HARVEY WHITE, JESSICA J.S. OPIE, BERNARD J. GERSH, LIONEL H. OPIE. . Antithrombotic Agents: Platelet Inhibitors, Anticoagulants, and Fibrinolytics. 2009:, 293-340.
    CrossRef

  682. 682

    Carita M. Eklund. . Chapter 5 Proinflammatory cytokines in CRP baseline regulation. 2009:, 111-136.
    CrossRef

  683. 683

    Brendan M. Everett, Sandeep Bansal, Nader Rifai, Julie E. Buring, Paul M. Ridker. (2009) Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. Atherosclerosis 202, 282-288
    CrossRef

  684. 684

    Thyago Proença de Moraes, Silvia Carreira Ribeiro, Roberto Pecoits Filho. . Inflamación y riesgo cardiovascular en diálisis peritoneal. 2009:, 361-377.
    CrossRef

  685. 685

    Adel A. Al-Hamdan, Rabba H. Al-Huthail, Mohamed A. Alsaif, Abdulaziz M. Al-Othman, May N. Al-Muammer, Saada M. Al-Orf, Abdallah A. Saeed, Badreldin A. Mohamed. (2009) The Effect of Weight Reduction Diet on C-Reactive Protein Level in Obese-Adult Subjects. Journal of Medical Sciences(Faisalabad) 9, 17-23
    CrossRef

  686. 686

    Zorica Caparevic, Nada Kostic, Sanja Ilic, Jana Radojkovic, Djordje Marina, Biljana Pencic, Ivan Radojkovic. (2009) Oxidized LDL and C-reactive protein level in relation to carotid intima-media thickness in population with risk factors for atherosclerosis. Srpski arhiv za celokupno lekarstvo 137, 140-145
    CrossRef

  687. 687

    Paolo Calabrò, Enrica Golia, Edward T. H. Yeh. (2009) CRP and the risk of atherosclerotic events. Seminars in Immunopathology 31:1, 79
    CrossRef

  688. 688

    Jessica R. Meendering, Britta N. Torgrimson, Nicole P. Miller, Paul F. Kaplan, Christopher T. Minson. (2009) Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women. Contraception 79, 41-49
    CrossRef

  689. 689

    Jens Minnerup, Wolf-Rüdiger Schäbitz. (2009) Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics 6, 43-52
    CrossRef

  690. 690

    D.G. Federman, M. Shelling, S. Prodanovich, C.G. Gunderson, R.S. Kirsner. (2009) Psoriasis: an opportunity to identify cardiovascular risk. British Journal of Dermatology 160:10.1111/bjd.2008.160.issue-1, 1-7
    CrossRef

  691. 691

    Hyo-Jin Lee, Sung-Ho Her, Yun-Sun Im, Kang-Yeon Won, Sun-Hong Yoo, Dong-Bin Kim, Dong-Il Shin, Pum-Joon Kim, Ki-Bae Seung, Jae-Hyung Kim, Keon-Yeop Kim. (2009) Significance of Inflammatory Markers in Diabetic Patients with Stable Coronary Artery Disease. The Korean Journal of Internal Medicine 24, 212
    CrossRef

  692. 692

    Csaba P. Kovesdy, Kamyar Kalantar-Zadeh. (2009) Why Is Protein–Energy Wasting Associated With Mortality in Chronic Kidney Disease?. Seminars in Nephrology 29, 3-14
    CrossRef

  693. 693

    Vicente Bertomeu Martínez, J. Ramón González-Juanatey. (2009) Markers of Inflammation and Cardiovascular Disease. American Journal Cardiovascular Drugs 9:Supplement 1, 3
    CrossRef

  694. 694

    Arshad Jahangir, Viqar Maria. . CORONARY ARTERY DISEASE. 2009:, 321-365.
    CrossRef

  695. 695

    Inmaculada del Rincón. (2009) Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?. Arthritis & Rheumatism 61:10, 1284
    CrossRef

  696. 696

    Mina Suh, Joo Young Lee, Song Vogue Ahn, Hyeon Chang Kim, Il Suh. (2009) C-reactive Protein and Carotid Intima-media Thickness in a Population of Middle-aged Koreans. Journal of Preventive Medicine and Public Health 42, 29
    CrossRef

  697. 697

    Stephen A. Badger, Chee V. Soong, Mark E. O' Donnell, Caroline Mercer, Ian S. Young, Anne E. Hughes. (2009) C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism. Journal of Vascular Surgery 49, 178-184
    CrossRef

  698. 698

    Mark Nash, Armando Mendez. (2009) Nonfasting Lipemia and Inflammation as Cardiovascular Disease Risks After SCI. Topics in Spinal Cord Injury Rehabilitation 14, 15-31
    CrossRef

  699. 699

    Remigio Vela Navarrete. (2009) Detecting Endothelial Dysfunction in Patients with Erectile Dysfunction: Are There Reliable Laboratory Markers?. European Urology Supplements 8, 67-70
    CrossRef

  700. 700

    Johnny Nijm, Lena Jonasson. (2009) Inflammation and cortisol response in coronary artery disease. Annals of Medicine 41, 224-233
    CrossRef

  701. 701

    Matthew L. Scherer, Thor Aspelund, Sigurdur Sigurdsson, Robert Detrano, Melissa Garcia, Gary F. Mitchell, Lenore J. Launer, Gudmundur Thorgeirsson, Vilmundur Gudnason, Tamara B. Harris. (2009) Abnormal T-wave axis is associated with coronary artery calcification in older adults. Scandinavian Cardiovascular Journal 43, 240-248
    CrossRef

  702. 702

    Paul Anaya. (2009) Diagnosis of subclinical coronary atherosclerosis: challenges and insight. Expert Opinion on Medical Diagnostics 3, 37-52
    CrossRef

  703. 703

    René Krummenacher, Paul S. Lukas, Franziska Demarmels Biasiutti, Stefan Begré, Hansjörg Znoj, Roland Von Känel. (2009) Independent association of sleep quality, fatigue, and vital exhaustion with platelet count in patients with a previous venous thromboembolic event. Platelets 20, 566-574
    CrossRef

  704. 704

    Johannes Winning, Julia Reichel, Yvonne Eisenhut, Jürg Hamacher, Matthias Kohl, Hans Peter Deigner, Ralf A. Claus, Michael Bauer, Wolfgang Lösche. (2009) Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms. Platelets 20, 50-57
    CrossRef

  705. 705

    J. Antonio Aviña-Zubieta, Hyon K. Choi, Mohsen Sadatsafavi, Mahyar Etminan, John M. Esdaile, Diane Lacaille. (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis & Rheumatism 59:10.1002/art.v59:12, 1690-1697
    CrossRef

  706. 706

    E. J. Giltay, A. Haider, F. Saad, L. J. Gooren. (2008) C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation. Andrologia 40:10.1111/and.2008.40.issue-6, 398-400
    CrossRef

  707. 707

    N C Ogston, K Karastergiou, M J Hosseinzadeh-Attar, R Bhome, R Madani, M Stables, D Gilroy, P Flachs, M Hensler, J Kopecky, V Mohamed-Ali. (2008) Low-dose acetylsalicylic acid inhibits the secretion of interleukin-6 from white adipose tissue. International Journal of Obesity 32, 1807-1815
    CrossRef

  708. 708

    Juey-Jen Hwang, Hung-Yuan Li, Gow-Jen Shieh, Yu-Fen Chien, Cyue-Huei Hua, Jou-Wei Lin. (2008) Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women – a cross-racial validation. Nutrition, Metabolism and Cardiovascular Diseases 18, 671-677
    CrossRef

  709. 709

    Christopher S. Vaccari, Syed T. Rahman, Qamar A. Khan, Faiz A. Cheema, Bobby V. Khan. (2008) Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Levels of Inflammatory Markers in Response to Exercise-Induced Stress: Studies in the Metabolic Syndrome. Journal of the CardioMetabolic Syndrome 3, 12-17
    CrossRef

  710. 710

    Giampaolo Niccoli, Francesca Graziani, Luigi M. Biasucci, Filippo Crea. (2008) C-reactive protein and coronary instability. International Journal of Cardiology 131, 136-137
    CrossRef

  711. 711

    Vincent E. Friedewald, Jennifer C. Cather, Joel M. Gelfand, Kenneth B. Gordon, Gary H. Gibbons, Scott M. Grundy, Michael T. Jarratt, James G. Krueger, Paul M. Ridker, Neil Stone, William C. Roberts. (2008) AJC Editor's Consensus: Psoriasis and Coronary Artery Disease. The American Journal of Cardiology 102, 1631-1643
    CrossRef

  712. 712

    Otso Lindy, Kimmo Suomalainen, Marja Mäkelä, Seppo Lindy. (2008) Statin use is associated with fewer periodontal lesions: A retrospective study. BMC Oral Health 8:1
    CrossRef

  713. 713

    David Goteiner, Ronald G. Craig, Robert Ashmen, Malvin N. Janal, Barnet Eskin, Neal Lehrman. (2008) Endotoxin Levels Are Associated With High-Density Lipoprotein, Triglycerides, and Troponin in Patients With Acute Coronary Syndrome and Angina: Possible Contributions From Periodontal Sources. Journal of Periodontology 79:12, 2331-2339
    CrossRef

  714. 714

    F. Montecucco, F. Mach. (2008) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 48, 11-22
    CrossRef

  715. 715

    Ridker , Paul M , Danielson , Eleanor , Fonseca , Francisco A.H. , Genest , Jacques , Gotto , Antonio M. Jr. , Kastelein , John J.P. , Koenig , Wolfgang , Libby , Peter , Lorenzatti , Alberto J. , MacFadyen , Jean G. , Nordestgaard , Børge G. , Shepherd , James , Willerson , James T. , Glynn , Robert J. , . (2008) Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine 359:21, 2195-2207
    Free Full Text

  716. 716

    A Yamashita, Y Soga, Y Iwamoto, T Asano, Y Li, Y Abiko, F Nishimura. (2008) DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin. International Journal of Obesity 32, 1725-1729
    CrossRef

  717. 717

    Vivek Sailam, Dean G. Karalis, Ashish Agarwal, Firas Alani, Susan Galardi, Veronica Covalesky, Christian Athanassious. (2008) Prevalence of Emerging Cardiovascular Risk Factors in Younger Individuals with a Family History of Premature Coronary Heart Disease and Low Framingham Risk Score. Clinical Cardiology 31:10.1002/clc.v31:11, 542-545
    CrossRef

  718. 718

    I. Loftus, M. Thompson. (2008) Plaque Biology: Interesting Science or Pharmacological Treasure Trove?. European Journal of Vascular and Endovascular Surgery 36, 507-516
    CrossRef

  719. 719

    Yasmin S. Hamirani, Shivda Pandey, Juan J. Rivera, Chiadi Ndumele, Matthew J. Budoff, Roger S. Blumenthal, Khurram Nasir. (2008) Markers of inflammation and coronary artery calcification: A systematic review. Atherosclerosis 201:1, 1-7
    CrossRef

  720. 720

    Robert Y.L. Zee, Hooman Hennessey, Sherri E. Michaud, Paul M. Ridker. (2008) Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: A nested case-control approach. Atherosclerosis 201:1, 124-129
    CrossRef

  721. 721

    B. Galarraga, F. Khan, P. Kumar, T. Pullar, J. J. F. Belch. (2008) C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology 47, 1780-1784
    CrossRef

  722. 722

    Kaisa M. Mäki-Petäjä, Joseph Cheriyan, Anthony D. Booth, Frances C. Hall, John Brown, Sharon M.L. Wallace, Mike J. Ashby, Carmel M. McEniery, Ian B. Wilkinson. (2008) Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction. International Journal of Cardiology 129, 399-405
    CrossRef

  723. 723

    Karin F. Hoth, Andreana P. Haley, John Gunstad, Robert H. Paul, Athena Poppas, Angela L. Jefferson, David F. Tate, Makoto Ono, Beth A. Jerskey, Ronald A. Cohen. (2008) Elevated C-Reactive Protein Is Related to Cognitive Decline in Older Adults with Cardiovascular Disease. Journal of the American Geriatrics Society 56:10.1111/jgs.2008.56.issue-10, 1898-1903
    CrossRef

  724. 724

    Arman S. Postadzhiyan, Anna V. Tzontcheva, Ivan Kehajov, Stanimir Kyurkchiev, Margarita D. Apostolova, Bojidar Finkov. (2008) Effect of Conventional and More Aggressive Rosuvastatin Treatment on Markers of Endothelial Activation. Journal of Medical Biochemistry 27, 432-438
    CrossRef

  725. 725

    Salim S. Virani, Christie M. Ballantyne. (2008) How to identify patients with vulnerable plaques. Diabetes, Obesity and Metabolism 10:10.1111/dom.2008.10.issue-10, 824-833
    CrossRef

  726. 726

    Kiran Musunuru, Brian G Kral, Roger S Blumenthal, Valentin Fuster, Catherine Y Campbell, Ty J Gluckman, Richard A Lange, Eric J Topol, James T Willerson, Milind Y Desai, Michael H Davidson, Samia Mora. (2008) The use of high-sensitivity assays for C-reactive protein in clinical practice. Nature Clinical Practice Cardiovascular Medicine 5, 621-635
    CrossRef

  727. 727

    J. P. Casas, T. Shah, A. D. Hingorani, J. Danesh, M. B. Pepys. (2008) C-reactive protein and coronary heart disease: a critical review. Journal of Internal Medicine 264:10.1111/jim.2008.264.issue-4, 295-314
    CrossRef

  728. 728

    Mohammad Tauseef, Mohd. Shahid, Krishna K. Sharma, Mohammad Fahim. (2008) Antioxidative Action of Aspirin on Endothelial Function in Hypercholesterolaemic Rats. Basic & Clinical Pharmacology & Toxicology 103:10.1111/pto.2008.103.issue-4, 314-321
    CrossRef

  729. 729

    Ervin R. Fox, Emelia J. Benjamin, Daniel F. Sarpong, Charles N. Rotimi, James G. Wilson, Michael W. Steffes, Guanjie Chen, Adebowale Adeyemo, Jason K. Taylor, Tandaw E. Samdarshi, Herman A. Taylor. (2008) Epidemiology, Heritability, and Genetic Linkage of C-Reactive Protein in African Americans (from the Jackson Heart Study). The American Journal of Cardiology 102, 835-841
    CrossRef

  730. 730

    Rachel Lampert, J. Douglas Bremner, Shaoyong Su, Andrew Miller, Forrester Lee, Faiz Cheema, Jack Goldberg, Viola Vaccarino. (2008) Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. American Heart Journal 156, 759.e1-759.e7
    CrossRef

  731. 731

    Stamatios Lerakis, Andreas Synetos, Konstantinos Toutouzas, Manolis Vavuranakis, Eleftherios Tsiamis, Chistodoulos Stefanadis, Stamatios Lerakis. (2008) Imaging of the Vulnerable Plaque: Noninvasive and Invasive Techniques. The American Journal of the Medical Sciences 336:4, 342-348
    CrossRef

  732. 732

    Jessica R. Swoboda, H. Asuman Kiyak, Richard Darveau, G. Rutger Persson. (2008) Correlates of Periodontal Decline and Biologic Markers in Older Adults. Journal of Periodontology 79:10, 1920-1926
    CrossRef

  733. 733

    Adriano Paula Sabino, Marinez De Oliveira Sousa, Luciana Moreira Lima, Daniel Dias Ribeiro, Luci Maria Sant'Ana Dusse, Maria Das Graças Carvalho, Ana Paula Fernandes. (2008) ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease. Translational Research 152, 113-118
    CrossRef

  734. 734

    Kerstyn C. Zalesin, Barry A. Franklin, Wendy M. Miller, Eric D. Peterson, Peter A. McCullough. (2008) Impact of Obesity on Cardiovascular Disease. Endocrinology and Metabolism Clinics of North America 37, 663-684
    CrossRef

  735. 735

    H KIM, S LEE, W JEON, H LYU, S LEE, S JEONG. (2008) Detection of C-reactive protein on a functional poly(thiophene) self-assembled monolayer using surface plasmon resonance. Ultramicroscopy 108, 1379-1383
    CrossRef

  736. 736

    Ankur Gupta, Dinesh K. Badyal, Prem P. Khosla, Bharti Uppal, Thannikot M. Jaison, Sandeep Chopra. (2008) Effect of atorvastatin on hs-CRP in acute coronary syndrome. British Journal of Clinical Pharmacology 66:10.1111/bcp.2008.66.issue-3, 411-413
    CrossRef

  737. 737

    Szu-Chia Chen, Ho-Ming Su, Hsiu-Chin Mai, Jui-Hsin Chen, Chiu-Yueh Chen, Jer-Ming Chang, Hung-Chun Chen. (2008) Associated Risk Factors for Abnormal Ankle-brachial Index in Hemodialysis Patients in a Hospital. The Kaohsiung Journal of Medical Sciences 24, 473-480
    CrossRef

  738. 738

    Serap Semiz, Simin Rota, Özmert Özdemir, Ayşegül Özdemir, Bünyamin Kaptanoğlu. (2008) Are C-reactive protein and homocysteine cardiovascular risk factors in obese children and adolescents?. Pediatrics International 50:10.1111/ped.2008.50.issue-4, 419-423
    CrossRef

  739. 739

    E. Reyna-Villasmil, J. Mejía, N. Reyna-Villasmil, D. Torres, E. Peña, M. Colmenares, O. Delgado, J. Santos. (2008) Efecto de diosgenina sobre la proteína C reactiva y homocisteína en pacientes menopáusicas. Clínica e Investigación en Ginecología y Obstetricia 35, 120-125
    CrossRef

  740. 740

    M. M. C. Hovens, J. D. Snoep, Y. Groeneveld, M. Frlich, J. T. Tamsma, M. V. Huisman. (2008) Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. Diabetes, Obesity and Metabolism 10:10.1111/dom.2008.10.issue-8, 668-674
    CrossRef

  741. 741

    (2008) Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation. European Journal of Epidemiology 23, 531-540
    CrossRef

  742. 742

    Stephen P. Glasser, Mary Cushman, Ronald Prineas, Dawn Kleindorfer, Valerie Prince, Zhiying You, Virginia J. Howard, George Howard. (2008) Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?. Preventive Medicine 47, 161-166
    CrossRef

  743. 743

    Kai M. Eggers, Mikael Dellborg, Jonas Oldgren, Eva Swahn, Per Venge, Bertil Lindahl. (2008) Risk prediction in chest pain patients by biochemical markers including estimates of renal function. International Journal of Cardiology 128:2, 207-213
    CrossRef

  744. 744

    Thomas E. Van Dyke, Kenneth S. Kornman. (2008) Inflammation and Factors That May Regulate Inflammatory Response. Journal of Periodontology 79:8s, 1503-1507
    CrossRef

  745. 745

    Paul M Ridker, Josh D Silvertown. (2008) Inflammation, C-Reactive Protein, and Atherothrombosis. Journal of Periodontology 79:8s, 1544-1551
    CrossRef

  746. 746

    (2008) Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia. New England Journal of Medicine 359:5, 529-533
    Free Full Text

  747. 747

    Wingman Leung, Cangel Puiyee Chan, Timothy H. Rainer, Margaret Ip, George W.H. Cautherley, Reinhard Renneberg. (2008) InfectCheck CRP barcode-style lateral flow assay for semi-quantitative detection of C-reactive protein in distinguishing between bacterial and viral infections. Journal of Immunological Methods 336, 30-36
    CrossRef

  748. 748

    Barbora de Courten, Melissa N Barber, Renea V Johnston, Danny Liew, Maximilian de Courten, Sharon van Doornum, Christopher Reid, Rachelle Buchbinder, Melissa N Barber. . Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis. 2008.
    CrossRef

  749. 749

    G. Morris-Stiff, D. Gomez, K.R. Prasad. (2008) C-reactive protein in liver cancer surgery. European Journal of Surgical Oncology (EJSO) 34, 727-729
    CrossRef

  750. 750

    Li Wei, Tom Fahey, Thomas M. MacDonald. (2008) Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome. British Journal of Clinical Pharmacology 66, 110-116
    CrossRef

  751. 751

    Shun-An Lee, Hsiu-Ting Tsai, Hsiu-Chung Ou, Chih-Ping Han, Yi-Torng Tee, Yi-Chen Chen, Ming-Tsang Wu, Ming-Chin Chou, Po-Hui Wang, Shun-Fa Yang. (2008) Plasma interleukin-1β, -6, -8 and tumor necrosis factor-α as highly informative markers of pelvic inflammatory disease. Clinical Chemistry and Laboratory Medicine 46, 997-1003
    CrossRef

  752. 752

    Yu Asanuma, Annette Oeser, Eran Stanley, David G. Bailey, Ayumi Shintani, C. Michael Stein. (2008) Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin. Archives of Drug Information 1, 14-22
    CrossRef

  753. 753

    Kiat Tsong Tan, Gregory Y.H. Lip. (2008) Imaging of the unstable plaque. International Journal of Cardiology 127, 157-165
    CrossRef

  754. 754

    Matt Fisher, Mary Cushman, Volker Knappertz, George Howard. (2008) An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration. American Heart Journal 156, 106-111
    CrossRef

  755. 755

    Efstrathios Karagiannis, Andreas Pfützner, Thomas Forst, Georg Lübben, Werner Roth, Martin Grabellus, Manja Flannery, Thomas Schöndorf. (2008) The IRIS V Study: Pioglitazone Improves Systemic Chronic Inflammation in Patients with Type 2 Diabetes Under Daily Routine Conditions. Diabetes Technology & Therapeutics 10, 206-212
    CrossRef

  756. 756

    Francesco Cairo, Sergio Castellani, Anna Maria Gori, Michele Nieri, Giorgia Baldelli, Rosanna Abbate, Giovan Paolo Pini-Prato. (2008) Severe periodontitis in young adults is associated with sub-clinical atherosclerosis. Journal of Clinical Periodontology 35, 465-472
    CrossRef

  757. 757

    Manuel Rodríguez-Yáñez, José Castillo. (2008) Role of inflammatory markers in brain ischemia. Current Opinion in Neurology 21, 353-357
    CrossRef

  758. 758

    Jordi Ferri, Sergio Martínez-Hervás, Olga Espinosa, Marta Fandos, Teresa Pedro, José Tomás Real, Felipe Javier Chaves, Concha Cerdá, Guillermo Sáez, Juan Francisco Ascaso. (2008) Estudio de los valores de 8-oxo-7,8-dihidro-2’-desoxiguanosina como marcador de estrés oxidativo del ADN en pacientes con hiperlipemia familiar combinada. Medicina Clínica 131, 1-4
    CrossRef

  759. 759

    A. L. EILERTSEN, L. SANDVIK, B. STEINSVIK, P. M. SANDSET. (2008) Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers. Journal of Thrombosis and Haemostasis 6, 928-934
    CrossRef

  760. 760

    Eswar Krishnan. (2008) Gout and coronary artery disease: Epidemiologic clues. Current Rheumatology Reports 10, 249-255
    CrossRef

  761. 761

    S. Le Jeune, M.-A. Pistorius, B. Planchon, P. Pottier. (2008) Risque thromboembolique veineux au cours des affections médicales aiguës. Partie 1 : modèles pathogéniques fondamentaux et cliniques, épidémiologie descriptive et analytique. La Revue de Médecine Interne 29, 452-461
    CrossRef

  762. 762

    M. Kompoti, S. Drimis, A. Papadaki, K. Kotsomytis, C. Poulopoulou, D. Gianneli, D. Voutsinas. (2008) Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. European Journal of Internal Medicine 19, 261-265
    CrossRef

  763. 763

    Ko-ichi Kawahara, Kamal Krishna Biswas, Masako Unoshima, Takashi Ito, Kiyoshi Kikuchi, Yoko Morimoto, Masahiro Iwata, Salunya Tancharoen, Yoko Oyama, Kazunori Takenouchi, Yuko Nawa, Noboru Arimura, Meng Xiao Jie, Binita Shrestha, Naoki Miura, Toshiaki Shimizu, Kentaro Mera, Shin-ichiro Arimura, Noboru Taniguchi, Hideo Iwasaka, Sonshin Takao, Teruto Hashiguchi, Ikuro Maruyama. (2008) C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells. Cardiovascular Pathology 17, 129-138
    CrossRef

  764. 764

    Bernard Abi-Saleh, Said B. Iskandar, Nader Elgharib, Michael V. Cohen. (2008) C-Reactive Protein: The Harbinger of Cardiovascular Diseases. Southern Medical Journal 101, 525-533
    CrossRef

  765. 765

    Alexandra Schneider, Demosthenes Panagiotakos, Sally Picciotto, Klea Katsouyanni, Hannelore Löwel, Bénédicte Jacquemin, Timo Lanki, Massimo Stafoggia, Tom Bellander, Wolfgang Koenig, Annette Peters. (2008) Air Temperature and Inflammatory Responses in Myocardial Infarction Survivors. Epidemiology 19, 391-400
    CrossRef

  766. 766

    Po-Hsun Huang, Tse-Min Lu, Tao-Cheng Wu, Feng-Yen Lin, Yung-Hsiang Chen, Jaw-Wen Chen, Shing-Jong Lin. (2008) Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease. Coronary Artery Disease 19, 187-193
    CrossRef

  767. 767

    Alicia J. Jenkins, Michelle Rothen, Richard L. Klein, Karina Moller, Leslie Eldridge, Deyi Zheng, Ramon Durazo-Arvizu, Daniel McGee, Daniel Lackland, Suzanne R. Thorpe, W. Timothy Garvey, Timothy J. Lyons. (2008) Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. Journal of Diabetes and its Complications 22, 153-163
    CrossRef

  768. 768

    Bernd Krüger, Carsten A. Böger, Bernd Schröppel, Stefan Farkas, Andreas A. Schnitzbauer, Ute Hoffmann, Aiman Obed, Barbara T. Murphy, Bernhard Banas, Bernhard K. Krämer. (2008) No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation. Transplant International 21, 452-458
    CrossRef

  769. 769

    Paul M. Ridker, Guillaume Pare, Alex Parker, Robert Y.L. Zee, Jacqueline S. Danik, Julie E. Buring, David Kwiatkowski, Nancy R. Cook, Joseph P. Miletich, Daniel I. Chasman. (2008) Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study. The American Journal of Human Genetics 82, 1185-1192
    CrossRef

  770. 770

    Armen Yuri Gasparyan, Timothy Watson, Gregory Y.H. Lip. (2008) The Role of Aspirin in Cardiovascular Prevention. Journal of the American College of Cardiology 51:19, 1829-1843
    CrossRef

  771. 771

    Kathleen Paul, Doris Boutain, Kathy Agnew, Joycelyn Thomas, Jane Hitti. (2008) The Relationship between Racial Identity, Income, Stress and C-Reactive Protein among Parous Women: Implications for Preterm Birth Disparity Research. Journal of the National Medical Association 100:5, 540-546
    CrossRef

  772. 772

    Priit Kampus, Jaak Kals, Eve Unt, Kersti Zilmer, Jaan Eha, Rein Teesalu, Aivo Normak, Mihkel Zilmer. (2008) Association between arterial elasticity, C-reactive protein and maximal oxygen consumption in well-trained cadets during three days extreme physical load: a pilot study. Physiological Measurement 29, 429-437
    CrossRef

  773. 773

    Bernard M.Y. Cheung, Kwok Leung Ong, Roberta V. Cheung, Louisa Y.F. Wong, Nelson M.S. Wat, Sidney Tam, Gabriel M. Leung, Chun Ho Cheng, Jean Woo, Edward D. Janus, Chu Pak Lau, Tai Hing Lam, Karen S.L. Lam. (2008) Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese. Clinical Chemistry and Laboratory Medicine 46, 523-527
    CrossRef

  774. 774

    Salim S. Virani, Venkateshwar R. Polsani, Vijay Nambi. (2008) Novel markers of inflammation in atherosclerosis. Current Atherosclerosis Reports 10, 164-170
    CrossRef

  775. 775

    Hidenori Nishida, Takeshi Horio, Yoshihiko Suzuki, Yoshio Iwashima, Kei Kamide, Kenji Kangawa, Yuhei Kawano. (2008) Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: Comparison with C-reactive protein and adiponectin. Peptides 29, 599-605
    CrossRef

  776. 776

    Spiros Paraskevas, John D. Huizinga, Bruno G. Loos. (2008) A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. Journal of Clinical Periodontology 35, 277-290
    CrossRef

  777. 777

    Adriana HUNG, Lara PUPIM, Chang YU, Ayumi SHINTANI, Edward SIEW, Carlos AYUS, Raymond M. HAKIM, Talat Alp IKIZLER. (2008) Determinants of C-reactive protein in chronic hemodialysis patients: Relevance of dialysis catheter utilization. Hemodialysis International 12, 236-243
    CrossRef

  778. 778

    Kayoung Lee, Yun-Mi Song, Joohon Sung. (2008) Which Obesity Indicators Are Better Predictors of Metabolic Risk?: Healthy Twin Study. Obesity 16, 834-840
    CrossRef

  779. 779

    Robert Y.L. Zee, Sherri E. Michaud, Kirsti A. Diehl, Daniel I. Chasman, Joseph Emmerich, Pascale Gaussem, Martine Aiach, Paul M. Ridker. (2008) Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism. Atherosclerosis 197, 694-699
    CrossRef

  780. 780

    J. De Haro, F. Acin, A. Lopez-Quintana, F.J. Medina, E. Martinez-Aguilar, A. Florez, J.R. March. (2008) Direct Association between C-reactive Protein Serum Levels and Endothelial Dysfunction in Patients with Claudication. European Journal of Vascular and Endovascular Surgery 35, 480-486
    CrossRef

  781. 781

    Lisa M. Mielniczuk, Marc A. Pfeffer, Eldrin F. Lewis, Michael A. Blazing, James A. de Lemos, Amy Shui, Satish Mohanavelu, Robert M. Califf, Eugene Braunwald. (2008) Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. American Heart Journal 155, 725-731
    CrossRef

  782. 782

    Leslie R. Morse, Kelly Stolzmann, Hiep P. Nguyen, Nitin B. Jain, Cara Zayac, David R. Gagnon, Carlos G. Tun, Eric Garshick. (2008) Association Between Mobility Mode and C-Reactive Protein Levels in Men With Chronic Spinal Cord Injury. Archives of Physical Medicine and Rehabilitation 89:4, 726-731
    CrossRef

  783. 783

    Alessandro Mauriello. . From Coronaries to Carotids. 2008:, 127-140.
    CrossRef

  784. 784

    K. M. Eggers, L. Lind, H. Ahlstrom, T. Bjerner, C. Ebeling Barbier, A. Larsson, P. Venge, B. Lindahl. (2008) Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. European Heart Journal 29, 2252-2258
    CrossRef

  785. 785

    A. ARCARI, F. ZITO, A. DI CASTELNUOVO, A. DE CURTIS, C. DIRCKX, J. ARNOUT, F. P. CAPPUCCIO, M. C. J. M. VAN DONGEN, M. DE LORGERIL, V. KROGH, A. SIANI, M. B. DONATI, G. DE GAETANO, L. IACOVIELLO, . (2008) C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project. Journal of Thrombosis and Haemostasis 6:10.1111/jth.2008.6.issue-3, 436-443
    CrossRef

  786. 786

    MacRae F. Linton, Sergio Fazio. (2008) Cyclooxygenase products and atherosclerosis. Drug Discovery Today: Therapeutic Strategies 5, 25-36
    CrossRef

  787. 787

    Jin Yang, Junhong Wang, Shushu Zhu, Xiangjian Chen, Hengfang Wu, Di Yang, Jinan Zhang. (2008) C-reactive protein augments hypoxia-induced apoptosis through mitochondrion-dependent pathway in cardiac myocytes. Molecular and Cellular Biochemistry 310, 215-226
    CrossRef

  788. 788

    Jeremiah P. Depta, Deepak L. Bhatt. (2008) Aspirin and Platelet Adenosine Diphosphate Receptor Antagonists in Acute Coronary Syndromes and Percutaneous Coronary Intervention. American Journal of Cardiovascular Drugs 8, 91-112
    CrossRef

  789. 789

    Jill Howie-Esquivel, Megan White. (2008) Biomarkers in Acute Cardiovascular Disease. The Journal of Cardiovascular Nursing 23, 124-131
    CrossRef

  790. 790

    William E. Boden, Prediman K. Shah, Vipul Gupta, E. Magnus Ohman. (2008) Contemporary Approach to the Diagnosis and Management of Non–ST-Segment Elevation Acute Coronary Syndromes. Progress in Cardiovascular Diseases 50, 311-351
    CrossRef

  791. 791

    Kosmas I. Paraskevas. (2008) Statin treatment for rheumatoid arthritis: a promising novel indication. Clinical Rheumatology 27, 281-287
    CrossRef

  792. 792

    Lisa R Tannock. (2008) Advances in the management of hyperlipidemia-induced atherosclerosis. Expert Review of Cardiovascular Therapy 6, 369-383
    CrossRef

  793. 793

    T. Forst, E. Karagiannis, G. Lübben, C. Hohberg, T. Schöndorf, G. Dikta, M. Drexler, M. Morcos, W. Dänschel, M. Borchert, A. Pfützner. (2008) Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease. Atherosclerosis 197:1, 311-317
    CrossRef

  794. 794

    Nicholas L. Mills, Simon D. Robinson, Paul H. B. Fokkens, Daan L. A. C. Leseman, Mark R. Miller, David Anderson, Evelyn J. Freney, Mathew R. Heal, Robert J. Donovan, Anders Blomberg, Thomas Sandström, William MacNee, Nicholas A. Boon, Ken Donaldson, David E. Newby, Flemming R. Cassee. (2008) Exposure to Concentrated Ambient Particles Does Not Affect Vascular Function in Patients with Coronary Heart Disease. Environmental Health Perspectives 116, 709-715
    CrossRef

  795. 795

    M.W. Lorenz, C. Stephan, A. Harmjanz, S. Staszewski, A. Buehler, M. Bickel, S. von Kegler, D. Ruhkamp, H. Steinmetz, M. Sitzer. (2008) Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 196, 720-726
    CrossRef

  796. 796

    Anna Benrick, Pernilla Jirholt, Ingrid Wernstedt, Maria Gustafsson, Juergen Scheller, Anna-Lena Eriksson, Jan Borén, Thomas Hedner, Claes Ohlsson, Torleif Härd, Stefan Rose-John, John-Olov Jansson. (2008) A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population. Regulatory Peptides 146, 189-196
    CrossRef

  797. 797

    José Pablo Werba, Fabrizio Veglia, Mauro Amato, Damiano Baldassarre, Paola Massironi, Pier Luigi Meroni, Piersandro Riboldi, Elena Tremoli, Marina Camera. (2008) Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus. Atherosclerosis 196, 835-840
    CrossRef

  798. 798

    Tracey M. Farragher, Nicola J. Goodson, Haris Naseem, Alan J. Silman, Wendy Thomson, Deborah Symmons, Anne Barton. (2008) Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis & Rheumatism 58:10.1002/art.v58:2, 359-369
    CrossRef

  799. 799

    Stephen J Carp, Ann E Barr, Mary F Barbe. (2008) Serum biomarkers as signals for risk and severity of work-related musculoskeletal injury. Biomarkers in Medicine 2, 67-79
    CrossRef

  800. 800

    Altan Onat, Günay Can, Gülay Hergenç. (2008) Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 57, 207-214
    CrossRef

  801. 801

    Bruce D. Lindsay. (2008) Are acute phase protein levels the link between atrial arrhythmias and inflammation?. Heart Rhythm 5, 222-223
    CrossRef

  802. 802

    Christophe Bauters, Nicolas Lamblin, Pascal de Groote. (2008) High-sensitivity C-reactive protein for risk stratification in patients with heart failure. American Heart Journal 155, e7
    CrossRef

  803. 803

    Irfan Moinuddin, David J. Leehey. (2008) A Comparison of Aerobic Exercise and Resistance Training in Patients With and Without Chronic Kidney Disease. Advances in Chronic Kidney Disease 15, 83-96
    CrossRef

  804. 804

    Chen-Chung Fu, Du-An Wu, Ji-hung Wang, Wen-Chin Yang, Chin-Hsiao Tseng. (2008) Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients. Acta Diabetologica 46:2, 127
    CrossRef

  805. 805

    Giuseppe Di Pasquale, Stefano Urbinati. . Chapter 51 The interactions between cardiovascular and cerebrovascular disease. 2008:, 1039-1057.
    CrossRef

  806. 806

    Tan Xu, Zhong Ju, Weijun Tong, Wei Hu, Yanbin Liu, Li Zhao, Yonghong Zhang. (2008) Relationship of C-Reactive Protein With Hypertension and Interactions Between Increased C-Reactive Protein and Other Risk Factors on Hypertension in Mongolian People, China. Circulation Journal 72, 1324-1328
    CrossRef

  807. 807

    Fumiyuki Otsuka, Seigo Sugiyama, Sunao Kojima, Hisao Ogawa. (2008) Reply to Letter Regarding Article, "Hypoadiponectinemia is Associated With Impaired Glucose Tolerance and Coronary Artery Disease in Non-Diabetic Men". Circulation Journal 72, 506-507
    CrossRef

  808. 808

    RG Craig. (2008) Interactions between chronic renal disease and periodontal disease. Oral Diseases 14, 1-7
    CrossRef

  809. 809

    Hideto Ishii, Toyohiro Tsukada, Masayuki Yoshida. (2008) Angiotensin II Type-I Receptor Blocker, Candesartan, Improves Brachial-Ankle Pulse Wave Velocity Independent of Its Blood Pressure Lowering Effects in Type 2 Diabetes Patients. Internal Medicine 47, 2013-2018
    CrossRef

  810. 810

    Christiane A. Geluk, Wendy J. Post, Hans L. Hillege, René A. Tio, Jan G.P. Tijssen, René B. van Dijk, W. Arnold Dijk, Stephan J.L. Bakker, Paul E. de Jong, Wiek H. van Gilst, Felix Zijlstra. (2008) C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: Data from the prospective PREVEND cohort. Atherosclerosis 196, 372-382
    CrossRef

  811. 811

    Megumi Tsushima, Yuriko Terayama, Akishi Momose, Tomihisa Funyu, Chikara Ohyama, Ryukichi Hada. (2008) Carotid intima media thickness and aortic calcification index closely relate to cerebro- and cardiovascular disorders in hemodialysis patients. International Journal of Urology 15, 48-51
    CrossRef

  812. 812

    Masafumi Koga, Hiroshi Saito, Mikio Mukai, Michio Otsuki, Soji Kasayama. (2008) Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels. Acta Diabetologica 46:2, 141
    CrossRef

  813. 813

    Vidosava B. Đorđević, Tatjana Ristić, Vladan Ćosić, Predrag Vlahović, Lilika Zvezdanović, Gordana Đorđević. (2008) Inflammatory and Apoptotic Markers in Ischemic Heart Disease Patients. Journal of Medical Biochemistry 27, 154-160
    CrossRef

  814. 814

    C-W Chen, Y-L Lin, T-K Lin, C-T Lin, B-C Chen, C-L Lin. (2008) Total cardiovascular risk profile of Taiwanese vegetarians. European Journal of Clinical Nutrition 62, 138-144
    CrossRef

  815. 815

    José Manuel Fernández-Real. (2008) Resistencia a la insulina y aterosclerosis. Impacto del estrés oxidativo en la función endotelial. Revista Española de Cardiología Suplementos 8, 45C-52C
    CrossRef

  816. 816

    Glenys A. Tennent, Winston L. Hutchinson, Melvyn C. Kahan, Gideon M. Hirschfield, J. Ruth Gallimore, Jackie Lewin, Caroline A. Sabin, Amar P. Dhillon, Mark B. Pepys. (2008) Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice. Atherosclerosis 196, 248-255
    CrossRef

  817. 817

    Eileen Crimmins, Sarinnapha Vasunilashorn, Jung Ki Kim, Dawn Alley. . Chapter 5 Biomarkers Related To Aging In Human Populations. 2008:, 161-216.
    CrossRef

  818. 818

    Narbeh Melikian, Bernard De Bruyne, William F. Fearon, Philip A. MacCarthy. (2008) The Pathophysiology and Clinical Course of the Normal Coronary Angina Syndrome (Cardiac Syndrome X). Progress in Cardiovascular Diseases 50, 294-310
    CrossRef

  819. 819

    Kosmas I. Paraskevas, George Hamilton, Jenny M. Cross, Dimitri P. Mikhailidis. (2008) Atherosclerotic Renal Artery Stenosis: Association with Emerging Vascular Risk Factors. Nephron Clinical Practice 108, c56-c66
    CrossRef

  820. 820

    Fenwick T. Nichols, Hashem M. Shaltoni, Frank M. Yatsu. . Chapter 11 A cerebrovascular perspective of atherosclerosis. 2008:, 215-238.
    CrossRef

  821. 821

    Hisashi Makino, Kentaro Doi, Aki Hiuge, Ayako Nagumo, Sadanori Okada, Yoshihiro Miyamoto, Masaaki Suzuki, Yasunao Yoshimasa. (2008) Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. Diabetes Research and Clinical Practice 79, 177-182
    CrossRef

  822. 822

    Prediman K. Shah. . Inflammation and atherothrombosis. 2008:, 1013-1021.
    CrossRef

  823. 823

    Hiromasa Otake, Junya Shite, Toshiro Shinke, Satoshi Watanabe, Yusuke Tanino, Daisuke Ogasawara, Takahiro Sawada, Ken-ichi Hirata, Mitsuhiro Yokoyama. (2008) Relation Between Plasma Adiponectin, High-Sensitivity C-Reactive Protein, and Coronary Plaque Components in Patients With Acute Coronary Syndrome. The American Journal of Cardiology 101, 1-7
    CrossRef

  824. 824

    Jean-Pierre Després, Amélie Cartier, Mélanie Côté, Benoit J. Arsenault. (2008) The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology. Annals of Medicine 40, 514-523
    CrossRef

  825. 825

    Dora Il'yasova, Anastasia Ivanova, Jason D. Morrow, Matteo Cesari, Marco Pahor. (2008) Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. Biomarkers 13, 41-51
    CrossRef

  826. 826

    Helge Røsjø, Torbjørn Omland. (2008) New cardiovascular risk markers: The race is on, but are there any winners?. Scandinavian Journal of Clinical and Laboratory Investigation 68, 673-677
    CrossRef

  827. 827

    Yoichiro Kusunoki, Tomonori Hayashi. (2008) Long-lasting alterations of the immune system by ionizing radiation exposure: Implications for disease development among atomic bomb survivors. International Journal of Radiation Biology 84, 1-14
    CrossRef

  828. 828

    Effat Razeghi, Sayeh Parkhideh, Farrokhlagha Ahmadi, Patricia Khashayar. (2008) Serum CRP Levels in Pre-Dialysis Patients. Renal Failure 30, 193-198
    CrossRef

  829. 829

    James D. Beck, David J. Couper, Karen L. Falkner, Susan P. Graham, Sara G. Grossi, John C. Gunsolley, Theresa Madden, Gerardo Maupome, Steven Offenbacher, Dawn D. Stewart, Maurizio Trevisan, Thomas E. Van Dyke, Robert J. Genco. (2008) The Periodontitis and Vascular Events (PAVE) Pilot Study: Adverse Events. Journal of Periodontology 79:1, 90-96
    CrossRef

  830. 830

    David Goteiner, Robert Ashmen, Neal Lehrman, Malvin N. Janal, Barnet Eskin. (2008) Presence and Significance of Interleukin-1 Polymorphism in Patients Who Present With Acute Coronary Syndrome, Angina, and Chronic Periodontitis: An Epidemiologic Pilot Study. Journal of Periodontology 79:1, 138-143
    CrossRef

  831. 831

    H R Nakhai-Pour, D E Grobbee, M L Bots, M Muller, Y T van der Schouw. (2007) C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community. Journal of Human Hypertension 21, 949-955
    CrossRef

  832. 832

    I DELRINCON, D OLEARY, G FREEMAN, A ESCALANTE. (2007) Acceleration of atherosclerosis during the course of rheumatoid arthritis☆. Atherosclerosis 195, 354-360
    CrossRef

  833. 833

    Christine Espinola-Klein, Hans J. Rupprecht, Christoph Bickel, Karl Lackner, Renate Schnabel, Thomas Munzel, Stefan Blankenberg. (2007) Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis 195, e126-e134
    CrossRef

  834. 834

    Radjesh J. Bisoendial, John J.P. Kastelein, Erik S.G. Stroes. (2007) C-reactive protein and atherogenesis: From fatty streak to clinical event. Atherosclerosis 195, e10-e18
    CrossRef

  835. 835

    Shuaib M. Abdullah, Amit Khera, David Leonard, Sandeep R. Das, Russell M. Canham, Sandeep A. Kamath, Gloria L. Vega, Scott M. Grundy, Darren K. McGuire, James A. de Lemos. (2007) Sex differences in the association between leptin and CRP: Results from the Dallas Heart Study. Atherosclerosis 195, 404-410
    CrossRef

  836. 836

    Paul M Ridker. (2007) Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity. Nutrition Reviews 65, S253-S259
    CrossRef

  837. 837

    OSVALDO P. ALMEIDA, PAUL NORMAN, GRAEME J. HANKEY, KONRAD JAMROZIK, LEON FLICKER. (2007) The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychological Medicine 37
    CrossRef

  838. 838

    Suzette E. Elias-Smale, Isabella Kardys, Matthijs Oudkerk, Albert Hofman, Jacqueline C.M. Witteman. (2007) C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 195, e195-e202
    CrossRef

  839. 839

    Michelle A. Albert. (2007) Inflammatory Biomarkers, Race/Ethnicity and Cardiovascular Disease. Nutrition Reviews 65, S234-S238
    CrossRef

  840. 840

    Matthey T. Harris, Warren W. Davis, Ngoc-Anh Le, Barry Eggleston, Garth E. Austin, Mohamad Moussa, W. Virgil Brown. (2007) Free oxygen radicals in whole blood correlate strongly with high-sensitivity C-reactive protein. Journal of Clinical Lipidology 1, 593-598
    CrossRef

  841. 841

    Katja B Vallbracht-Israng, Ilkay Kazak, Peter L Schwimmbeck. (2007) Association of cytokines with endothelium dependent flow mediated vasodilation (FMD) of systemic arteries in patients with non-ischemic cardiomyopathy. Cardiovascular Ultrasound 5:1
    CrossRef

  842. 842

    , Susan R Kahn, Hadia Shbaklo, Stan Shapiro, Philip S Wells, Michael J Kovacs, Marc A Rodger, David R Anderson, Jeffrey S Ginsberg, Mira Johri, Vicky Tagalakis. (2007) Effectiveness of compression stockings to prevent the post-thrombotic syndrome (The SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial. BMC Cardiovascular Disorders 7:1
    CrossRef

  843. 843

    Aydin Nazmi, Cesar G Victora. (2007) Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 7:1
    CrossRef

  844. 844

    Mien-Cheng Chen, Chien-Jen Chen, Cheng-Hsu Yang, Chiung-Jen Wu, Chih-Yuan Fang, Yuan-Kai Hsieh, Hsueh-Wen Chang. (2007) Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart and Vessels 22, 371-375
    CrossRef

  845. 845

    Akiko Yamashita, Yoshihiko Soga, Yoshihiro Iwamoto, Sayuri Yoshizawa, Hirotaka Iwata, Susumu Kokeguchi, Shogo Takashiba, Fusanori Nishimura. (2007) Macrophage-Adipocyte Interaction: Marked Interleukin-6 Production by Lipopolysaccharide**. Obesity 15, 2549-2552
    CrossRef

  846. 846

    Vittoria Rizzello, Giovanna Liuzzo, Giovanna Di Giannuario, Elisabetta Trabetti, Salvatore Brugaletta, Matteo Santamaria, Maddalena Piro, Pier Franco Pignatti, Attilio Maseri, Luigi M. Biasucci, Filippo Crea. (2007) 1059G/C polymorphism within the exon 2 of the C-reactive protein gene: relationship to C-reactive protein levels and prognosis in unstable angina. Coronary Artery Disease 18, 533-538
    CrossRef

  847. 847

    Danielle J. Frey, Monika Fleshner, Kenneth P. Wright. (2007) The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain, Behavior, and Immunity 21, 1050-1057
    CrossRef

  848. 848

    L Y F Wong, R Y H Leung, K L Ong, B M Y Cheung. (2007) Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene −572C>G polymorphism in subjects with and without hypertension. Journal of Human Hypertension 21, 875-882
    CrossRef

  849. 849

    Tzung-Dau Wang, Yen-Ho Wang, Tien-Shang Huang, Ta-Chen Su, Shin-Liang Pan, Ssu-Yuan Chen. (2007) Circulating Levels of Markers of Inflammation and Endothelial Activation are Increased in Men with Chronic Spinal Cord Injury. Journal of the Formosan Medical Association 106, 919-928
    CrossRef

  850. 850

    Abigail May, Thomas J Wang. (2007) Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin. Expert Review of Molecular Diagnostics 7, 793-804
    CrossRef

  851. 851

    Tim T. Issac, Hisham Dokainish, Nasser M. Lakkis. (2007) Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation. Journal of the American College of Cardiology 50:21, 2021-2028
    CrossRef

  852. 852

    Hisham Nassar, Ehud Lavi, Sa’ed Akkawi, Khalil Bdeir, Samuel N. Heyman, P.N. Raghunath, John Tomaszewski, Abd Al-Roof Higazi. (2007) α-Defensin: Link between inflammation and atherosclerosis. Atherosclerosis 194, 452-457
    CrossRef

  853. 853

    Rohit Bhatheja, Debabrata Mukherjee. (2007) Acute Coronary Syndromes: Unstable Angina/Non-ST Elevation Myocardial Infarction. Critical Care Clinics 23, 709-735
    CrossRef

  854. 854

    Stephan Lindemann, Björn Krämer, Karin Daub, Konstantinos Stellos, Meinrad Gawaz. (2007) Molecular pathways used by platelets to initiate and accelerate atherogenesis. Current Opinion in Lipidology 18, 566-573
    CrossRef

  855. 855

    Tânia B. Ferraz, Rosa S. Motta, Camila Lousada Ferraz, Diego Moreira Capibaribe, Adriana C. Forti, Antônio R. Chacra. (2007) C-reactive protein and features of metabolic syndrome in Brazilian women with previous gestational diabetes. Diabetes Research and Clinical Practice 78, 23-29
    CrossRef

  856. 856

    Adam Young, Gouri Koduri. (2007) Extra-articular manifestations and complications of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 21, 907-927
    CrossRef

  857. 857

    Jean Éthier, Jennifer L. Bragg-Gresham, Luis Piera, Tadao Akizawa, Yasushi Asano, Nancy Mason, Brenda W. Gillespie, Eric W. Young. (2007) Aspirin Prescription and Outcomes in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 50, 602-611
    CrossRef

  858. 858

    Ken Donaldson, Nicholas Mills, David E. Newby, William MacNee, Vicki Stone. . Toxicology of Nanoparticles in Environmental Air Pollution. 2007.
    CrossRef

  859. 859

    A TANIGUCHI, M FUKUSHIMA, Y NAKAI, A KUROE, M OHYA, M OHGUSHI, Y SEINO. (2007) Factors responsible for the evolution of insulin resistance in Japanese type 2 diabetic patients: Association with atherosclerosis. Diabetes Research and Clinical Practice 77, S213-S219
    CrossRef

  860. 860

    Oyku Gulmez, Cagatay Ertan, Aylin Yildirir, Didem Konas, Ugur Bal, Alp Aydinalp, Ozlem Demir, Bulent Ozin, Haldun Muderrisoglu. (2007) C-reactive protein levels increase after exercise testing in patients with increased platelet reactivity. Coronary Artery Disease 18, 437-442
    CrossRef

  861. 861

    Kaushik Bhowmick, A. V. M. Kutty, H. V. Shetty. (2007) Glycemic control modifies the association between microalbuminuria and c-reactive protein in Type 2 Diabetes Mellitus. Indian Journal of Clinical Biochemistry 22, 53-59
    CrossRef

  862. 862

    Robert N. Foley. (2007) Infections in Patients with Chronic Kidney Disease. Infectious Disease Clinics of North America 21, 659-672
    CrossRef

  863. 863

    Masato Kikuchi, Makoto Nakamura, Kohei Ishikawa, Toshimitsu Suzuki, Hiroaki Nishihara, Tomomi Yamakoshi, Kazuko Nishio, Kentaro Taki, Toshimitsu Niwa, Nobuyuki Hamajima, Hiroko Terasaki. (2007) Elevated C-Reactive Protein Levels in Patients with Polypoidal Choroidal Vasculopathy and Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology 114, 1722-1727
    CrossRef

  864. 864

    Jianping Liu, Jinquan Cheng, Ji Peng, Shenghong Han, Lei Yu, Shaofa Nie. (2007) Effects of polymorphisms of heat shock protein 70 gene on ischemic stroke, and interaction with smoking in China. Clinica Chimica Acta 384, 64-68
    CrossRef

  865. 865

    Anoop Shankar, Jialiang Li, F. Javier Nieto, Barbara E.K. Klein, Ronald Klein. (2007) Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. American Heart Journal 154, 495-501
    CrossRef

  866. 866

    Ruben H. Willemsen, Paul G. H. Mulder, Albert W. van Toorenenbergen, Anita C. S. Hokken-Koelega. (2007) Long-term GH treatment is not associated with disadvantageous changes of inflammatory markers and adipocytokines in children born small for gestational age. Clinical Endocrinology 0:10.1111/cen.0.0.issue-0, 070902090319002-???
    CrossRef

  867. 867

    Paola De Pablo, Thomas Dietrich, Elizabeth W. Karlson. (2007) Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample. Arthritis & Rheumatism 57:10.1002/art.v57:6, 953-962
    CrossRef

  868. 868

    Omer Guran, Figen Akalin, Canan Ayabakan, Feyza Yagmur Dereli, Goncagul Haklar. (2007) High-sensitivity C-reactive protein in children at risk for coronary artery disease. Acta Paediatrica 96, 1214-1219
    CrossRef

  869. 869

    Wei Yue, Alexandra Schneider, Matthias Stölzel, Regina Rückerl, Josef Cyrys, Xiaochuan Pan, Wojciech Zareba, Wolfgang Koenig, H.-Erich Wichmann, Annette Peters. (2007) Ambient source-specific particles are associated with prolonged repolarization and increased levels of inflammation in male coronary artery disease patients. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 621, 50-60
    CrossRef

  870. 870

    Susan G. Lakoski, Mary Cushman, Roger S. Blumenthal, Richard Kronmal, Donna Arnett, Ralph B. D’Agostino, Robert C. Detrano, David M. Herrington. (2007) Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. Atherosclerosis 193, 401-407
    CrossRef

  871. 871

    David Conen, Paul M Ridker. (2007) Clinical significance of high-sensitivity C-reactive protein in cardiovascular disease. Biomarkers in Medicine 1, 229-241
    CrossRef

  872. 872

    Benjamin Z. Leder. (2007) Testosterone, estradiol and aromatase inhibitor therapy in elderly men. The Journal of Steroid Biochemistry and Molecular Biology 106, 162-167
    CrossRef

  873. 873

    A. G. Nikitin, D. A. Chudakova, E. V. Spitsina, L. O. Minushkina, D. A. Zateishchikov, V. V. Nosikov, V. G. Debabov. (2007) Association of GNB3 gene C825T polymorphism with coronary heart disease. Russian Journal of Genetics 43, 937-941
    CrossRef

  874. 874

    Cynthia M. Westerhout, Judy Gnarpe, Wei-Ching Chang, Susan FitzPatrick, Elliot S. Barnathan, Eric Boersma, Robert M. Califf, Lars Wallentin, Maarten L. Simoons, Paul W. Armstrong. (2007) No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: Insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial. American Heart Journal 154, 306-312
    CrossRef

  875. 875

    Jeffrey L. Anderson, Cynthia D. Adams, Elliott M. Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin, A. Michael Lincoff, Eric D. Peterson, Pierre Theroux, Nanette Kass Wenger, R. Scott Wright, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Jonathan L. Halperin, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2007) ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 50:7, e1-e157
    CrossRef

  876. 876

    Masato Yoneda, Hironori Mawatari, Koji Fujita, Hiroshi Iida, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama, Atsushi Nakajima. (2007) High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. Journal of Gastroenterology 42, 573-582
    CrossRef

  877. 877

    D. M. Musher, A. M. Rueda, A. S. Kaka, S. M. Mapara. (2007) The Association between Pneumococcal Pneumonia and Acute Cardiac Events. Clinical Infectious Diseases 45, 158-165
    CrossRef

  878. 878

    John Farmer. . Inflammatory Mediators and C-Reactive Protein. 2007:, 441-462.
    CrossRef

  879. 879

    Adnan Chhatriwalla, Deepak Bhatt. . Anticoagulation and Antiplatelet Agents. 2007:, 501-524.
    CrossRef

  880. 880

    Shyam Prabhakaran, Bernardo Liberato, Ralph Sacco. . Stroke Prevention. 2007:, 545-583.
    CrossRef

  881. 881

    James Willerson, Paul Armstrong. . Acute Myocardial Infarction. 2007:, 611-646.
    CrossRef

  882. 882

    Ulrich Broeckel, Christian Hengstenberg, Bjoern Mayer, Karen Maresso, Daniel Gaudet, Ondrej Seda, Johanne Tremblay, Stephan Holmer, Jeanette Erdmann, Christian Glöckner, Michael Harrison, Lisa J. Martin, Jeff T. Williams, Gerd Schmitz, Guenter A. J. Riegger, Howard J. Jacob, Pavel Hamet, Heribert Schunkert. (2007) A locus on chromosome 10 influences C-reactive protein levels in two independent populations. Human Genetics 122, 95-102
    CrossRef

  883. 883

    Trine Madsen, Erik B. Schmidt, Jeppe H. Christensen. (2007) The Effect of n-3 Fatty Acids on C-Reactive Protein Levels in Patients With Chronic Renal Failure. Journal of Renal Nutrition 17, 258-263
    CrossRef

  884. 884

    Beom-Jun Kim, Yong Mi Yu, Euy Nyong Kim, Yun-Ey Chung, Jung-Min Koh, Ghi Su Kim. (2007) Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clinical Endocrinology 67:10.1111/cen.2007.67.issue-1, 152-158
    CrossRef

  885. 885

    Carolyn Katrinchak, Kathryn Fritz. (2007) Clinical implications of C-reactive protein as a predictor of vascular risk. Journal of the American Academy of Nurse Practitioners 19:10.1111/jaan.2007.19.issue-7, 335-340
    CrossRef

  886. 886

    Samar Basu. (2007) Novel cyclooxygenase-catalyzed bioactive prostaglandin F2α from physiology to new principles in inflammation. Medicinal Research Reviews 27:10.1002/med.v27:4, 435-468
    CrossRef

  887. 887

    Omer Kozan, Kemalettin Buyukozturk, Baris Ilerigelen, Giray Kabakci, Nevrez Koylan, . (2007) The Impact of Plasma High-Sensitivity C-Reactive Protein Levels on Cardiovascular Risk Stratification of Hypertensive Patients: Results of the ICEBERG Study. The Journal of Clinical Hypertension 9:10.1111/jch.2007.9.issue-7, 500-505
    CrossRef

  888. 888

    Alena Lorenzová, Vladimír Staněk, Marie Gebauerová, Romana Bohuslavová, Petr Stávek, Jaroslav A. Hubáček, Věra Lánská, Rudolf Poledne. (2007) High-sensitivity C-reactive protein concentration in patients with myocardial infarction-environmental factors, and polymorphisms in interleukin-10 and CD14 genes. Clinical Chemistry and Laboratory Medicine 45, 855-861
    CrossRef

  889. 889

    Trine Madsen, Jeppe Hagstrup Christensen, Egon Toft, Erik Berg Schmidt. (2007) C-Reactive Protein Is Associated with Heart Rate Variability. Annals of Noninvasive Electrocardiology 12:10.1111/anec.2007.12.issue-3, 216-222
    CrossRef

  890. 890

    Koichi Tomoda, Masanori Yoshikawa, Takefumi Itoh, Shinji Tamaki, Atsuhiko Fukuoka, Kazuyuki Komeda, Hiroshi Kimura. (2007) Elevated Circulating Plasma Adiponectin in Underweight Patients With COPD. Chest 132:1, 135-140
    CrossRef

  891. 891

    A. Abdellaoui, H. Al-Khaffaf. (2007) C-Reactive Protein (CRP) as a Marker in Peripheral Vascular Disease. European Journal of Vascular and Endovascular Surgery 34:1, 18-22
    CrossRef

  892. 892

    Christian Madsen, Per Nafstad, Lars Eikvar, Per E. Schwarze, Kjersti S. Rønningen, Lise Lund Haaheim. (2007) Association between tobacco smoke exposure and levels of C-reactive protein in the Oslo II Study. European Journal of Epidemiology 22, 311-317
    CrossRef

  893. 893

    Yun Fang Liu, Hui Ming Yu, Cheng Zhang, Rui Xue Yang, Fang Fang Yan, Yan Liu, Yun Zhang, Yu Xia Zhao. (2007) Effects of Quyu Xiaoban Capsules on Clinical Outcomes and Platelet Activation and Aggregation in Patients with Unstable Angina Pectoris. The Journal of Alternative and Complementary Medicine 13, 571-576
    CrossRef

  894. 894

    David W. Paquette, Nadine Brodala, Timothy C. Nichols. (2007) Cardiovascular disease, inflammation, and periodontal infection. Periodontology 2000 44:10.1111/prd.2007.44.issue-1, 113-126
    CrossRef

  895. 895

    Maikki K. Heliövaara, Anita Remitz, Sakari Reitamo, Anna-Maija Teppo, Sirkka-Liisa Karonen, Pertti Ebeling. (2007) 13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentration. Metabolism 56, 786-791
    CrossRef

  896. 896

    David H. Lee, Theodore E. Warkentin. . Frequency of Heparin-Induced Thrombocytopenia. 2007:, 67-116.
    CrossRef

  897. 897

    G ZULIANI, S VOLPATO, A BLE, S BANDINELLI, A CORSI, F LAURETANI, G PAOLISSO, R FELLIN, L FERRUCCI. (2007) High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: The InChianti study. Atherosclerosis 192, 384-390
    CrossRef

  898. 898

    Keith W Muir, Pippa Tyrrell, Naveed Sattar, Elizabeth Warburton. (2007) Inflammation and ischaemic stroke. Current Opinion in Neurology 20, 334-342
    CrossRef

  899. 899

    Martin K.C. Ng. (2007) New Perspectives on Mars and Venus: Unravelling the Role of Androgens in Gender Differences in Cardiovascular Biology and Disease. Heart, Lung and Circulation 16, 185-192
    CrossRef

  900. 900

    Sandeep Bansal, Paul M. Ridker. (2007) Comparison of Characteristics of Future Myocardial Infarctions in Women With Baseline High Versus Baseline Low Levels of High-Sensitivity C-Reactive Protein. The American Journal of Cardiology 99, 1500-1503
    CrossRef

  901. 901

    James R. Sowers. (2007) The Role of C-Reactive Protein in the Metabolic Syndrome and Diabetes Mellitus. The Endocrinologist 17, 163-168
    CrossRef

  902. 902

    Jing Qian, Baowu Wang, Norma Dawkins, Alexandria Gray, Ralphenia D. Pace. (2007) Reduction of risk factors for cardiovascular diseases in African Americans with a 12-week nutrition education program. Nutrition Research 27, 252-257
    CrossRef

  903. 903

    Preethi Yerram, Poorna R. Karuparthi, Laura Hesemann, Jennifer Horst, Adam Whaley-Connell. (2007) Chronic kidney disease and cardiovascular risk. Journal of the American Society of Hypertension 1, 178-184
    CrossRef

  904. 904

    Bernd Krüger, Carsten A. Böger, Aiman Obed, Stefan Farkas, Ute Hoffmann, Bernhard Banas, Michael Fischereder, Bernhard K. Krämer. (2007) RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection. Clinical Transplantation 21:10.1111/ctr.2007.21.issue-3, 385-390
    CrossRef

  905. 905

    Nitsan Maharshak, Yaron Arbel, Natan M. Bornstein, Amir Gal-Oz, Alexander Y. Gur, Itzahk Shapira, Ori Rogowski, Shlomo Berliner, Zamir Halpern, Iris Dotan. (2007) Inflammatory Bowel Disease Is Not Associated With Increased Intimal Media Thickening. The American Journal of Gastroenterology 102:10.1111/ajg.2007.102.issue-5, 1050-1055
    CrossRef

  906. 906

    Xiansong Wang, Yi Sun, Fei Xie, Juan Feng, Xuemei Ma. . (2007) C-reactive Protein Immunoassay Through Surface Plasmon Resonance Detection Based On a Microfluidic Platform. , 1752-1755
    CrossRef

  907. 907

    Dao-Fu Dai, Fu-Tien Chiang, Jiunn-Lee Lin, Li-Ying Huang, Chi-Ling Chen, Chee-Jen Chang, Ling-Ping Lai, Kwan-Lih Hsu, Chuen-Den Tseng, Yung-Zu Tseng, Juey-Jen Hwang. (2007) Human C-reactive Protein (CRP) Gene 1059 G > C Polymorphism is Associated with Plasma CRP Concentration in Patients Receiving Coronary Angiography. Journal of the Formosan Medical Association 106, 347-354
    CrossRef

  908. 908

    Paul M. Ridker. (2007) C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk. Journal of the American College of Cardiology 49:21, 2129-2138
    CrossRef

  909. 909

    Clinical outcomes of patients with cardiometabolic risk factors. 2007:, 105-136.
    CrossRef

  910. 910

    Yun Fang Liu, Hui Ming Yu, Cheng Zhang, Rui Xue Yang, Fang Fang Yan, Yan Liu, Yun Zhang, Yu Xia Zhao. (2007) Effects of Quyu Xiaoban Capsules on Clinical Outcomes and Platelet Activation and Aggregation in Patients with Unstable Angina Pectoris. The Journal of Alternative and Complementary Medicine 13, 369-374
    CrossRef

  911. 911

    Huyn-Chul Kim, Soo-Keun Lee, Young-Soo Sohn, Hong-Kun Ryu, Sang Won Jeong. (2007) Preparation of a Sensing Membrane for C-Reactive Protein. Macromolecular Symposia 249-250:10.1002/masy.v249:1, 71-75
    CrossRef

  912. 912

    Zhiqiang Wang, Wendy E. Hoy. (2007) C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians. Diabetes Research and Clinical Practice 76, 37-43
    CrossRef

  913. 913

    M. K. Heliövaara, M. Herz, A. M. Teppo, E. Leinonen, P. Ebeling. (2007) Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes. Journal of Endocrinological Investigation 30, 292-297
    CrossRef

  914. 914

    Craig J. McMackin, Michael E. Widlansky, Naomi M. Hamburg, Alex L. Huang, Susan Weller, Monika Holbrook, Noyan Gokce, Tory M. Hagen, John F. Keaney, Joseph A. Vita. (2007) Effect of Combined Treatment With α-Lipoic Acid and Acetyl-L-Carnitine on Vascular Function and Blood Pressure in Patients With Coronary Artery Disease. The Journal of Clinical Hypertension 9:10.1111/jch.2007.9.issue-4, 249-255
    CrossRef

  915. 915

    Michael E. Widlansky, Naomi M. Hamburg, Elad Anter, Monika Holbrook, David F. Kahn, James G. Elliott, John F. Keaney, Joseph A. Vita. (2007) Acute EGCG Supplementation Reverses Endothelial Dysfunction in Patients with Coronary Artery Disease. Journal of the American College of Nutrition 26, 95-102
    CrossRef

  916. 916

    Vijay Nambi, Christie M. Ballantyne. (2007) Role of Biomarkers in Developing New Therapies for Vascular Disease. World Journal of Surgery 31, 676-681
    CrossRef

  917. 917

    Tullio Palmerini, Antonio Marzocchi, Cinzia Marrozzini, Letizia Bacchi Reggiani, Carlo Savini, Giuseppe Marinelli, Roberto Di Bartolomeo, Angelo Branzi. (2007) Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. European Journal of Cardio-Thoracic Surgery 31, 685-690
    CrossRef

  918. 918

    Rishi Sukhija, Ibrahim Fahdi, Luis Garza, Louis Fink, Margaret Scott, Wady Aude, Rebecca Pacheco, Zoran Bursac, April Grant, Jawahar L. Mehta. (2007) Inflammatory Markers, Angiographic Severity of Coronary Artery Disease, and Patient Outcome. The American Journal of Cardiology 99, 879-884
    CrossRef

  919. 919

    Fulvio Bellocci, Luigi M Biasucci, Gian Franco Gensini, Luigi Padeletti, Antonio Raviele, Massimo Santini, Giovanna Giubilato, Maurizio Landolina, Giuseppe Biondi-Zoccai, Giovanni Raciti, Massimo Sassara, Antonello Castro, Antoine Kheir, Filippo Crea. (2007) Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Journal of Cardiovascular Medicine 8:4, 293-299
    CrossRef

  920. 920

    Jerzy Krupinski, Esther Catena, Marta Miguel, Pere Domenech, Ramon Vila, Sergio Morchon, Francisco Rubio, Marc Cairols, Mark Slevin, Lina Badimon. (2007) D-dimer local expression is increased in symptomatic patients undergoing carotid endarterectomy. International Journal of Cardiology 116, 174-179
    CrossRef

  921. 921

    Hans-Joachim Priebe. . Mechanisms of Perioperative Myocardial Injury. 2007:, 39-61.
    CrossRef

  922. 922

    Pierre-Guy Chassot. . Preoperative Assessment. 2007:, 87-115.
    CrossRef

  923. 923

    Pierre-Guy Chassot, Carlo Marcucci. . Urgent or Semiurgent Surgery in Patients with Severe Coronary Artery Disease. 2007:, 305-334.
    CrossRef

  924. 924

    Olle Melander. (2007) Are minor gene effects of clinical importance?. Journal of Hypertension 25, 505-507
    CrossRef

  925. 925

    Po-Hsun Huang, Jaw-Wen Chen, Tse-Min Lu, Philip Yu-An Ding, Shing-Jong Lin. (2007) Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events. Clinical Cardiology 30:10.1002/clc.v30:3, 135-140
    CrossRef

  926. 926

    Masafumi Koga, Michio Otsuki, Sueko Matsumoto, Hiroshi Saito, Mikio Mukai, Soji Kasayama. (2007) Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clinica Chimica Acta 378, 48-52
    CrossRef

  927. 927

    Antonio M. Gotto. (2007) Role of C-Reactive Protein in Coronary Risk Reduction: Focus on Primary Prevention. The American Journal of Cardiology 99, 718-725
    CrossRef

  928. 928

    Hamid Reza Nakhai Pour, Diederick E. Grobbee, Majon Muller, Yvonne T. van der Schouw. (2007) Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men. Clinical Endocrinology 66:10.1111/cen.2007.66.issue-3, 394-398
    CrossRef

  929. 929

    A. Picardi, M. G. Valorani, U. Vespasiani Gentilucci, S. Manfrini, O. Ciofini, M. Cappa, C. Guglielmi, P. Pozzilli, . (2007) Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Diabetes/Metabolism Research and Reviews 23:10.1002/dmrr.v23:3, 211-214
    CrossRef

  930. 930

    Pia Lundman, Susanna Boquist, Ann Samnegård, Marie Bennermo, Claes Held, Carl-Göran Ericsson, Angela Silveira, Anders Hamsten, Per Tornvall. (2007) A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Nutrition, Metabolism and Cardiovascular Diseases 17, 195-202
    CrossRef

  931. 931

    Walter Stefan Speidl, Mariam Nikfardjam, Alexander Niessner, Nelli Jordanova, Gerlinde Zorn, Gerald Maurer, Wolfgang Schreiber, Johann Wojta, Kurt Huber. (2007) Premature compared with late onset of coronary artery disease: young patients show a severe defect in fibrinolytic response to venous occlusion. Blood Coagulation & Fibrinolysis 18, 165-171
    CrossRef

  932. 932

    Natale Daniele Brunetti, Michele Correale, Pier Luigi Pellegrino, Andrea Cuculo, Matteo Di Biase. (2007) Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings. European Journal of Internal Medicine 18:2, 109-117
    CrossRef

  933. 933

    Elyiahu Stoupel, Evgeny Abramson, Peter Israelevich, Jaqueline Sulkes, Daniela Harell. (2007) Dynamics of serum C-reactive protein (CRP) level and cosmophysical activity. European Journal of Internal Medicine 18:2, 124-128
    CrossRef

  934. 934

    T NAGASAKI, M INABA, K SHIRAKAWA, Y HIURA, H TAHARA, Y KUMEDA, T ISHIKAWA, E ISHIMURA, Y NISHIZAWA. (2007) Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery. Biomedicine & Pharmacotherapy 61, 167-172
    CrossRef

  935. 935

    Mohammad Tauseef, Krishna K. Sharma, Mohammad Fahim. (2007) Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action. European Journal of Pharmacology 556, 136-143
    CrossRef

  936. 936

    Gordon D. O. Lowe, Mark B. Pepys. (2007) C-reactive protein and cardiovascular disease: Weighing the evidence. Current Cardiovascular Risk Reports 1, 72-79
    CrossRef

  937. 937

    C. A. Garza, V. M. Montori, J. P. McConnell, V. K. Somers, I. J. Kullo, F. Lopez-Jimenez. (2007) Association Between Lipoprotein-Associated Phospholipase A2 and Cardiovascular Disease: A Systematic Review. Mayo Clinic Proceedings 82, 159-165
    CrossRef

  938. 938

    M. Caliskan, D. Erdogan, H. Gullu, D. Tok, M. Bilgi, H. Muderrisoglu. (2007) Low serum bilirubin concentrations are associated with impaired aortic elastic properties, but not impaired left ventricular diastolic function. International Journal of Clinical Practice 61:10.1111/ijcp.2007.61.issue-2, 218-224
    CrossRef

  939. 939

    Luisa Deutsch. (2007) Evaluation of the Effect of Neptune Krill Oil on Chronic Inflammation and Arthritic Symptoms. Journal of the American College of Nutrition 26, 39-48
    CrossRef

  940. 940

    S ALBERT, M HAAS, A MOORADIAN. (2007) The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects. Growth Hormone & IGF Research 17, 19-25
    CrossRef

  941. 941

    Santina Cottone, Giuseppe Mulè, Emilio Nardi, Anna Vadalà, Maria C Lorito, Marco Guarneri, Rosalia Arsena, Alessandro Palermo, Giovanni Cerasola. (2007) C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension. Journal of Hypertension 25, 423-428
    CrossRef

  942. 942

    D. I. Steinberg, A. Mayer. (2007) Lipoprotein-Associated Phospholipase A2 and Risk Stratification for Cardiovascular Disease: Not Ready for 'Prime Time'. Mayo Clinic Proceedings 82, 155-157
    CrossRef

  943. 943

    S STEINHUBL. (2007) Platelets as Mediators of Inflammation. Hematology/Oncology Clinics of North America 21, 115-121
    CrossRef

  944. 944

    Fusanori Nishimura, Yoshihiro Iwamoto, Yoshihiko Soga. (2007) The periodontal host response with diabetes. Periodontology 2000 43:10.1111/prd.2007.43.issue-1, 245-253
    CrossRef

  945. 945

    B. Müller, N. Morgenthaler, D. Stolz, P. Schuetz, C. Müller, R. Bingisser, A. Bergmann, M. Tamm, M. Christ-Crain. (2007) Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. European Journal of Clinical Investigation 37:10.1111/eci.2007.37.issue-2, 145-152
    CrossRef

  946. 946

    Boaz D. Rosen, Mary Cushman, Khurram Nasir, David A. Bluemke, Thor Edvardsen, Verônica Fernandes, Shenghan Lai, Russell P. Tracy, João A.C. Lima. (2007) Relationship Between C-Reactive Protein Levels and Regional Left Ventricular Function in Asymptomatic Individuals. Journal of the American College of Cardiology 49:5, 594-600
    CrossRef

  947. 947

    A. Danese, C. M. Pariante, A. Caspi, A. Taylor, R. Poulton. (2007) Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences 104, 1319-1324
    CrossRef

  948. 948

    Vilborg Sigurdardottir, Björn Fagerberg, John Wikstrand, Caroline Schmidt, Johannes Hulthe. (2007) Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men. Atherosclerosis 190, 187-193
    CrossRef

  949. 949

    Caroline Bulc??o, Fernando Flexa Ribeiro-Filho, Adriana Sa??udo, Sandra G Roberta Ferreira. (2007) Effects of Simvastatin and Metformin on Inflammation and Insulin Resistance in Individuals with Mild Metabolic Syndrome. American Journal of Cardiovascular Drugs 7, 219-224
    CrossRef

  950. 950

    Hsu-Ko Kuo, Chung-Jen Yen, Jen-Hau Chen, Yau-Hua Yu, Jonathan F. Bean. (2007) Association of cardiorespiratory fitness and levels of C-reactive protein: Data from the National Health and Nutrition Examination Survey 1999–2002. International Journal of Cardiology 114, 28-33
    CrossRef

  951. 951

    J. de Haro-Miralles, F.J. Medina-Maldonado, E. Martínez-Aguilar, A. Flórez-González, C. Varela-Casariego, F. Acín. (2007) Relación del tamaño del aneurisma de aorta abdominal asintomático con los niveles plasmáticos de proteína C reactiva. Angiología 59, 111-120
    CrossRef

  952. 952

    Masami Kosuge, Toshiaki Ebina, Toshiyuki Ishikawa, Kiyoshi Hibi, Kengo Tsukahara, Jyun Okuda, Noriaki Iwahashi, Hiroyuki Ozaki, Hideto Yano, Ikuyoshi Kusama, Tastuya Nakati, Satoshi Umemura, Kazuo Kimura. (2007) Serum Amyloid A is a Better Predictor of Clinical Outcomes than C-Reactive Protein in Non-ST-Segment Elevation Acute Coronary Syndromes. Circulation Journal 71, 186-190
    CrossRef

  953. 953

    Brian M. Wong, Michael Huang, Jeffrey S. Zaltzman, G V. Ramesh Prasad. (2007) Mycophenolate Mofetil and C-Reactive Protein in Renal Transplant Recipients. Transplantation 83, 48-53
    CrossRef

  954. 954

    Anna Frisinghelli, Antonio Mafrici. (2007) Regression or Reduction in Progression of Atherosclerosis, and Avoidance of Coronary Events, With Lovastatin in Patients With or at High Risk of Cardiovascular Disease. Clinical Drug Investigation 27, 591-604
    CrossRef

  955. 955

    Gunnar Engström, Bo Hedblad, Lars Janzon, Folke Lindgärde. (2007) Long-Term Change in Cholesterol in Relation to Inflammation-Sensitive Plasma Proteins: A Longitudinal Study. Annals of Epidemiology 17, 57-63
    CrossRef

  956. 956

    Young Mi Hong, Hee Sun Koo, Jae Young Lee, Jo Won Jung, Nam Su Kim, Chung IL Noh. (2007) Serum Cytokine Levels in Hypertensive Children - Tumor Necrosis Factor-α, Interleukin-6 -. Korean Circulation Journal 37, 312
    CrossRef

  957. 957

    Masayo Fukuhara, Kiyoshi Matsumura, Masanori Wakisaka, Yutaka Takata, Kazuo Sonoki, Kiyoshi Fujisawa, Toshihiro Ansai, Sumio Akifusa, Koji Fujii, Mitsuo Iida, Tadamichi Takehara. (2007) Hyperglycemia Promotes Microinflammation as Evaluated by C-Reactive Protein in the Very Elderly. Internal Medicine 46, 207-212
    CrossRef

  958. 958

    Frederick Palm, Armin Grau. (2007) Infection as a risk factor for stroke. Future Neurology 2, 59-71
    CrossRef

  959. 959

    F. Purroy, J. Montaner, C. A. Molina, P. Delgado, J. F. Arenillas, P. Chacon, M. Quintana, J. Alvarez-Sabin. (2007) C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurologica Scandinavica 115:10.1111/ane.2007.115.issue-1, 60-66
    CrossRef

  960. 960

    Marta Artieda, Ana Cenarro, Alberto Ga&ntilde;&aacute;n, Antonela Lukic, Eva Moreno, Jos&eacute; Puzo, Miguel Pocov&iacute;, Fernando Civeira. (2007) Serum Chitotriosidase Activity, a Marker of Activated Macrophages, Predicts New Cardiovascular Events Independently of C-Reactive Protein. Cardiology 108, 297-306
    CrossRef

  961. 961

    K. Graf. (2007) CRP ist kein unabhängiger Prädiktor für das Auftreten eines akuten Schlaganfalls. Clinical Research in Cardiology Supplements 2, 43-44
    CrossRef

  962. 962

    Sun Mee Yang, Sung Yong Kim, Ki Young Lee, Yeun Sun Kim, Moon Suk Nam, Ie Byung Park. (2007) Inflammatory Markers are Associated with Microvascular Complications in Type 2 Diabetes. The Journal of Korean Diabetes Association 31, 472
    CrossRef

  963. 963

    Judith Meadows, Jacqueline Suk Danik, Michelle A. Albert. . Primary Prevention of Ischemic Heart Disease. 2007:, 178-220.
    CrossRef

  964. 964

    M. John Chapman. (2007) From pathophysiology to targeted therapy for atherothrombosis: A role for the combination of statin and aspirin in secondary prevention. Pharmacology & Therapeutics 113, 184-196
    CrossRef

  965. 965

    David W. JOHNSON, Ann-Maree CRAVEN, Nicole Maree ISBEL. (2007) Modification of cardiovascular risk in hemodialysis patients: An evidence-based review. Hemodialysis International 11:10.1111/hdi.2007.11.issue-1
    CrossRef

  966. 966

    Valentin Fuster, Javier Sanz. (2007) Vascular inflammation. Journal of the American Society of Hypertension 1, 68-81
    CrossRef

  967. 967

    A. Räkel, G. Renier, A. Roussin, J. Buithieu, J.-C. Mamputu, O. Serri. (2007) Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 9:10.1111/dom.2007.9.issue-1, 127-129
    CrossRef

  968. 968

    Hedley C. A. Emsley, Craig J. Smith, Pippa J. Tyrrell, Stephen J. Hopkins. (2007) Inflammation in Acute Ischemic Stroke and its Relevance to Stroke Critical Care. Neurocritical Care 9:1, 125
    CrossRef

  969. 969

    Thorsten Kälsch, Elif Elmas, Xuan Duc Nguyen, Stefan Kralev, Hans Leweling, Harald Klüter, Carl-Erik Dempfle, Martin Borggrefe. (2007) Effects of alimentary lipemia and inflammation on platelet CD40-ligand. Thrombosis Research 120, 703-708
    CrossRef

  970. 970

    A C Scheurig, B Thorand, B Fischer, M Heier, W Koenig. (2007) Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study. European Journal of Clinical Nutrition 62:1, 127
    CrossRef

  971. 971

    M BONCLER, B LUZAK, M ROZALSKI, J GOLANSKI, B RYCHLIK, C WATALA. (2007) Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein. Thrombosis Research 119, 209-216
    CrossRef

  972. 972

    T YANAGAWA, A TANIGUCHI, M FUKUSHIMA, Y NAKAI, S NAGASAKA, M OHGUSHI, K MATSUMOTO, A KUROE, M OHYA, Y SEINO. (2007) Leptin, triglycerides, and interleukin 6 are independently associated with C-reactive protein in Japanese type 2 diabetic patients. Diabetes Research and Clinical Practice 75, 2-6
    CrossRef

  973. 973

    Moo-Yong Rhee, Hyun Kyu Chang, Seong-Kyu Kim. (2007) Intima-media Thickness and Arterial Stiffness of Carotid Artery in Korean Patients with Behçet's Disease. Journal of Korean Medical Science 22, 387
    CrossRef

  974. 974

    Sarah D. de Ferranti, Nader Rifai. (2007) C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovascular Pathology 16, 14-21
    CrossRef

  975. 975

    Shizukiyo Ishikawa, Kazunori Kayaba, Tadao Gotoh, Yosikazu Nakamura, Eiji Kajii. (2007) Metabolic Syndrome and C-Reactive Protein in the General Population. Circulation Journal 71, 26-31
    CrossRef

  976. 976

    Jaime G&aacute;llego, Eduardo Mart&iacute;nez Vila, Roberto Mu&ntilde;oz. (2007) Patients at High Risk for Ischemic Stroke: Identification and Actions. Cerebrovascular Diseases 24, 49-63
    CrossRef

  977. 977

    G. Hornstra, C. A. Barth, C. Galli, R. P. Mensink, M. Mutanen, R. A. Riemersma, M. Roberfroid, K. Salminen, G. Vansant, P. M. Verschuren. (2007) Functional food science and the cardiovascular system. British Journal of Nutrition 80:S1, S113
    CrossRef

  978. 978

    Mary Cushman, Barbara M. Alving. . Risk Factors for Cardiovascular Disease and Arterial Thrombosis. 2007:, 371-378.
    CrossRef

  979. 979

    RYUICHI AJISAKA, TAKUMI TANABE, TAKESHI OTSUKI, HARUKA MURAKAMI, SEIJI MAEDA, KIYOJI TANAKA, HIROHITO SONE, SHINYA KUNO. (2007) EFFECT OF EXERCISE TRAINING ON SERUM HIGH-SENSITIVITY C-REACTIVE PROTEIN CONCENTRATION IN HEALTHY MIDDLE-AGED AND ELDERLY SUBJECTS. Japanese Journal of Physical Fitness and Sports Medicine 56, 179-190
    CrossRef

  980. 980

    Christopher D. Owens, Paul M. Ridker, Michael Belkin, Allen D. Hamdan, Frank Pomposelli, Frank Logerfo, Mark A. Creager, Michael S. Conte. (2007) Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. Journal of Vascular Surgery 45, 2-9
    CrossRef

  981. 981

    Won-Young Lee, Matthew A. Allison, Dong-Jun Kim, Chan-Hee Song, Elizabeth Barrett-Connor. (2007) Association of Interleukin-6 and C-Reactive Protein With Subclinical Carotid Atherosclerosis (the Rancho Bernardo Study). The American Journal of Cardiology 99, 99-102
    CrossRef

  982. 982

    W KOP, N COHEN. . Psychoneuroimmunological Pathways Involved in Acute Coronary Syndromes. 2007:, 921-943.
    CrossRef

  983. 983

    C. K. Wong, C. C. Szeto, M. H. M. Chan, C. B. Leung, P. K. T. Li, C. W. K. Lam. (2007) Elevation of Pro-Inflammatory Cytokines, C-Reactive Protein and Cardiac Troponin T in Chronic Renal Failure Patients on Dialysis. Immunological Investigations 36, 47-57
    CrossRef

  984. 984

    Banu Aktas Yilmaz, Türkan Mete, Irem Dincer, Sim Kutlay, Sule Sengül, Kenan Keven, Sehsuvar Ertürk. (2007) Predictors of Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease. Renal Failure 29, 303-307
    CrossRef

  985. 985

    Pascal J. Goldschmidt, Neuza Lopes, Lawrence E. Crawford, Richard C. Becker. . Atherothrombosis and Coronary Artery Disease. 2007:, 629-655.
    CrossRef

  986. 986

    Eric H. Awtry, Joseph Loscalzo. . Aspirin. 2007:, 1099-1125.
    CrossRef

  987. 987

    JOSÉ MARÍN-GARCÍA. . Molecular Basis of Lipoprotein Disorders, Atherogenesis, and Thrombosis. 2007:, 211-260.
    CrossRef

  988. 988

    Markolf Hanefeld, Nikolaus Marx, Andreas Pfützner, Werner Baurecht, Georg Lübben, Efstrathios Karagiannis, Ulf Stier, Thomas Forst. (2007) Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein. Journal of the American College of Cardiology 49:3, 290-297
    CrossRef

  989. 989

    Irene M. van der Meer, Hok-Hay S. Oei, Albert Hofman, Huibert A.P. Pols, Frank H. de Jong, Jacqueline C.M. Witteman. (2006) Soluble Fas, a mediator of apoptosis, C-reactive protein, and coronary and extracoronary atherosclerosis. Atherosclerosis 189, 464-469
    CrossRef

  990. 990

    Madhusmita Misra, Karen K. Miller, Patrika Tsai, Victoria Stewart, Alison End, Natalie Freed, David B. Herzog, Mark Goldstein, Suzanne Riggs, Anne Klibanski. (2006) Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa. The Journal of Pediatrics 149, 763-769.e1
    CrossRef

  991. 991

    Hemendra Basu, Steven Pernecky, Aditi Sengupta, George U. Liepa. (2006) Coronary heart disease: How do the benefits of ω-3 fatty acids compare with those of aspirin, alcohol/red wine, and statin drugs?. Journal of the American Oil Chemists' Society 83, 985-997
    CrossRef

  992. 992

    Maria L. Canale, Stefano Stroppa, Paolo Caravelli, Anna S. Petronio, Rita Mariotti, Mario Mariani, Alberto Balbarini, Antonio Barsotti. (2006) Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation. Coronary Artery Disease 17, 693-698
    CrossRef

  993. 993

    Rabih R. Azar, Antoine Sarkis, Elie Salameh, Marie-Hélène Gannagé-Yared, Mireille Amm-Azar, Georges Badaoui, Mirna Germanos, Roland Kassab. (2006) Percutaneous coronary intervention increases leptin and decreases adiponectin levels. Clinical Endocrinology 65:10.1111/cen.2006.65.issue-6, 712-716
    CrossRef

  994. 994

    Kazunari Matsumoto, Naruhiro Fujita, Masako Ozaki, Tan Tominaga, Yukitaka Ueki, Seibei Miyake. (2006) Coexistence of insulin resistance and inflammation effectively predicts cardiac disease but not stroke in Japanese patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 74, 316-321
    CrossRef

  995. 995

    , G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1, 103-117
    CrossRef

  996. 996

    Rafea Shaaban, Sabine Kony, Fathi Driss, Bénédicte Leynaert, David Soussan, Isabelle Pin, Françoise Neukirch, Mahmoud Zureik. (2006) Change in C-reactive protein levels and FEV1 decline: A longitudinal population-based study. Respiratory Medicine 100, 2112-2120
    CrossRef

  997. 997

    William Clifford Roberts. (2006) Atherosclerosis: Its Cause and Its Prevention. The American Journal of Cardiology 98:11, 1550-1555
    CrossRef

  998. 998

    Brendan M. Everett, Tobias Kurth, Julie E. Buring, Paul M. Ridker. (2006) The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. Journal of the American College of Cardiology 48:11, 2235-2242
    CrossRef

  999. 999

    Sameer Nagamia, Martin Thoenes, Qamar A Khan, Anbu Pandian, Bobby V Khan. (2006) Potential role of statin therapy in heart failure, atrial fibrillation and aortic stenosis. Future Cardiology 2, 687-693
    CrossRef

  1000. 1000

    AHMAD SAJADIEH, OLAV WENDELBOE NIELSEN, VERNER RASMUSSEN, HANS OLE HEIN, JØRGEN FISCHER HANSEN. (2006) Increased Ventricular Ectopic Activity in Relation to C-Reactive Protein, and NT-Pro-Brain Natriuretic Peptide in Subjects With No Apparent Heart Disease. Pacing and Clinical Electrophysiology 29:10.1111/pace.2006.29.issue-11, 1188-1194
    CrossRef

Letters

Trends

Most Viewed (Last Week)